{
    "filename": "978-3-030-33803-9_6.pdf",
    "content_type": "text/html",
    "file_size": 0,
    "metadata": {
        "identifiers": {
            "doi": "10.1007/978-3-030-33803-9_6",
            "url": "https://dx.doi.org/10.1007/978-3-030-33803-9_6"
        },
        "doi": "10.1007/978-3-030-33803-9_6",
        "author": "Ryan C. Maves, Catherine M. Berjohn",
        "title": "Zoonotic Infections and Biowarfare Agents in Critical Care: Anthrax, Plague, and Tularemia",
        "date": 2020,
        "journal": "Highly Infectious Diseases in Critical Care",
        "abstract": "Bacterial zoonotic infections are rare in developed countries in the twenty-first century but may cause major morbidity and mortality in developing regions of the world. In addition, their potential use as biological weapons makes early recognition and effective empiric therapy important for the critical care practitioner. Anthrax, plague, and tularemia share overlapping presenting syndromes, including fulminant respiratory infections and less severe but still highly morbid lymphocutaneous infections. Although all three may be transmitted as infectious aerosols, only plague has a risk of direct human-to-human transmission. Diagnostic testing will require special precautions for laboratory staff and most often involvement of regional and national reference laboratories. Empiric therapy with aminoglycosides may be life-saving for plague and tularemia, while the treatment of anthrax is complex and varies depending on the site of infection. In outbreaks or for post-exposure prophylaxis, treatment with doxycycline or a fluoroquinolone is recommended for all three diseases.",
        "references": "@article{taylor2001a,\n  author = {Taylor, L.H. and Latham, S.M. and Woolhouse, M.E.},\n  title = {Risk factors for human disease emergence. Philos Trans R Soc Lond Ser},\n  journal = {B Biol Sci},\n  date = {2001},\n  volume = {356},\n  pages = {983\u20139},\n  source = {CrossRefGoogle Scholar},\n  language = {}\n}\n@book{barras2014a,\n  author = {Barras, V. and Greub, G.},\n  title = {History of biological warfare and bioterrorism. Clin Microbiol Infect},\n  date = {2014},\n  volume = {20},\n  pages = {497\u2013502},\n  publisher = {PubMedCrossRefPubMedCentralGoogle Scholar},\n  language = {}\n}\n@article{meselson1994a,\n  author = {Meselson, M. and Guillemin, J. and Hugh-Jones, M.},\n  title = {The Sverdlovsk anthrax outbreak of 1979},\n  journal = {Science},\n  date = {1994},\n  volume = {266},\n  pages = {1202\u20138},\n  publisher = {PubMedCrossRefPubMedCentralGoogle Scholar},\n  more-authors = {true},\n  language = {}\n}\n@book{jaton2014a,\n  author = {Jaton, K. and Greub, G.},\n  title = {Clinical microbiologists facing an anthrax alert. Clin Microbiol Infect},\n  date = {2014},\n  volume = {20},\n  pages = {503\u20136},\n  publisher = {PubMedCrossRefPubMedCentralGoogle Scholar},\n  language = {}\n}\n@incollection{vieira-a,\n  author = {Vieira, A.R. and Salzer, J.S. and Traxler, R.M.},\n  title = {Enhancing surveillance and diagnostics in anthrax-endemic countries. Emerg Infect Dis. 2017; 23},\n  source = {Google Scholar},\n  more-authors = {true},\n  language = {}\n}\n@article{bush2001a,\n  author = {Bush, L.M. and Abrams, B.H. and Beall, A. and Johnson, C.C.},\n  title = {Index case of fatal inhalational anthrax due to bioterrorism in the United States},\n  journal = {N Engl J Med},\n  date = {2001},\n  volume = {345},\n  pages = {1607\u201310},\n  publisher = {PubMedCrossRefPubMedCentralGoogle Scholar},\n  language = {}\n}\n@article{hughes2002a,\n  author = {Hughes, J.M. and Gerberding, J.L.},\n  title = {Anthrax bioterrorism: lessons learned and future directions},\n  journal = {Emerg Infect Dis},\n  date = {2002},\n  volume = {8},\n  pages = {1013\u20134},\n  publisher = {PubMedPubMedCentralCrossRefGoogle Scholar},\n  language = {}\n}\n@incollection{friebe-a,\n  author = {Friebe, S. and van der Goot, F.G. and Burgi, J.},\n  title = {The ins and outs of anthrax toxin. Toxins (Basel). 2016; 8},\n  source = {Google Scholar},\n  language = {}\n}\n@article{adalja2015a,\n  author = {Adalja, A.A. and Toner, E.},\n  title = {Inglesby TV. Clinical management of potential bioterrorism-related conditions},\n  journal = {N Engl J Med},\n  date = {2015},\n  volume = {372},\n  pages = {954\u201362},\n  source = {CrossRefGoogle Scholar},\n  language = {}\n}\n@article{shafazand2003a,\n  author = {Shafazand, S.},\n  title = {When bioterrorism strikes: diagnosis and management of inhalational anthrax},\n  journal = {Semin Respir Infect},\n  date = {2003},\n  volume = {18},\n  pages = {134\u201345},\n  publisher = {PubMedGoogle Scholar},\n  language = {}\n}\n@article{doganay2010a,\n  author = {Doganay, M. and Metan, G. and Alp, E.},\n  title = {A review of cutaneous anthrax and its outcome},\n  journal = {J Infect Public Health},\n  date = {2010},\n  volume = {3},\n  pages = {98\u2013105},\n  publisher = {PubMedCrossRefGoogle Scholar},\n  language = {}\n}\n@book{sirisanthana2002a,\n  author = {Sirisanthana, T. and Brown, A.E.},\n  title = {Anthrax of the gastrointestinal tract. Emerg Infect Dis},\n  date = {2002},\n  volume = {8},\n  pages = {649\u201351},\n  publisher = {PubMedPubMedCentralCrossRefGoogle Scholar},\n  language = {}\n}\n@incollection{purcell2007a,\n  author = {Purcell, B. and Worsham, P. and Friedlander, A.},\n  title = {Anthrax},\n  editor = {Dembek, Z.S.},\n  publisher = {Borden Institute and US Army Office of the Surgeon General},\n  date = {2007},\n  source = {Medical aspects of biological warfare. Falls Church},\n  language = {},\n  address = {VA}\n}\n@article{barakat2002a,\n  author = {Barakat, L.A. and Quentzel, H.L. and Jernigan, J.A.},\n  title = {Fatal inhalational anthrax in a 94-year-old Connecticut woman},\n  journal = {JAMA},\n  date = {2002},\n  volume = {287},\n  pages = {863\u20138},\n  publisher = {PubMedCrossRefGoogle Scholar},\n  more-authors = {true},\n  language = {}\n}\n@incollection{abramova1993a,\n  author = {Abramova, F.A. and Grinberg, L.M. and Yampolskaya, O.V. and Walker, D.H.},\n  title = {Pathology of inhalational anthrax in 42 cases from the Sverdlovsk},\n  booktitle = {outbreak of 1979. Proc Natl Acad Sci},\n  volume = \"U\" # \"90:\",\n  date = {1993},\n  pages = {2291\u20134},\n  publisher = {PubMedPubMedCentralCrossRefGoogle Scholar},\n  unmatched-author = {S A.},\n  unmatched-volume = {90:},\n  language = {}\n}\n@article{bower2015a,\n  author = {Bower, W.A. and Hendricks, K. and Pillai, S.},\n  title = {Clinical framework and medical countermeasure use during an anthrax mass-casualty incident},\n  journal = {MMWR Recomm Rep},\n  date = {2015},\n  volume = {64},\n  pages = {1\u201322},\n  publisher = {PubMedCrossRefGoogle Scholar},\n  more-authors = {true},\n  language = {}\n}\n@article{mayer2001a,\n  author = {Mayer, T.A. and Bersoff-Matcha, S. and Murphy, C.},\n  title = {Clinical presentation of inhalational anthrax following bioterrorism exposure: report of 2 surviving patients},\n  journal = {JAMA},\n  date = {2001},\n  volume = {286},\n  pages = {2549\u201353},\n  publisher = {PubMedCrossRefGoogle Scholar},\n  more-authors = {true},\n  language = {}\n}\n@article{holty2006a,\n  author = {Holty, J.E. and Bravata, D.M. and Liu, H. and Olshen, R.A. and McDonald, K.M. and Owens, D.K.},\n  title = {Systematic review: a century of inhalational anthrax cases from 1900 to 2005},\n  journal = {Ann Intern Med},\n  date = {2006},\n  volume = {144},\n  pages = {270\u201380},\n  publisher = {PubMedCrossRefGoogle Scholar},\n  language = {}\n}\n@article{holty2006b,\n  author = {Holty, J.E. and Kim, R.Y. and Bravata, D.M.},\n  title = {Anthrax: a systematic review of atypical presentations},\n  journal = {Ann Emerg Med},\n  date = {2006},\n  volume = {48},\n  pages = {200\u201311},\n  publisher = {PubMedCrossRefGoogle Scholar},\n  language = {}\n}\n@book{hendricks2014a,\n  author = {Hendricks, K.A. and Wright, M.E. and Shadomy, S.V.},\n  title = {Centers for disease control and prevention expert panel meetings on prevention and treatment of anthrax in adults. Emerg Infect Dis},\n  date = {2014},\n  volume = {20},\n  pages = {130687},\n  publisher = {PubMedCentralCrossRefPubMedGoogle Scholar},\n  more-authors = {true},\n  language = {}\n}\n@article{katharios-lanwermeyer2016a,\n  author = {Katharios-Lanwermeyer, S. and Holty, J.E. and Person, M.},\n  title = {Identifying meningitis during an anthrax mass casualty incident: systematic review of systemic anthrax since 1880},\n  journal = {Clinical Infect Dis},\n  date = {2016},\n  volume = {62},\n  pages = {1537\u201345},\n  source = {CrossRefGoogle Scholar},\n  more-authors = {true},\n  language = {}\n}\n@incollection{meaney-delman2014a,\n  author = {Meaney-Delman, D. and Zotti, M.E. and Creanga, A.A.},\n  title = {Special considerations for prophylaxis for and treatment of anthrax in pregnant and postpartum women. Emerg Infect Dis},\n  date = {2014},\n  source = {Google Scholar},\n  more-authors = {true},\n  language = {}\n}\n@book{bartlett2002a,\n  author = {Bartlett, J.G. and TV, Jr, Inglesby and Borio, L.},\n  title = {Management of anthrax. Clin Infect Dis},\n  date = {2002},\n  volume = {35},\n  pages = {851\u20138},\n  publisher = {PubMedCrossRefGoogle Scholar},\n  language = {}\n}\n@article{inglesby2002a,\n  author = {Inglesby, T.V. and O\u2019Toole, T. and Henderson, D.A.},\n  title = {Anthrax as a biological weapon, 2002: updated recommendations for management},\n  journal = {JAMA},\n  date = {2002},\n  volume = {287},\n  pages = {2236\u201352},\n  publisher = {PubMedCrossRefGoogle Scholar},\n  more-authors = {true},\n  language = {}\n}\n@article{walsh2007a,\n  author = {Walsh, J.J. and Pesik, N. and Quinn, C.P.},\n  title = {A case of naturally acquired inhalation anthrax: clinical care and analyses of anti-protective antigen immunoglobulin G and lethal factor},\n  journal = {Clin Infect Dis},\n  date = {2007},\n  volume = {44},\n  pages = {968\u201371},\n  publisher = {PubMedCrossRefGoogle Scholar},\n  more-authors = {true},\n  language = {}\n}\n@article{klempner2010a,\n  author = {Klempner, M.S. and Talbot, E.A. and Lee, S.I. and Zaki, S. and Ferraro, M.J.},\n  title = {Case records of the Massachusetts General Hospital. Case 25-2010. A 24-year-old woman with abdominal pain and shock},\n  journal = {N Engl J Med},\n  date = {2010},\n  volume = {363},\n  pages = {766\u201377},\n  publisher = {PubMedCrossRefGoogle Scholar},\n  language = {}\n}\n@article{webster2004a,\n  author = {Webster, J.I. and Moayeri, M. and Sternberg, E.M.},\n  title = {Novel repression of the glucocorticoid receptor by anthrax lethal toxin},\n  journal = {Ann N Y Acad Sci},\n  date = {2004},\n  volume = {1024},\n  pages = {9\u201323},\n  publisher = {PubMedCrossRefGoogle Scholar},\n  language = {}\n}\n@article{yamamoto2016a,\n  author = {Yamamoto, B.J. and Shadiack, A.M. and Carpenter, S.},\n  title = {Efficacy projection of obiltoxaximab for treatment of inhalational anthrax across a range of disease severity},\n  journal = {Antimicrob Agents Chemother},\n  date = {2016},\n  volume = {60},\n  pages = {5787\u201395},\n  publisher = {PubMedPubMedCentralCrossRefGoogle Scholar},\n  more-authors = {true},\n  language = {}\n}\n@article{yamamoto2016b,\n  author = {Yamamoto, B.J. and Shadiack, A.M. and Carpenter, S.},\n  title = {Obiltoxaximab prevents disseminated Bacillus anthracis infection and improves survival during pre- and postexposure prophylaxis in animal models of inhalational anthrax},\n  journal = {Antimicrob Agents Chemother},\n  date = {2016},\n  volume = {60},\n  pages = {5796\u2013805},\n  publisher = {PubMedPubMedCentralCrossRefGoogle Scholar},\n  more-authors = {true},\n  language = {}\n}\n@article{migone2015a,\n  author = {Migone, T.S. and Bolmer, S. and Zhong, J.},\n  title = {Added benefit of raxibacumab to antibiotic treatment of inhalational anthrax},\n  journal = {Antimicrob Agents Chemother},\n  date = {2015},\n  volume = {59},\n  pages = {1145\u201351},\n  publisher = {PubMedPubMedCentralCrossRefGoogle Scholar},\n  more-authors = {true},\n  language = {}\n}\n@article{kummerfeldt2014a,\n  author = {Kummerfeldt, C.E.},\n  title = {Raxibacumab: potential role in the treatment of inhalational anthrax},\n  journal = {Infect Drug Resist},\n  date = {2014},\n  volume = {7},\n  pages = {101\u20139},\n  publisher = {PubMedPubMedCentralCrossRefGoogle Scholar},\n  language = {}\n}\n@article{kammanadiminti2014a,\n  author = {Kammanadiminti, S. and Patnaikuni, R.K. and Comer, J. and Meister, G. and Sinclair, C. and Kodihalli, S.},\n  title = {Combination therapy with antibiotics and anthrax immune globulin intravenous (AIGIV) is potentially more effective than antibiotics alone in rabbit model of inhalational anthrax},\n  journal = {PLoS One},\n  date = {2014},\n  volume = {9},\n  pages = {106393},\n  publisher = {PubMedPubMedCentralCrossRefGoogle Scholar},\n  language = {}\n}\n@article{andrianaivoarimanana2013a,\n  author = {Andrianaivoarimanana, V. and Kreppel, K. and Elissa, N.},\n  title = {Understanding the persistence of plague foci in Madagascar},\n  journal = {PLoS Negl Trop Dis},\n  date = {2013},\n  volume = {7},\n  pages = {2382},\n  publisher = {PubMedPubMedCentralCrossRefGoogle Scholar},\n  more-authors = {true},\n  language = {}\n}\n@article{hinnebusch2017a,\n  author = {Hinnebusch, B.J. and Bland, D.M. and Bosio, C.F. and Jarrett, C.O.},\n  title = {Comparative ability of Oropsylla montana and Xenopsylla cheopis fleas to transmit Yersinia pestis by two different mechanisms},\n  journal = {PLoS Negl Trop Dis},\n  date = {2017},\n  volume = {11},\n  pages = {0005276},\n  publisher = {PubMedPubMedCentralCrossRefGoogle Scholar},\n  language = {}\n}\n@article{smego1999a,\n  author = {Smego, R.A. and Frean, J. and Koornhof, H.J.},\n  title = {Yersiniosis I: microbiological and clinicoepidemiological aspects of plague and non-plague Yersinia infections},\n  journal = {Eur J Clin Microbiol Infect Dis},\n  date = {1999},\n  volume = {18},\n  pages = {1\u201315},\n  publisher = {PubMedCrossRefPubMedCentralGoogle Scholar},\n  language = {}\n}\n@article{inglesby2000a,\n  author = {Inglesby, T.V. and Dennis, D.T. and Henderson, D.A.},\n  title = {Plague as a biological weapon: medical and public health managemen. Working Group on Civilian Biodefense t},\n  journal = {JAMA},\n  date = {2000},\n  volume = {283},\n  pages = {2281\u201390},\n  publisher = {PubMedCrossRefGoogle Scholar},\n  more-authors = {true},\n  language = {}\n}\n@incollection{atkinson2016a,\n  author = {Atkinson, S. and Williams, P.},\n  title = {Yersinia virulence factors \u2013 a sophisticated arsenal for combating host defences. F1000Res},\n  date = {2016},\n  source = {CrossRefGoogle Scholar},\n  language = {}\n}\n@article{knirel2012a,\n  author = {Knirel, Y.A. and Anisimov, A.P.},\n  title = {Lipopolysaccharide of Yersinia pestis, the cause of plague: structure, genetics, biological properties},\n  journal = {Acta Nat},\n  date = {2012},\n  volume = {4},\n  pages = {46\u201358},\n  source = {CrossRefGoogle Scholar},\n  language = {}\n}\n@book{khan2004a,\n  author = {Khan, I.A.},\n  title = {Plague: the dreadful visitation occupying the human mind for centuries. Trans R Soc Trop Med Hyg},\n  date = {2004},\n  volume = {98},\n  pages = {270\u20137},\n  publisher = {PubMedCrossRefPubMedCentralGoogle Scholar},\n  language = {}\n}\n@book{andrianaivoarimanana2019a,\n  author = {Andrianaivoarimanana, V. and Piola, P. and Wagner, D.M.},\n  title = {Trends of human plague, Madagascar, 1998\u20132016. Emerg Infect Dis},\n  date = {2019},\n  volume = {25},\n  pages = {220\u20138},\n  publisher = {PubMedPubMedCentralCrossRefGoogle Scholar},\n  more-authors = {true},\n  language = {}\n}\n@article{mead2018a,\n  author = {Mead, P.S.},\n  title = {Plague in Madagascar \u2013 a tragic opportunity for improving public health},\n  journal = {N Engl J Med},\n  date = {2018},\n  volume = {378},\n  pages = {106\u20138},\n  publisher = {PubMedCrossRefGoogle Scholar},\n  language = {}\n}\n@article{christopher1997a,\n  author = {Christopher, G.W. and Cieslak, T.J. and Pavlin, J.A. and EM, Jr, Eitzen},\n  title = {Biological warfare. A historical perspective},\n  journal = {JAMA},\n  date = {1997},\n  volume = {278},\n  pages = {412\u20137},\n  publisher = {PubMedCrossRefGoogle Scholar},\n  language = {}\n}\n@article{kwit2015a,\n  author = {Kwit, N. and Nelson, C. and Kugeler, K.},\n  title = {Human plague - United States, 2015},\n  journal = {MMWR Morb Mortal Wkly Rep},\n  date = {2015},\n  volume = {64},\n  pages = {918\u20139},\n  publisher = {PubMedCrossRefGoogle Scholar},\n  more-authors = {true},\n  language = {}\n}\n@article{crook1992a,\n  author = {Crook, L.D. and Tempest, B.},\n  title = {Plague. A clinical review of 27 cases},\n  journal = {Arch Intern Med},\n  date = {1992},\n  volume = {152},\n  pages = {1253\u20136},\n  publisher = {PubMedCrossRefGoogle Scholar},\n  language = {}\n}\n@article{watson2017a,\n  author = {Watson, A.K. and Ellington, S. and Nelson, C. and Treadwell, T. and Jamieson, D.J. and Meaney-Delman, D.M.},\n  title = {Preparing for biological threats: addressing the needs of pregnant women},\n  journal = {Birth Defects Res},\n  date = {2017},\n  volume = {109},\n  pages = {391\u20138},\n  publisher = {PubMedCrossRefGoogle Scholar},\n  language = {}\n}\n@incollection{wong1986a,\n  author = {Wong, T.W.},\n  title = {Plague in a pregnant patient. Trop Dr},\n  date = {1986},\n  volume = {16},\n  pages = {187\u20139},\n  source = {CrossRefGoogle Scholar},\n  language = {}\n}\n@article{welty1985a,\n  author = {Welty, T.K. and Grabman, J. and Kompare, E.},\n  title = {Nineteen cases of plague in Arizona. A spectrum including ecthyma gangrenosum due to plague and plague in pregnancy},\n  journal = {West J Med},\n  date = {1985},\n  volume = {142},\n  pages = {641\u20136},\n  publisher = {PubMedPubMedCentralGoogle Scholar},\n  more-authors = {true},\n  language = {}\n}\n@article{guinet2015a,\n  author = {Guinet, F. and Ave, P. and Filali, S.},\n  title = {Dissociation of tissue destruction and bacterial expansion during bubonic plague},\n  journal = {PLoS Pathog},\n  date = {2015},\n  volume = {11},\n  pages = {1005222},\n  publisher = {PubMedPubMedCentralCrossRefGoogle Scholar},\n  more-authors = {true},\n  language = {}\n}\n@article{guinet2008a,\n  author = {Guinet, F. and Ave, P. and Jones, L. and Huerre, M. and Carniel, E.},\n  title = {Defective innate cell response and lymph node infiltration specify Yersinia pestis infection},\n  journal = {PLoS One},\n  date = {2008},\n  volume = {3},\n  pages = {1688},\n  publisher = {PubMedPubMedCentralCrossRefGoogle Scholar},\n  language = {}\n}\n@article{sodeinde1992a,\n  author = {Sodeinde, O.A. and Subrahmanyam, Y.V. and Stark, K. and Quan, T. and Bao, Y. and Goguen, J.D.},\n  title = {A surface protease and the invasive character of plague},\n  journal = {Science},\n  date = {1992},\n  volume = {258},\n  pages = {1004\u20137},\n  publisher = {PubMedCrossRefGoogle Scholar},\n  language = {}\n}\n@article{straley1988a,\n  author = {Straley, S.C.},\n  title = {The plasmid-encoded outer-membrane proteins of Yersinia pestis},\n  journal = {Rev Infect Dis},\n  date = {1988},\n  volume = {2},\n  pages = {323\u20136},\n  publisher = {PubMedCrossRefGoogle Scholar},\n  language = {}\n}\n@article{straley1993a,\n  author = {Straley, S.C. and Skrzypek, E. and Plano, G.V. and Bliska, J.B.},\n  title = {Yops of Yersinia spp. pathogenic for humans},\n  journal = {Infect Immun},\n  date = {1993},\n  volume = {61},\n  pages = {3105\u201310},\n  publisher = {PubMedPubMedCentralGoogle Scholar},\n  language = {}\n}\n@article{lemaitre2006a,\n  author = {Lemaitre, N. and Sebbane, F. and Long, D. and Hinnebusch, B.J.},\n  title = {Yersinia pestis YopJ suppresses tumor necrosis factor alpha induction and contributes to apoptosis of immune cells in the lymph node but is not required for virulence in a rat model of bubonic plague},\n  journal = {Infect Immun},\n  date = {2006},\n  volume = {74},\n  pages = {5126\u201331},\n  publisher = {PubMedPubMedCentralCrossRefGoogle Scholar},\n  language = {}\n}\n@article{zhou2006a,\n  author = {Zhou, D. and Han, Y. and Yang, R.},\n  title = {Molecular and physiological insights into plague transmission, virulence and etiology},\n  journal = {Microbes Infect},\n  date = {2006},\n  volume = {8},\n  pages = {273\u201384},\n  publisher = {PubMedCrossRefGoogle Scholar},\n  language = {}\n}\n@article{ketai2007a,\n  author = {Ketai, L.},\n  title = {Tchoyoson Lim CC. Radiology of biological weapons--old and the new?},\n  journal = {Semin Roentgenol},\n  date = {2007},\n  volume = {42},\n  pages = {49\u201359},\n  publisher = {PubMedCrossRefGoogle Scholar},\n  language = {}\n}\n@misc{siegel-a,\n  author = {Siegel, J.D. and Rhinehart, E. and Jackson, M. and Chiarello, L.},\n  title = {the Healthcare Infection Control Practices Advisory Committee. 2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Healthcare Settings},\n  url = {https://www.cdc.gov/infectioncontrol/guidelines/isolation/index.html.},\n  language = {},\n  urldate = {Updated September 2018. online on 11 March 2019}\n}\n@article{pechous2016a,\n  author = {Pechous, R.D. and Sivaraman, V. and Stasulli, N.M. and Goldman, W.E.},\n  title = {Pneumonic plague: the darker side of Yersinia pestis},\n  journal = {Trends Microbiol},\n  date = {2016},\n  volume = {24},\n  pages = {190\u20137},\n  source = {PubMedCrossRefGoogle Scholar},\n  language = {}\n}\n@book{silver2015a,\n  author = {Silver, S.},\n  title = {Laboratory-acquired lethal infections by potential bioweapons pathogens including Ebola in 2014. FEMS Microbiol Lett},\n  date = {2015},\n  volume = {362},\n  pages = {1\u20136},\n  publisher = {PubMedCrossRefGoogle Scholar},\n  language = {}\n}\n@article{kugeler2015a,\n  author = {Kugeler, K.J. and Staples, J.E. and Hinckley, A.F. and Gage, K.L. and Mead, P.S.},\n  title = {Epidemiology of human plague in the United States, 1900\u20132012},\n  journal = {Emerg Infect Dis},\n  date = {2015},\n  volume = {21},\n  pages = {16\u201322},\n  publisher = {PubMedPubMedCentralCrossRefGoogle Scholar},\n  language = {}\n}\n@book{forrester2017a,\n  author = {Forrester, J.D. and Apangu, T. and Griffith, K.},\n  title = {Patterns of human plague in Uganda, 2008\u20132016. Emerg Infect Dis},\n  date = {2017},\n  volume = {23},\n  pages = {1517\u201321},\n  publisher = {PubMedPubMedCentralCrossRefGoogle Scholar},\n  more-authors = {true},\n  language = {}\n}\n@article{hull1987a,\n  author = {Hull, H.F. and Montes, J.M. and Mann, J.M.},\n  title = {Septicemic plague in New Mexico},\n  journal = {J Infect Dis},\n  date = {1987},\n  volume = {155},\n  pages = {113\u20138},\n  publisher = {PubMedCrossRefGoogle Scholar},\n  language = {}\n}\n@article{tourdjman2012a,\n  author = {Tourdjman, M. and Ibraheem, M. and Brett, M.},\n  title = {Misidentification of Yersinia pestis by automated systems, resulting in delayed diagnoses of human plague infections--Oregon and New Mexico, 2010\u20132011},\n  journal = {Clin Infect Dis},\n  date = {2012},\n  volume = {55},\n  pages = {58\u201360},\n  publisher = {PubMedCrossRefGoogle Scholar},\n  more-authors = {true},\n  language = {}\n}\n@article{demeure2019a,\n  author = {Demeure, C.E. and Dussurget, O. and Mas Fiol, G. and Le Guern, A.S. and Savin, C. and Pizarro-Cerda, J.},\n  title = {Yersinia pestis and plague: an updated view on evolution, virulence determinants, immune subversion, vaccination, and diagnostics},\n  journal = {Genes Immun},\n  date = {2019},\n  volume = {20},\n  pages = {357},\n  publisher = {PubMedPubMedCentralCrossRefGoogle Scholar},\n  language = {}\n}\n@article{koirala2006a,\n  author = {Koirala, J.},\n  title = {Plague: disease, management, and recognition of act of terrorism},\n  journal = {Infect Dis Clin N Am},\n  date = {2006},\n  volume = {20},\n  pages = {273\u201387},\n  source = {CrossRefGoogle Scholar},\n  language = {}\n}\n@article{mwengee2006a,\n  author = {Mwengee, W. and Butler, T. and Mgema, S. and Mhina, G. and Almasi, Y. and Bradley, C. and Formanik, J.B. and Rochester, C.G.},\n  title = {Treatment of plague with gentamicin or doxycycline in a randomized clinical trial in Tanzania},\n  journal = {Clin Infect Dis},\n  date = {2006},\n  volume = {42},\n  pages = {614\u201321},\n  publisher = {PubMedCrossRefGoogle Scholar},\n  number = {5},\n  language = {}\n}\n@article{russell1998a,\n  author = {Russell, P. and Eley, S.M. and Green, M.},\n  title = {Efficacy of doxycycline and ciprofloxacin against experimental Yersinia pestis infection},\n  journal = {J Antimicrob Chemother},\n  date = {1998},\n  volume = {41},\n  pages = {301\u20135},\n  publisher = {PubMedCrossRefGoogle Scholar},\n  more-authors = {true},\n  language = {}\n}\n@article{steward2004a,\n  author = {Steward, J. and Lever, M.S. and Russell, P.},\n  title = {Efficacy of the latest fluoroquinolones against experimental Yersinia pestis},\n  journal = {Int J Antimicrob Agents},\n  date = {2004},\n  volume = {24},\n  pages = {609\u201312},\n  source = {PubMedCrossRefGoogle Scholar},\n  more-authors = {true},\n  language = {}\n}\n@article{heine2015a,\n  author = {Heine, H.S. and Hershfield, J. and Marchand, C.},\n  title = {In vitro antibiotic susceptibilities of Yersinia pestis determined by broth microdilution following CLSI methods},\n  journal = {Antimicrob Agents Chemother},\n  date = {2015},\n  volume = {59},\n  pages = {1919\u201321},\n  publisher = {PubMedPubMedCentralCrossRefGoogle Scholar},\n  more-authors = {true},\n  language = {}\n}\n@article{wendte2011a,\n  author = {Wendte, J.M. and Ponnusamy, D. and Reiber, D. and Blair, J.L. and Clinkenbeard, K.D.},\n  title = {In vitro efficacy of antibiotics commonly used to treat human plague against intracellular Yersinia pestis},\n  journal = {Antimicrob Agents Chemother},\n  date = {2011},\n  volume = {55},\n  pages = {3752\u20137},\n  publisher = {PubMedPubMedCentralCrossRefGoogle Scholar},\n  language = {}\n}\n@article{levy2016a,\n  author = {Levy, Y. and Vagima, Y. and Tidhar, A.},\n  title = {Adjunctive corticosteroid treatment against Yersinia pestis improves bacterial clearance, immunopathology, and survival in the mouse model of bubonic plague},\n  journal = {J Infect Dis},\n  date = {2016},\n  volume = {214},\n  pages = {970\u20137},\n  publisher = {PubMedCrossRefPubMedCentralGoogle Scholar},\n  more-authors = {true},\n  language = {}\n}\n@article{heine2014a,\n  author = {Heine, H.S. and Louie, A. and Adamovicz, J.J.},\n  title = {Evaluation of imipenem for prophylaxis and therapy of Yersinia pestis delivered by aerosol in a mouse model of pneumonic plague},\n  journal = {Antimicrob Agents Chemother},\n  date = {2014},\n  volume = {58},\n  pages = {3276\u201384},\n  publisher = {PubMedPubMedCentralCrossRefGoogle Scholar},\n  more-authors = {true},\n  language = {}\n}\n@article{inglesby2000b,\n  author = {Inglesby, T.V. and Henderson, D.A. and O\u2019Toole, T. and Dennis, D.T.},\n  title = {Safety precautions to limit exposure from plague-infected patients},\n  journal = {JAMA},\n  date = {2000},\n  volume = {284},\n  pages = {1648\u20139},\n  publisher = {PubMedCrossRefPubMedCentralGoogle Scholar},\n  language = {}\n}\n@incollection{siegel2007a,\n  author = {Siegel, J.D. and Rhinehart, E. and Jackson, M. and Chiarello, L.},\n  title = {the Healthcare infection Control Practices Advisory Committee. 2007 Guideline for isolation precautions: preventing transmission of infectious agents in healthcare settings},\n  publisher = {Centers for Disease Control and Prevention},\n  date = {2007},\n  source = {Google Scholar},\n  language = {},\n  address = {Atlanta}\n}\n@article{hepburn2008a,\n  author = {Hepburn, M.J. and Simpson, A.J.},\n  title = {Tularemia: current diagnosis and treatment options},\n  journal = {Expert Rev Anti-Infect Ther},\n  date = {2008},\n  volume = {6},\n  pages = {231\u201340},\n  publisher = {PubMedCrossRefPubMedCentralGoogle Scholar},\n  language = {}\n}\n@book{balali-mood2013a,\n  author = {Balali-Mood, M. and Moshiri, M. and Etemad, L.},\n  title = {Medical aspects of bio-terrorism. Toxicon},\n  date = {2013},\n  volume = {69},\n  pages = {131\u201342},\n  publisher = {PubMedCrossRefPubMedCentralGoogle Scholar},\n  language = {}\n}\n@article{unknown2013a,\n  title = {Tularemia \u2013 United States, 2001\u20132010},\n  journal = {MMWR Morb Mortal Wkly Rep},\n  date = {2013},\n  volume = {62},\n  pages = {963\u20136},\n  source = {Google Scholar},\n  language = {},\n  organization = {Centers for Disease C, Prevention}\n}\n@book{maurin2016a,\n  author = {Maurin, M. and Gyuranecz, M.},\n  title = {Tularaemia: clinical aspects in Europe. Lancet Infect Dis},\n  date = {2016},\n  volume = {16},\n  pages = {113\u201324},\n  publisher = {PubMedCrossRefGoogle Scholar},\n  language = {}\n}\n@article{vayrynen2017a,\n  author = {Vayrynen, S.A. and Saarela, E. and Henry, J. and Lahti, S. and Harju, T. and Kauma, H.},\n  title = {Pneumonic tularaemia: experience of 58 cases from 2000 to 2012 in Northern Finland},\n  journal = {Infect Dis (Lond)},\n  date = {2017},\n  volume = {49},\n  pages = {758\u201364},\n  source = {CrossRefGoogle Scholar},\n  language = {}\n}\n@article{dennis2001a,\n  author = {Dennis, D.T. and Inglesby, T.V. and Henderson, D.A.},\n  title = {Tularemia as a biological weapon: medical and public health management},\n  journal = {JAMA},\n  date = {2001},\n  volume = {285},\n  pages = {2763\u201373},\n  publisher = {PubMedCrossRefGoogle Scholar},\n  more-authors = {true},\n  language = {}\n}\n@article{rubin1978a,\n  author = {Rubin, S.A.},\n  title = {Radiographic spectrum of pleuropulmonary tularemia},\n  journal = {AJR Am J Roentgenol},\n  date = {1978},\n  volume = {131},\n  pages = {277\u201381},\n  publisher = {PubMedCrossRefGoogle Scholar},\n  language = {}\n}\n@article{yanes2018a,\n  author = {Yanes, H. and Hennebique, A. and Pelloux, I.},\n  title = {Evaluation of in-house and commercial serological tests for diagnosis of human tularemia},\n  journal = {J Clin Microbiol},\n  date = {2018},\n  source = {Google Scholar},\n  more-authors = {true},\n  language = {}\n}\n@article{chaignat2014a,\n  author = {Chaignat, V. and Djordjevic-Spasic, M. and Ruettger, A.},\n  title = {Performance of seven serological assays for diagnosing tularemia},\n  journal = {BMC Infect Dis},\n  date = {2014},\n  volume = {14},\n  pages = {234},\n  publisher = {PubMedPubMedCentralCrossRefGoogle Scholar},\n  more-authors = {true},\n  language = {}\n}\n@article{kilic2012a,\n  author = {Kilic, S. and Celebi, B. and Yesilyurt, M.},\n  title = {Evaluation of a commercial immunochromatographic assay for the serologic diagnosis of tularemia},\n  journal = {Diagn Microbiol Infect Dis},\n  date = {2012},\n  volume = {74},\n  pages = {1\u20135},\n  publisher = {PubMedCrossRefGoogle Scholar},\n  language = {}\n}\n@article{gunnell2012a,\n  author = {Gunnell, M.K. and Lovelace, C.D. and Satterfield, B.A. and Moore, E.A. and O\u2019Neill, K.L. and Robison, R.A.},\n  title = {A multiplex real-time PCR assay for the detection and differentiation of Francisella tularensis subspecies},\n  journal = {J Med Microbiol},\n  date = {2012},\n  volume = {61},\n  pages = {1525\u201331},\n  publisher = {PubMedCrossRefGoogle Scholar},\n  language = {}\n}\n@article{yapar2016a,\n  author = {Yapar, D. and Erenler, A.K. and Terzi, O. and Akdogan, O. and Ece, Y. and Baykam, N.},\n  title = {Predicting tularemia with clinical, laboratory and demographical findings in the},\n  journal = {ED. Am J Emerg Med},\n  date = {2016},\n  volume = {34},\n  pages = {218\u201321},\n  publisher = {PubMedCrossRefGoogle Scholar},\n  language = {}\n}\n@book{mulligan2017a,\n  author = {Mulligan, M.J. and Stapleton, J.T. and Keitel, W.A.},\n  title = {Tularemia vaccine: safety, reactogenicity, \u201cTake\u201d skin reactions, and antibody responses following vaccination with a new lot of the Francisella tularensis live vaccine strain \u2013 a phase 2 randomized clinical Trial. Vaccine},\n  date = {2017},\n  volume = {35},\n  pages = {4730\u20137},\n  publisher = {PubMedPubMedCentralCrossRefGoogle Scholar},\n  more-authors = {true},\n  language = {}\n}\n@article{todd2015a,\n  author = {Todd, SR, Dahlgren and FS, Traeger and MS, Beltr\u00e1n-Aguilar and ED, Marianos and DW, Hamilton and C, McQuiston and JH, Regan and J.J.},\n  title = {No visible dental staining in children treated with doxycycline for suspected Rocky Mountain spotted fever},\n  journal = {J Pediatr},\n  date = {2015},\n  volume = {16},\n  pages = {1246\u201351},\n  source = {CrossRefGoogle Scholar},\n  number = {5},\n  language = {}\n}\n@article{boulanger2004a,\n  author = {Boulanger, L.L. and Ettestad, P. and Fogarty, J.D. and Dennis, D.T. and Romig, D. and Mertz, G.},\n  title = {Gentamicin and tetracyclines for the treatment of human plague: review of 75 cases in New Mexico, 1985\u20131999},\n  journal = {Clin Infect Dis},\n  date = {2004},\n  volume = {38},\n  pages = {663\u20139},\n  publisher = {PubMedCrossRefGoogle Scholar},\n  number = {5},\n  language = {}\n}\n",
        "pages": "97-118",
        "references_ris": "TY  - JOUR\nAU  - Taylor, L.H.\nAU  - Latham, S.M.\nAU  - Woolhouse, M.E.\nTI  - Risk factors for human disease emergence. Philos Trans R Soc Lond Ser\nT2  - B Biol Sci\nPY  - 2001\nDA  - 2001\nVL  - 356\nSP  - 983\nEP  - 9\nT2  - CrossRefGoogle Scholar\nLA  - \nER  - \n\nTY  - BOOK\nAU  - Barras, V.\nAU  - Greub, G.\nTI  - History of biological warfare and bioterrorism. Clin Microbiol Infect\nPY  - 2014\nDA  - 2014\nVL  - 20\nSP  - 497\nEP  - 502\nPB  - PubMedCrossRefPubMedCentralGoogle Scholar\nLA  - \nER  - \n\nTY  - JOUR\nAU  - Meselson, M.\nAU  - Guillemin, J.\nAU  - Hugh-Jones, M.\nTI  - The Sverdlovsk anthrax outbreak of 1979\nT2  - Science\nPY  - 1994\nDA  - 1994\nVL  - 266\nSP  - 1202\nEP  - 8\nPB  - PubMedCrossRefPubMedCentralGoogle Scholar\nC1  - true\nLA  - \nER  - \n\nTY  - BOOK\nAU  - Jaton, K.\nAU  - Greub, G.\nTI  - Clinical microbiologists facing an anthrax alert. Clin Microbiol Infect\nPY  - 2014\nDA  - 2014\nVL  - 20\nSP  - 503\nEP  - 6\nPB  - PubMedCrossRefPubMedCentralGoogle Scholar\nLA  - \nER  - \n\nTY  - CHAP\nAU  - Vieira, A.R.\nAU  - Salzer, J.S.\nAU  - Traxler, R.M.\nTI  - Enhancing surveillance and diagnostics in anthrax-endemic countries. Emerg Infect Dis. 2017; 23\nT2  - Google Scholar\nC1  - true\nLA  - \nER  - \n\nTY  - JOUR\nAU  - Bush, L.M.\nAU  - Abrams, B.H.\nAU  - Beall, A.\nAU  - Johnson, C.C.\nTI  - Index case of fatal inhalational anthrax due to bioterrorism in the United States\nT2  - N Engl J Med\nPY  - 2001\nDA  - 2001\nVL  - 345\nSP  - 1607\nEP  - 10\nPB  - PubMedCrossRefPubMedCentralGoogle Scholar\nLA  - \nER  - \n\nTY  - JOUR\nAU  - Hughes, J.M.\nAU  - Gerberding, J.L.\nTI  - Anthrax bioterrorism: lessons learned and future directions\nT2  - Emerg Infect Dis\nPY  - 2002\nDA  - 2002\nVL  - 8\nSP  - 1013\nEP  - 4\nPB  - PubMedPubMedCentralCrossRefGoogle Scholar\nLA  - \nER  - \n\nTY  - CHAP\nAU  - Friebe, S.\nAU  - van der Goot, F.G.\nAU  - Burgi, J.\nTI  - The ins and outs of anthrax toxin. Toxins (Basel). 2016; 8\nT2  - Google Scholar\nLA  - \nER  - \n\nTY  - JOUR\nAU  - Adalja, A.A.\nAU  - Toner, E.\nTI  - Inglesby TV. Clinical management of potential bioterrorism-related conditions\nT2  - N Engl J Med\nPY  - 2015\nDA  - 2015\nVL  - 372\nSP  - 954\nEP  - 62\nT2  - CrossRefGoogle Scholar\nLA  - \nER  - \n\nTY  - JOUR\nAU  - Shafazand, S.\nTI  - When bioterrorism strikes: diagnosis and management of inhalational anthrax\nT2  - Semin Respir Infect\nPY  - 2003\nDA  - 2003\nVL  - 18\nSP  - 134\nEP  - 45\nPB  - PubMedGoogle Scholar\nLA  - \nER  - \n\nTY  - JOUR\nAU  - Doganay, M.\nAU  - Metan, G.\nAU  - Alp, E.\nTI  - A review of cutaneous anthrax and its outcome\nT2  - J Infect Public Health\nPY  - 2010\nDA  - 2010\nVL  - 3\nSP  - 98\nEP  - 105\nPB  - PubMedCrossRefGoogle Scholar\nLA  - \nER  - \n\nTY  - BOOK\nAU  - Sirisanthana, T.\nAU  - Brown, A.E.\nTI  - Anthrax of the gastrointestinal tract. Emerg Infect Dis\nPY  - 2002\nDA  - 2002\nVL  - 8\nSP  - 649\nEP  - 51\nPB  - PubMedPubMedCentralCrossRefGoogle Scholar\nLA  - \nER  - \n\nTY  - CHAP\nAU  - Purcell, B.\nAU  - Worsham, P.\nAU  - Friedlander, A.\nTI  - Anthrax\nA2  - Dembek, Z.S.\nPB  - Borden Institute and US Army Office of the Surgeon General\nPY  - 2007\nDA  - 2007\nT2  - Medical aspects of biological warfare. Falls Church\nLA  - \nCY  - VA\nER  - \n\nTY  - JOUR\nAU  - Barakat, L.A.\nAU  - Quentzel, H.L.\nAU  - Jernigan, J.A.\nTI  - Fatal inhalational anthrax in a 94-year-old Connecticut woman\nT2  - JAMA\nPY  - 2002\nDA  - 2002\nVL  - 287\nSP  - 863\nEP  - 8\nPB  - PubMedCrossRefGoogle Scholar\nC1  - true\nLA  - \nER  - \n\nTY  - CHAP\nAU  - Abramova, F.A.\nAU  - Grinberg, L.M.\nAU  - Yampolskaya, O.V.\nAU  - Walker, D.H.\nTI  - Pathology of inhalational anthrax in 42 cases from the Sverdlovsk\nT2  - outbreak of 1979. Proc Natl Acad Sci\nVL  - \"U\" # \"90:\"\nPY  - 1993\nDA  - 1993\nSP  - 2291\nEP  - 4\nPB  - PubMedPubMedCentralCrossRefGoogle Scholar\nC1  - S A.\nC1  - 90:\nLA  - \nER  - \n\nTY  - JOUR\nAU  - Bower, W.A.\nAU  - Hendricks, K.\nAU  - Pillai, S.\nTI  - Clinical framework and medical countermeasure use during an anthrax mass-casualty incident\nT2  - MMWR Recomm Rep\nPY  - 2015\nDA  - 2015\nVL  - 64\nSP  - 1\nEP  - 22\nPB  - PubMedCrossRefGoogle Scholar\nC1  - true\nLA  - \nER  - \n\nTY  - JOUR\nAU  - Mayer, T.A.\nAU  - Bersoff-Matcha, S.\nAU  - Murphy, C.\nTI  - Clinical presentation of inhalational anthrax following bioterrorism exposure: report of 2 surviving patients\nT2  - JAMA\nPY  - 2001\nDA  - 2001\nVL  - 286\nSP  - 2549\nEP  - 53\nPB  - PubMedCrossRefGoogle Scholar\nC1  - true\nLA  - \nER  - \n\nTY  - JOUR\nAU  - Holty, J.E.\nAU  - Bravata, D.M.\nAU  - Liu, H.\nAU  - Olshen, R.A.\nAU  - McDonald, K.M.\nAU  - Owens, D.K.\nTI  - Systematic review: a century of inhalational anthrax cases from 1900 to 2005\nT2  - Ann Intern Med\nPY  - 2006\nDA  - 2006\nVL  - 144\nSP  - 270\nEP  - 80\nPB  - PubMedCrossRefGoogle Scholar\nLA  - \nER  - \n\nTY  - JOUR\nAU  - Holty, J.E.\nAU  - Kim, R.Y.\nAU  - Bravata, D.M.\nTI  - Anthrax: a systematic review of atypical presentations\nT2  - Ann Emerg Med\nPY  - 2006\nDA  - 2006\nVL  - 48\nSP  - 200\nEP  - 11\nPB  - PubMedCrossRefGoogle Scholar\nLA  - \nER  - \n\nTY  - BOOK\nAU  - Hendricks, K.A.\nAU  - Wright, M.E.\nAU  - Shadomy, S.V.\nTI  - Centers for disease control and prevention expert panel meetings on prevention and treatment of anthrax in adults. Emerg Infect Dis\nPY  - 2014\nDA  - 2014\nVL  - 20\nSP  - 130687\nPB  - PubMedCentralCrossRefPubMedGoogle Scholar\nC1  - true\nLA  - \nER  - \n\nTY  - JOUR\nAU  - Katharios-Lanwermeyer, S.\nAU  - Holty, J.E.\nAU  - Person, M.\nTI  - Identifying meningitis during an anthrax mass casualty incident: systematic review of systemic anthrax since 1880\nT2  - Clinical Infect Dis\nPY  - 2016\nDA  - 2016\nVL  - 62\nSP  - 1537\nEP  - 45\nT2  - CrossRefGoogle Scholar\nC1  - true\nLA  - \nER  - \n\nTY  - CHAP\nAU  - Meaney-Delman, D.\nAU  - Zotti, M.E.\nAU  - Creanga, A.A.\nTI  - Special considerations for prophylaxis for and treatment of anthrax in pregnant and postpartum women. Emerg Infect Dis\nPY  - 2014\nDA  - 2014\nT2  - Google Scholar\nC1  - true\nLA  - \nER  - \n\nTY  - BOOK\nAU  - Bartlett, J.G.\nAU  - TV, Jr, Inglesby\nAU  - Borio, L.\nTI  - Management of anthrax. Clin Infect Dis\nPY  - 2002\nDA  - 2002\nVL  - 35\nSP  - 851\nEP  - 8\nPB  - PubMedCrossRefGoogle Scholar\nLA  - \nER  - \n\nTY  - JOUR\nAU  - Inglesby, T.V.\nAU  - O\u2019Toole, T.\nAU  - Henderson, D.A.\nTI  - Anthrax as a biological weapon, 2002: updated recommendations for management\nT2  - JAMA\nPY  - 2002\nDA  - 2002\nVL  - 287\nSP  - 2236\nEP  - 52\nPB  - PubMedCrossRefGoogle Scholar\nC1  - true\nLA  - \nER  - \n\nTY  - JOUR\nAU  - Walsh, J.J.\nAU  - Pesik, N.\nAU  - Quinn, C.P.\nTI  - A case of naturally acquired inhalation anthrax: clinical care and analyses of anti-protective antigen immunoglobulin G and lethal factor\nT2  - Clin Infect Dis\nPY  - 2007\nDA  - 2007\nVL  - 44\nSP  - 968\nEP  - 71\nPB  - PubMedCrossRefGoogle Scholar\nC1  - true\nLA  - \nER  - \n\nTY  - JOUR\nAU  - Klempner, M.S.\nAU  - Talbot, E.A.\nAU  - Lee, S.I.\nAU  - Zaki, S.\nAU  - Ferraro, M.J.\nTI  - Case records of the Massachusetts General Hospital. Case 25-2010. A 24-year-old woman with abdominal pain and shock\nT2  - N Engl J Med\nPY  - 2010\nDA  - 2010\nVL  - 363\nSP  - 766\nEP  - 77\nPB  - PubMedCrossRefGoogle Scholar\nLA  - \nER  - \n\nTY  - JOUR\nAU  - Webster, J.I.\nAU  - Moayeri, M.\nAU  - Sternberg, E.M.\nTI  - Novel repression of the glucocorticoid receptor by anthrax lethal toxin\nT2  - Ann N Y Acad Sci\nPY  - 2004\nDA  - 2004\nVL  - 1024\nSP  - 9\nEP  - 23\nPB  - PubMedCrossRefGoogle Scholar\nLA  - \nER  - \n\nTY  - JOUR\nAU  - Yamamoto, B.J.\nAU  - Shadiack, A.M.\nAU  - Carpenter, S.\nTI  - Efficacy projection of obiltoxaximab for treatment of inhalational anthrax across a range of disease severity\nT2  - Antimicrob Agents Chemother\nPY  - 2016\nDA  - 2016\nVL  - 60\nSP  - 5787\nEP  - 95\nPB  - PubMedPubMedCentralCrossRefGoogle Scholar\nC1  - true\nLA  - \nER  - \n\nTY  - JOUR\nAU  - Yamamoto, B.J.\nAU  - Shadiack, A.M.\nAU  - Carpenter, S.\nTI  - Obiltoxaximab prevents disseminated Bacillus anthracis infection and improves survival during pre- and postexposure prophylaxis in animal models of inhalational anthrax\nT2  - Antimicrob Agents Chemother\nPY  - 2016\nDA  - 2016\nVL  - 60\nSP  - 5796\nEP  - 805\nPB  - PubMedPubMedCentralCrossRefGoogle Scholar\nC1  - true\nLA  - \nER  - \n\nTY  - JOUR\nAU  - Migone, T.S.\nAU  - Bolmer, S.\nAU  - Zhong, J.\nTI  - Added benefit of raxibacumab to antibiotic treatment of inhalational anthrax\nT2  - Antimicrob Agents Chemother\nPY  - 2015\nDA  - 2015\nVL  - 59\nSP  - 1145\nEP  - 51\nPB  - PubMedPubMedCentralCrossRefGoogle Scholar\nC1  - true\nLA  - \nER  - \n\nTY  - JOUR\nAU  - Kummerfeldt, C.E.\nTI  - Raxibacumab: potential role in the treatment of inhalational anthrax\nT2  - Infect Drug Resist\nPY  - 2014\nDA  - 2014\nVL  - 7\nSP  - 101\nEP  - 9\nPB  - PubMedPubMedCentralCrossRefGoogle Scholar\nLA  - \nER  - \n\nTY  - JOUR\nAU  - Kammanadiminti, S.\nAU  - Patnaikuni, R.K.\nAU  - Comer, J.\nAU  - Meister, G.\nAU  - Sinclair, C.\nAU  - Kodihalli, S.\nTI  - Combination therapy with antibiotics and anthrax immune globulin intravenous (AIGIV) is potentially more effective than antibiotics alone in rabbit model of inhalational anthrax\nT2  - PLoS One\nPY  - 2014\nDA  - 2014\nVL  - 9\nSP  - 106393\nPB  - PubMedPubMedCentralCrossRefGoogle Scholar\nLA  - \nER  - \n\nTY  - JOUR\nAU  - Andrianaivoarimanana, V.\nAU  - Kreppel, K.\nAU  - Elissa, N.\nTI  - Understanding the persistence of plague foci in Madagascar\nT2  - PLoS Negl Trop Dis\nPY  - 2013\nDA  - 2013\nVL  - 7\nSP  - 2382\nPB  - PubMedPubMedCentralCrossRefGoogle Scholar\nC1  - true\nLA  - \nER  - \n\nTY  - JOUR\nAU  - Hinnebusch, B.J.\nAU  - Bland, D.M.\nAU  - Bosio, C.F.\nAU  - Jarrett, C.O.\nTI  - Comparative ability of Oropsylla montana and Xenopsylla cheopis fleas to transmit Yersinia pestis by two different mechanisms\nT2  - PLoS Negl Trop Dis\nPY  - 2017\nDA  - 2017\nVL  - 11\nSP  - 0005276\nPB  - PubMedPubMedCentralCrossRefGoogle Scholar\nLA  - \nER  - \n\nTY  - JOUR\nAU  - Smego, R.A.\nAU  - Frean, J.\nAU  - Koornhof, H.J.\nTI  - Yersiniosis I: microbiological and clinicoepidemiological aspects of plague and non-plague Yersinia infections\nT2  - Eur J Clin Microbiol Infect Dis\nPY  - 1999\nDA  - 1999\nVL  - 18\nSP  - 1\nEP  - 15\nPB  - PubMedCrossRefPubMedCentralGoogle Scholar\nLA  - \nER  - \n\nTY  - JOUR\nAU  - Inglesby, T.V.\nAU  - Dennis, D.T.\nAU  - Henderson, D.A.\nTI  - Plague as a biological weapon: medical and public health managemen. Working Group on Civilian Biodefense t\nT2  - JAMA\nPY  - 2000\nDA  - 2000\nVL  - 283\nSP  - 2281\nEP  - 90\nPB  - PubMedCrossRefGoogle Scholar\nC1  - true\nLA  - \nER  - \n\nTY  - CHAP\nAU  - Atkinson, S.\nAU  - Williams, P.\nTI  - Yersinia virulence factors \u2013 a sophisticated arsenal for combating host defences. F1000Res\nPY  - 2016\nDA  - 2016\nT2  - CrossRefGoogle Scholar\nLA  - \nER  - \n\nTY  - JOUR\nAU  - Knirel, Y.A.\nAU  - Anisimov, A.P.\nTI  - Lipopolysaccharide of Yersinia pestis, the cause of plague: structure, genetics, biological properties\nT2  - Acta Nat\nPY  - 2012\nDA  - 2012\nVL  - 4\nSP  - 46\nEP  - 58\nT2  - CrossRefGoogle Scholar\nLA  - \nER  - \n\nTY  - BOOK\nAU  - Khan, I.A.\nTI  - Plague: the dreadful visitation occupying the human mind for centuries. Trans R Soc Trop Med Hyg\nPY  - 2004\nDA  - 2004\nVL  - 98\nSP  - 270\nEP  - 7\nPB  - PubMedCrossRefPubMedCentralGoogle Scholar\nLA  - \nER  - \n\nTY  - BOOK\nAU  - Andrianaivoarimanana, V.\nAU  - Piola, P.\nAU  - Wagner, D.M.\nTI  - Trends of human plague, Madagascar, 1998\u20132016. Emerg Infect Dis\nPY  - 2019\nDA  - 2019\nVL  - 25\nSP  - 220\nEP  - 8\nPB  - PubMedPubMedCentralCrossRefGoogle Scholar\nC1  - true\nLA  - \nER  - \n\nTY  - JOUR\nAU  - Mead, P.S.\nTI  - Plague in Madagascar \u2013 a tragic opportunity for improving public health\nT2  - N Engl J Med\nPY  - 2018\nDA  - 2018\nVL  - 378\nSP  - 106\nEP  - 8\nPB  - PubMedCrossRefGoogle Scholar\nLA  - \nER  - \n\nTY  - JOUR\nAU  - Christopher, G.W.\nAU  - Cieslak, T.J.\nAU  - Pavlin, J.A.\nAU  - EM, Jr, Eitzen\nTI  - Biological warfare. A historical perspective\nT2  - JAMA\nPY  - 1997\nDA  - 1997\nVL  - 278\nSP  - 412\nEP  - 7\nPB  - PubMedCrossRefGoogle Scholar\nLA  - \nER  - \n\nTY  - JOUR\nAU  - Kwit, N.\nAU  - Nelson, C.\nAU  - Kugeler, K.\nTI  - Human plague - United States, 2015\nT2  - MMWR Morb Mortal Wkly Rep\nPY  - 2015\nDA  - 2015\nVL  - 64\nSP  - 918\nEP  - 9\nPB  - PubMedCrossRefGoogle Scholar\nC1  - true\nLA  - \nER  - \n\nTY  - JOUR\nAU  - Crook, L.D.\nAU  - Tempest, B.\nTI  - Plague. A clinical review of 27 cases\nT2  - Arch Intern Med\nPY  - 1992\nDA  - 1992\nVL  - 152\nSP  - 1253\nEP  - 6\nPB  - PubMedCrossRefGoogle Scholar\nLA  - \nER  - \n\nTY  - JOUR\nAU  - Watson, A.K.\nAU  - Ellington, S.\nAU  - Nelson, C.\nAU  - Treadwell, T.\nAU  - Jamieson, D.J.\nAU  - Meaney-Delman, D.M.\nTI  - Preparing for biological threats: addressing the needs of pregnant women\nT2  - Birth Defects Res\nPY  - 2017\nDA  - 2017\nVL  - 109\nSP  - 391\nEP  - 8\nPB  - PubMedCrossRefGoogle Scholar\nLA  - \nER  - \n\nTY  - CHAP\nAU  - Wong, T.W.\nTI  - Plague in a pregnant patient. Trop Dr\nPY  - 1986\nDA  - 1986\nVL  - 16\nSP  - 187\nEP  - 9\nT2  - CrossRefGoogle Scholar\nLA  - \nER  - \n\nTY  - JOUR\nAU  - Welty, T.K.\nAU  - Grabman, J.\nAU  - Kompare, E.\nTI  - Nineteen cases of plague in Arizona. A spectrum including ecthyma gangrenosum due to plague and plague in pregnancy\nT2  - West J Med\nPY  - 1985\nDA  - 1985\nVL  - 142\nSP  - 641\nEP  - 6\nPB  - PubMedPubMedCentralGoogle Scholar\nC1  - true\nLA  - \nER  - \n\nTY  - JOUR\nAU  - Guinet, F.\nAU  - Ave, P.\nAU  - Filali, S.\nTI  - Dissociation of tissue destruction and bacterial expansion during bubonic plague\nT2  - PLoS Pathog\nPY  - 2015\nDA  - 2015\nVL  - 11\nSP  - 1005222\nPB  - PubMedPubMedCentralCrossRefGoogle Scholar\nC1  - true\nLA  - \nER  - \n\nTY  - JOUR\nAU  - Guinet, F.\nAU  - Ave, P.\nAU  - Jones, L.\nAU  - Huerre, M.\nAU  - Carniel, E.\nTI  - Defective innate cell response and lymph node infiltration specify Yersinia pestis infection\nT2  - PLoS One\nPY  - 2008\nDA  - 2008\nVL  - 3\nSP  - 1688\nPB  - PubMedPubMedCentralCrossRefGoogle Scholar\nLA  - \nER  - \n\nTY  - JOUR\nAU  - Sodeinde, O.A.\nAU  - Subrahmanyam, Y.V.\nAU  - Stark, K.\nAU  - Quan, T.\nAU  - Bao, Y.\nAU  - Goguen, J.D.\nTI  - A surface protease and the invasive character of plague\nT2  - Science\nPY  - 1992\nDA  - 1992\nVL  - 258\nSP  - 1004\nEP  - 7\nPB  - PubMedCrossRefGoogle Scholar\nLA  - \nER  - \n\nTY  - JOUR\nAU  - Straley, S.C.\nTI  - The plasmid-encoded outer-membrane proteins of Yersinia pestis\nT2  - Rev Infect Dis\nPY  - 1988\nDA  - 1988\nVL  - 2\nSP  - 323\nEP  - 6\nPB  - PubMedCrossRefGoogle Scholar\nLA  - \nER  - \n\nTY  - JOUR\nAU  - Straley, S.C.\nAU  - Skrzypek, E.\nAU  - Plano, G.V.\nAU  - Bliska, J.B.\nTI  - Yops of Yersinia spp. pathogenic for humans\nT2  - Infect Immun\nPY  - 1993\nDA  - 1993\nVL  - 61\nSP  - 3105\nEP  - 10\nPB  - PubMedPubMedCentralGoogle Scholar\nLA  - \nER  - \n\nTY  - JOUR\nAU  - Lemaitre, N.\nAU  - Sebbane, F.\nAU  - Long, D.\nAU  - Hinnebusch, B.J.\nTI  - Yersinia pestis YopJ suppresses tumor necrosis factor alpha induction and contributes to apoptosis of immune cells in the lymph node but is not required for virulence in a rat model of bubonic plague\nT2  - Infect Immun\nPY  - 2006\nDA  - 2006\nVL  - 74\nSP  - 5126\nEP  - 31\nPB  - PubMedPubMedCentralCrossRefGoogle Scholar\nLA  - \nER  - \n\nTY  - JOUR\nAU  - Zhou, D.\nAU  - Han, Y.\nAU  - Yang, R.\nTI  - Molecular and physiological insights into plague transmission, virulence and etiology\nT2  - Microbes Infect\nPY  - 2006\nDA  - 2006\nVL  - 8\nSP  - 273\nEP  - 84\nPB  - PubMedCrossRefGoogle Scholar\nLA  - \nER  - \n\nTY  - JOUR\nAU  - Ketai, L.\nTI  - Tchoyoson Lim CC. Radiology of biological weapons--old and the new?\nT2  - Semin Roentgenol\nPY  - 2007\nDA  - 2007\nVL  - 42\nSP  - 49\nEP  - 59\nPB  - PubMedCrossRefGoogle Scholar\nLA  - \nER  - \n\nTY  - GEN\nAU  - Siegel, J.D.\nAU  - Rhinehart, E.\nAU  - Jackson, M.\nAU  - Chiarello, L.\nTI  - the Healthcare Infection Control Practices Advisory Committee. 2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Healthcare Settings\nUR  - https://www.cdc.gov/infectioncontrol/guidelines/isolation/index.html.\nLA  - \nC1  - Updated September 2018. online on 11 March 2019\nER  - \n\nTY  - JOUR\nAU  - Pechous, R.D.\nAU  - Sivaraman, V.\nAU  - Stasulli, N.M.\nAU  - Goldman, W.E.\nTI  - Pneumonic plague: the darker side of Yersinia pestis\nT2  - Trends Microbiol\nPY  - 2016\nDA  - 2016\nVL  - 24\nSP  - 190\nEP  - 7\nT2  - PubMedCrossRefGoogle Scholar\nLA  - \nER  - \n\nTY  - BOOK\nAU  - Silver, S.\nTI  - Laboratory-acquired lethal infections by potential bioweapons pathogens including Ebola in 2014. FEMS Microbiol Lett\nPY  - 2015\nDA  - 2015\nVL  - 362\nSP  - 1\nEP  - 6\nPB  - PubMedCrossRefGoogle Scholar\nLA  - \nER  - \n\nTY  - JOUR\nAU  - Kugeler, K.J.\nAU  - Staples, J.E.\nAU  - Hinckley, A.F.\nAU  - Gage, K.L.\nAU  - Mead, P.S.\nTI  - Epidemiology of human plague in the United States, 1900\u20132012\nT2  - Emerg Infect Dis\nPY  - 2015\nDA  - 2015\nVL  - 21\nSP  - 16\nEP  - 22\nPB  - PubMedPubMedCentralCrossRefGoogle Scholar\nLA  - \nER  - \n\nTY  - BOOK\nAU  - Forrester, J.D.\nAU  - Apangu, T.\nAU  - Griffith, K.\nTI  - Patterns of human plague in Uganda, 2008\u20132016. Emerg Infect Dis\nPY  - 2017\nDA  - 2017\nVL  - 23\nSP  - 1517\nEP  - 21\nPB  - PubMedPubMedCentralCrossRefGoogle Scholar\nC1  - true\nLA  - \nER  - \n\nTY  - JOUR\nAU  - Hull, H.F.\nAU  - Montes, J.M.\nAU  - Mann, J.M.\nTI  - Septicemic plague in New Mexico\nT2  - J Infect Dis\nPY  - 1987\nDA  - 1987\nVL  - 155\nSP  - 113\nEP  - 8\nPB  - PubMedCrossRefGoogle Scholar\nLA  - \nER  - \n\nTY  - JOUR\nAU  - Tourdjman, M.\nAU  - Ibraheem, M.\nAU  - Brett, M.\nTI  - Misidentification of Yersinia pestis by automated systems, resulting in delayed diagnoses of human plague infections--Oregon and New Mexico, 2010\u20132011\nT2  - Clin Infect Dis\nPY  - 2012\nDA  - 2012\nVL  - 55\nSP  - 58\nEP  - 60\nPB  - PubMedCrossRefGoogle Scholar\nC1  - true\nLA  - \nER  - \n\nTY  - JOUR\nAU  - Demeure, C.E.\nAU  - Dussurget, O.\nAU  - Mas Fiol, G.\nAU  - Le Guern, A.S.\nAU  - Savin, C.\nAU  - Pizarro-Cerda, J.\nTI  - Yersinia pestis and plague: an updated view on evolution, virulence determinants, immune subversion, vaccination, and diagnostics\nT2  - Genes Immun\nPY  - 2019\nDA  - 2019\nVL  - 20\nSP  - 357\nPB  - PubMedPubMedCentralCrossRefGoogle Scholar\nLA  - \nER  - \n\nTY  - JOUR\nAU  - Koirala, J.\nTI  - Plague: disease, management, and recognition of act of terrorism\nT2  - Infect Dis Clin N Am\nPY  - 2006\nDA  - 2006\nVL  - 20\nSP  - 273\nEP  - 87\nT2  - CrossRefGoogle Scholar\nLA  - \nER  - \n\nTY  - JOUR\nAU  - Mwengee, W.\nAU  - Butler, T.\nAU  - Mgema, S.\nAU  - Mhina, G.\nAU  - Almasi, Y.\nAU  - Bradley, C.\nAU  - Formanik, J.B.\nAU  - Rochester, C.G.\nTI  - Treatment of plague with gentamicin or doxycycline in a randomized clinical trial in Tanzania\nT2  - Clin Infect Dis\nPY  - 2006\nDA  - 2006\nVL  - 42\nSP  - 614\nEP  - 21\nPB  - PubMedCrossRefGoogle Scholar\nIS  - 5\nLA  - \nER  - \n\nTY  - JOUR\nAU  - Russell, P.\nAU  - Eley, S.M.\nAU  - Green, M.\nTI  - Efficacy of doxycycline and ciprofloxacin against experimental Yersinia pestis infection\nT2  - J Antimicrob Chemother\nPY  - 1998\nDA  - 1998\nVL  - 41\nSP  - 301\nEP  - 5\nPB  - PubMedCrossRefGoogle Scholar\nC1  - true\nLA  - \nER  - \n\nTY  - JOUR\nAU  - Steward, J.\nAU  - Lever, M.S.\nAU  - Russell, P.\nTI  - Efficacy of the latest fluoroquinolones against experimental Yersinia pestis\nT2  - Int J Antimicrob Agents\nPY  - 2004\nDA  - 2004\nVL  - 24\nSP  - 609\nEP  - 12\nT2  - PubMedCrossRefGoogle Scholar\nC1  - true\nLA  - \nER  - \n\nTY  - JOUR\nAU  - Heine, H.S.\nAU  - Hershfield, J.\nAU  - Marchand, C.\nTI  - In vitro antibiotic susceptibilities of Yersinia pestis determined by broth microdilution following CLSI methods\nT2  - Antimicrob Agents Chemother\nPY  - 2015\nDA  - 2015\nVL  - 59\nSP  - 1919\nEP  - 21\nPB  - PubMedPubMedCentralCrossRefGoogle Scholar\nC1  - true\nLA  - \nER  - \n\nTY  - JOUR\nAU  - Wendte, J.M.\nAU  - Ponnusamy, D.\nAU  - Reiber, D.\nAU  - Blair, J.L.\nAU  - Clinkenbeard, K.D.\nTI  - In vitro efficacy of antibiotics commonly used to treat human plague against intracellular Yersinia pestis\nT2  - Antimicrob Agents Chemother\nPY  - 2011\nDA  - 2011\nVL  - 55\nSP  - 3752\nEP  - 7\nPB  - PubMedPubMedCentralCrossRefGoogle Scholar\nLA  - \nER  - \n\nTY  - JOUR\nAU  - Levy, Y.\nAU  - Vagima, Y.\nAU  - Tidhar, A.\nTI  - Adjunctive corticosteroid treatment against Yersinia pestis improves bacterial clearance, immunopathology, and survival in the mouse model of bubonic plague\nT2  - J Infect Dis\nPY  - 2016\nDA  - 2016\nVL  - 214\nSP  - 970\nEP  - 7\nPB  - PubMedCrossRefPubMedCentralGoogle Scholar\nC1  - true\nLA  - \nER  - \n\nTY  - JOUR\nAU  - Heine, H.S.\nAU  - Louie, A.\nAU  - Adamovicz, J.J.\nTI  - Evaluation of imipenem for prophylaxis and therapy of Yersinia pestis delivered by aerosol in a mouse model of pneumonic plague\nT2  - Antimicrob Agents Chemother\nPY  - 2014\nDA  - 2014\nVL  - 58\nSP  - 3276\nEP  - 84\nPB  - PubMedPubMedCentralCrossRefGoogle Scholar\nC1  - true\nLA  - \nER  - \n\nTY  - JOUR\nAU  - Inglesby, T.V.\nAU  - Henderson, D.A.\nAU  - O\u2019Toole, T.\nAU  - Dennis, D.T.\nTI  - Safety precautions to limit exposure from plague-infected patients\nT2  - JAMA\nPY  - 2000\nDA  - 2000\nVL  - 284\nSP  - 1648\nEP  - 9\nPB  - PubMedCrossRefPubMedCentralGoogle Scholar\nLA  - \nER  - \n\nTY  - CHAP\nAU  - Siegel, J.D.\nAU  - Rhinehart, E.\nAU  - Jackson, M.\nAU  - Chiarello, L.\nTI  - the Healthcare infection Control Practices Advisory Committee. 2007 Guideline for isolation precautions: preventing transmission of infectious agents in healthcare settings\nPB  - Centers for Disease Control and Prevention\nPY  - 2007\nDA  - 2007\nT2  - Google Scholar\nLA  - \nCY  - Atlanta\nER  - \n\nTY  - JOUR\nAU  - Hepburn, M.J.\nAU  - Simpson, A.J.\nTI  - Tularemia: current diagnosis and treatment options\nT2  - Expert Rev Anti-Infect Ther\nPY  - 2008\nDA  - 2008\nVL  - 6\nSP  - 231\nEP  - 40\nPB  - PubMedCrossRefPubMedCentralGoogle Scholar\nLA  - \nER  - \n\nTY  - BOOK\nAU  - Balali-Mood, M.\nAU  - Moshiri, M.\nAU  - Etemad, L.\nTI  - Medical aspects of bio-terrorism. Toxicon\nPY  - 2013\nDA  - 2013\nVL  - 69\nSP  - 131\nEP  - 42\nPB  - PubMedCrossRefPubMedCentralGoogle Scholar\nLA  - \nER  - \n\nTY  - JOUR\nTI  - Tularemia \u2013 United States, 2001\u20132010\nT2  - MMWR Morb Mortal Wkly Rep\nPY  - 2013\nDA  - 2013\nVL  - 62\nSP  - 963\nEP  - 6\nT2  - Google Scholar\nLA  - \nC1  - Centers for Disease C, Prevention\nER  - \n\nTY  - BOOK\nAU  - Maurin, M.\nAU  - Gyuranecz, M.\nTI  - Tularaemia: clinical aspects in Europe. Lancet Infect Dis\nPY  - 2016\nDA  - 2016\nVL  - 16\nSP  - 113\nEP  - 24\nPB  - PubMedCrossRefGoogle Scholar\nLA  - \nER  - \n\nTY  - JOUR\nAU  - Vayrynen, S.A.\nAU  - Saarela, E.\nAU  - Henry, J.\nAU  - Lahti, S.\nAU  - Harju, T.\nAU  - Kauma, H.\nTI  - Pneumonic tularaemia: experience of 58 cases from 2000 to 2012 in Northern Finland\nT2  - Infect Dis (Lond)\nPY  - 2017\nDA  - 2017\nVL  - 49\nSP  - 758\nEP  - 64\nT2  - CrossRefGoogle Scholar\nLA  - \nER  - \n\nTY  - JOUR\nAU  - Dennis, D.T.\nAU  - Inglesby, T.V.\nAU  - Henderson, D.A.\nTI  - Tularemia as a biological weapon: medical and public health management\nT2  - JAMA\nPY  - 2001\nDA  - 2001\nVL  - 285\nSP  - 2763\nEP  - 73\nPB  - PubMedCrossRefGoogle Scholar\nC1  - true\nLA  - \nER  - \n\nTY  - JOUR\nAU  - Rubin, S.A.\nTI  - Radiographic spectrum of pleuropulmonary tularemia\nT2  - AJR Am J Roentgenol\nPY  - 1978\nDA  - 1978\nVL  - 131\nSP  - 277\nEP  - 81\nPB  - PubMedCrossRefGoogle Scholar\nLA  - \nER  - \n\nTY  - JOUR\nAU  - Yanes, H.\nAU  - Hennebique, A.\nAU  - Pelloux, I.\nTI  - Evaluation of in-house and commercial serological tests for diagnosis of human tularemia\nT2  - J Clin Microbiol\nPY  - 2018\nDA  - 2018\nT2  - Google Scholar\nC1  - true\nLA  - \nER  - \n\nTY  - JOUR\nAU  - Chaignat, V.\nAU  - Djordjevic-Spasic, M.\nAU  - Ruettger, A.\nTI  - Performance of seven serological assays for diagnosing tularemia\nT2  - BMC Infect Dis\nPY  - 2014\nDA  - 2014\nVL  - 14\nSP  - 234\nPB  - PubMedPubMedCentralCrossRefGoogle Scholar\nC1  - true\nLA  - \nER  - \n\nTY  - JOUR\nAU  - Kilic, S.\nAU  - Celebi, B.\nAU  - Yesilyurt, M.\nTI  - Evaluation of a commercial immunochromatographic assay for the serologic diagnosis of tularemia\nT2  - Diagn Microbiol Infect Dis\nPY  - 2012\nDA  - 2012\nVL  - 74\nSP  - 1\nEP  - 5\nPB  - PubMedCrossRefGoogle Scholar\nLA  - \nER  - \n\nTY  - JOUR\nAU  - Gunnell, M.K.\nAU  - Lovelace, C.D.\nAU  - Satterfield, B.A.\nAU  - Moore, E.A.\nAU  - O\u2019Neill, K.L.\nAU  - Robison, R.A.\nTI  - A multiplex real-time PCR assay for the detection and differentiation of Francisella tularensis subspecies\nT2  - J Med Microbiol\nPY  - 2012\nDA  - 2012\nVL  - 61\nSP  - 1525\nEP  - 31\nPB  - PubMedCrossRefGoogle Scholar\nLA  - \nER  - \n\nTY  - JOUR\nAU  - Yapar, D.\nAU  - Erenler, A.K.\nAU  - Terzi, O.\nAU  - Akdogan, O.\nAU  - Ece, Y.\nAU  - Baykam, N.\nTI  - Predicting tularemia with clinical, laboratory and demographical findings in the\nT2  - ED. Am J Emerg Med\nPY  - 2016\nDA  - 2016\nVL  - 34\nSP  - 218\nEP  - 21\nPB  - PubMedCrossRefGoogle Scholar\nLA  - \nER  - \n\nTY  - BOOK\nAU  - Mulligan, M.J.\nAU  - Stapleton, J.T.\nAU  - Keitel, W.A.\nTI  - Tularemia vaccine: safety, reactogenicity, \u201cTake\u201d skin reactions, and antibody responses following vaccination with a new lot of the Francisella tularensis live vaccine strain \u2013 a phase 2 randomized clinical Trial. Vaccine\nPY  - 2017\nDA  - 2017\nVL  - 35\nSP  - 4730\nEP  - 7\nPB  - PubMedPubMedCentralCrossRefGoogle Scholar\nC1  - true\nLA  - \nER  - \n\nTY  - JOUR\nAU  - Todd, SR, Dahlgren\nAU  - FS, Traeger\nAU  - MS, Beltr\u00e1n-Aguilar\nAU  - ED, Marianos\nAU  - DW, Hamilton\nAU  - C, McQuiston\nAU  - JH, Regan\nAU  - J.J.\nTI  - No visible dental staining in children treated with doxycycline for suspected Rocky Mountain spotted fever\nT2  - J Pediatr\nPY  - 2015\nDA  - 2015\nVL  - 16\nSP  - 1246\nEP  - 51\nT2  - CrossRefGoogle Scholar\nIS  - 5\nLA  - \nER  - \n\nTY  - JOUR\nAU  - Boulanger, L.L.\nAU  - Ettestad, P.\nAU  - Fogarty, J.D.\nAU  - Dennis, D.T.\nAU  - Romig, D.\nAU  - Mertz, G.\nTI  - Gentamicin and tetracyclines for the treatment of human plague: review of 75 cases in New Mexico, 1985\u20131999\nT2  - Clin Infect Dis\nPY  - 2004\nDA  - 2004\nVL  - 38\nSP  - 663\nEP  - 9\nPB  - PubMedCrossRefGoogle Scholar\nIS  - 5\nLA  - \nER  - \n\n",
        "links": [],
        "author_conclusions": [],
        "table_captions": [],
        "figure_captions": []
    },
    "sections": {
        "introduction": [
            "Bacterial zoonotic infections are rare in developed countries in the twenty-first century but may cause major morbidity and mortality in developing regions of the world. In addition, their potential use as biological weapons makes early recognition and effective empiric therapy important for the critical care practitioner. Anthrax, plague, and tularemia share overlapping presenting syndromes, including fulminant respiratory infections and less severe but still highly morbid lymphocutaneous infections. Although all three may be transmitted as infectious aerosols, only plague has a risk of direct human-to-human transmission. Diagnostic testing will require special precautions for laboratory staff and most often involvement of regional and national reference laboratories. Empiric therapy with aminoglycosides may be life-saving for plague and tularemia, while the treatment of anthrax is complex and varies depending on the site of infection. In outbreaks or for post-exposure prophylaxis, treatment with doxycycline or a fluoroquinolone is recommended for all three diseases."
        ]
    },
    "structured_content": {
        "Abstract": [
            "Bacterial zoonotic infections are rare in developed countries in the twenty-first century but may cause major morbidity and mortality in developing regions of the world. In addition, their potential use as biological weapons makes early recognition and effective empiric therapy important for the critical care practitioner. Anthrax, plague, and tularemia share overlapping presenting syndromes, including fulminant respiratory infections and less severe but still highly morbid lymphocutaneous infections. Although all three may be transmitted as infectious aerosols, only plague has a risk of direct human-to-human transmission. Diagnostic testing will require special precautions for laboratory staff and most often involvement of regional and national reference laboratories. Empiric therapy with aminoglycosides may be life-saving for plague and tularemia, while the treatment of anthrax is complex and varies depending on the site of infection. In outbreaks or for post-exposure prophylaxis, treatment with doxycycline or a fluoroquinolone is recommended for all three diseases."
        ],
        "References": [
            "1. Taylor LH, Latham SM, Woolhouse ME. Risk factors for human disease emergence. Philos Trans R Soc Lond Ser B Biol Sci. 2001;356:983\u20139.CrossRefGoogle Scholar",
            "2. Barras V, Greub G. History of biological warfare and bioterrorism. Clin Microbiol Infect. 2014;20:497\u2013502.PubMedCrossRefPubMedCentralGoogle Scholar",
            "3. Meselson M, Guillemin J, Hugh-Jones M, et al The Sverdlovsk anthrax outbreak of 1979. Science. 1994;266:1202\u20138.PubMedCrossRefPubMedCentralGoogle Scholar",
            "4. Jaton K, Greub G. Clinical microbiologists facing an anthrax alert. Clin Microbiol Infect. 2014;20:503\u20136.PubMedCrossRefPubMedCentralGoogle Scholar",
            "5. Vieira AR, Salzer JS, Traxler RM, et al Enhancing surveillance and diagnostics in anthrax-endemic countries. Emerg Infect Dis. 2017;23.Google Scholar",
            "6. Bush LM, Abrams BH, Beall A, Johnson CC. Index case of fatal inhalational anthrax due to bioterrorism in the United States. N Engl J Med. 2001;345:1607\u201310.PubMedCrossRefPubMedCentralGoogle Scholar",
            "7. Hughes JM, Gerberding JL. Anthrax bioterrorism: lessons learned and future directions. Emerg Infect Dis. 2002;8:1013\u20134.PubMedPubMedCentralCrossRefGoogle Scholar",
            "8. Friebe S, van der Goot FG, Burgi J. The ins and outs of anthrax toxin. Toxins (Basel). 2016;8.Google Scholar",
            "9. Adalja AA, Toner E, Inglesby TV. Clinical management of potential bioterrorism-related conditions. N Engl J Med. 2015;372:954\u201362.CrossRefGoogle Scholar",
            "10. Shafazand S. When bioterrorism strikes: diagnosis and management of inhalational anthrax. Semin Respir Infect. 2003;18:134\u201345.PubMedGoogle Scholar",
            "11. Doganay M, Metan G, Alp E. A review of cutaneous anthrax and its outcome. J Infect Public Health. 2010;3:98\u2013105.PubMedCrossRefGoogle Scholar",
            "12. Sirisanthana T, Brown AE. Anthrax of the gastrointestinal tract. Emerg Infect Dis. 2002;8:649\u201351.PubMedPubMedCentralCrossRefGoogle Scholar",
            "13. Purcell B, Worsham P, Friedlander A. Anthrax. In: Dembek ZS, editor. Medical aspects of biological warfare. Falls Church, VA: Borden Institute and US Army Office of the Surgeon General; 2007.Google Scholar",
            "14. Barakat LA, Quentzel HL, Jernigan JA, et al Fatal inhalational anthrax in a 94-year-old Connecticut woman. JAMA. 2002;287:863\u20138.PubMedCrossRefGoogle Scholar",
            "15. Abramova FA, Grinberg LM, Yampolskaya OV, Walker DH. Pathology of inhalational anthrax in 42 cases from the Sverdlovsk outbreak of 1979. Proc Natl Acad Sci U S A. 1993;90:2291\u20134.PubMedPubMedCentralCrossRefGoogle Scholar",
            "16. Bower WA, Hendricks K, Pillai S, et al Clinical framework and medical countermeasure use during an anthrax mass-casualty incident. MMWR Recomm Rep. 2015;64:1\u201322.PubMedCrossRefGoogle Scholar",
            "17. Mayer TA, Bersoff-Matcha S, Murphy C, et al Clinical presentation of inhalational anthrax following bioterrorism exposure: report of 2 surviving patients. JAMA. 2001;286:2549\u201353.PubMedCrossRefGoogle Scholar",
            "18. Holty JE, Bravata DM, Liu H, Olshen RA, McDonald KM, Owens DK. Systematic review: a century of inhalational anthrax cases from 1900 to 2005. Ann Intern Med. 2006;144:270\u201380.PubMedCrossRefGoogle Scholar",
            "19. Holty JE, Kim RY, Bravata DM. Anthrax: a systematic review of atypical presentations. Ann Emerg Med. 2006;48:200\u201311.PubMedCrossRefGoogle Scholar",
            "20. Hendricks KA, Wright ME, Shadomy SV, et al Centers for disease control and prevention expert panel meetings on prevention and treatment of anthrax in adults. Emerg Infect Dis. 2014;20:e130687.PubMedCentralCrossRefPubMedGoogle Scholar",
            "21. Katharios-Lanwermeyer S, Holty JE, Person M, et al Identifying meningitis during an anthrax mass casualty incident: systematic review of systemic anthrax since 1880. Clinical Infect Dis. 2016;62:1537\u201345.CrossRefGoogle Scholar",
            "22. Meaney-Delman D, Zotti ME, Creanga AA, et al Special considerations for prophylaxis for and treatment of anthrax in pregnant and postpartum women. Emerg Infect Dis. 2014;20.Google Scholar",
            "23. Bartlett JG, Inglesby TV Jr, Borio L. Management of anthrax. Clin Infect Dis. 2002;35:851\u20138.PubMedCrossRefGoogle Scholar",
            "24. Inglesby TV, O\u2019Toole T, Henderson DA, et al Anthrax as a biological weapon, 2002: updated recommendations for management. JAMA. 2002;287:2236\u201352.PubMedCrossRefGoogle Scholar",
            "25. Walsh JJ, Pesik N, Quinn CP, et al A case of naturally acquired inhalation anthrax: clinical care and analyses of anti-protective antigen immunoglobulin G and lethal factor. Clin Infect Dis. 2007;44:968\u201371.PubMedCrossRefGoogle Scholar",
            "26. Klempner MS, Talbot EA, Lee SI, Zaki S, Ferraro MJ. Case records of the Massachusetts General Hospital. Case 25-2010. A 24-year-old woman with abdominal pain and shock. N Engl J Med. 2010;363:766\u201377.PubMedCrossRefGoogle Scholar",
            "27. Webster JI, Moayeri M, Sternberg EM. Novel repression of the glucocorticoid receptor by anthrax lethal toxin. Ann N Y Acad Sci. 2004;1024:9\u201323.PubMedCrossRefGoogle Scholar",
            "28. Yamamoto BJ, Shadiack AM, Carpenter S, et al Efficacy projection of obiltoxaximab for treatment of inhalational anthrax across a range of disease severity. Antimicrob Agents Chemother. 2016;60:5787\u201395.PubMedPubMedCentralCrossRefGoogle Scholar",
            "29. Yamamoto BJ, Shadiack AM, Carpenter S, et al Obiltoxaximab prevents disseminated Bacillus anthracis infection and improves survival during pre- and postexposure prophylaxis in animal models of inhalational anthrax. Antimicrob Agents Chemother. 2016;60:5796\u2013805.PubMedPubMedCentralCrossRefGoogle Scholar",
            "30. Migone TS, Bolmer S, Zhong J, et al Added benefit of raxibacumab to antibiotic treatment of inhalational anthrax. Antimicrob Agents Chemother. 2015;59:1145\u201351.PubMedPubMedCentralCrossRefGoogle Scholar",
            "31. Kummerfeldt CE. Raxibacumab: potential role in the treatment of inhalational anthrax. Infect Drug Resist. 2014;7:101\u20139.PubMedPubMedCentralCrossRefGoogle Scholar",
            "32. Kammanadiminti S, Patnaikuni RK, Comer J, Meister G, Sinclair C, Kodihalli S. Combination therapy with antibiotics and anthrax immune globulin intravenous (AIGIV) is potentially more effective than antibiotics alone in rabbit model of inhalational anthrax. PLoS One. 2014;9:e106393.PubMedPubMedCentralCrossRefGoogle Scholar",
            "33. Andrianaivoarimanana V, Kreppel K, Elissa N, et al Understanding the persistence of plague foci in Madagascar. PLoS Negl Trop Dis. 2013;7:e2382.PubMedPubMedCentralCrossRefGoogle Scholar",
            "34. Hinnebusch BJ, Bland DM, Bosio CF, Jarrett CO. Comparative ability of Oropsylla montana and Xenopsylla cheopis fleas to transmit Yersinia pestis by two different mechanisms. PLoS Negl Trop Dis. 2017;11:e0005276.PubMedPubMedCentralCrossRefGoogle Scholar",
            "35. Smego RA, Frean J, Koornhof HJ. Yersiniosis I: microbiological and clinicoepidemiological aspects of plague and non-plague Yersinia infections. Eur J Clin Microbiol Infect Dis. 1999;18:1\u201315.PubMedCrossRefPubMedCentralGoogle Scholar",
            "36. Inglesby TV, Dennis DT, Henderson DA, et al Plague as a biological weapon: medical and public health managemen. Working Group on Civilian Biodefense t. JAMA. 2000;283:2281\u201390.PubMedCrossRefGoogle Scholar",
            "37. Atkinson S, Williams P. Yersinia virulence factors\u00a0\u2013 a sophisticated arsenal for combating host defences. F1000Res. 2016;5.CrossRefGoogle Scholar",
            "38. Knirel YA, Anisimov AP. Lipopolysaccharide of Yersinia pestis, the cause of plague: structure, genetics, biological properties. Acta Nat. 2012;4:46\u201358.CrossRefGoogle Scholar",
            "39. Khan IA. Plague: the dreadful visitation occupying the human mind for centuries. Trans R Soc Trop Med Hyg. 2004;98:270\u20137.PubMedCrossRefPubMedCentralGoogle Scholar",
            "40. Andrianaivoarimanana V, Piola P, Wagner DM, et al Trends of human plague, Madagascar, 1998\u20132016. Emerg Infect Dis. 2019;25:220\u20138.PubMedPubMedCentralCrossRefGoogle Scholar",
            "41. Mead PS. Plague in Madagascar\u00a0\u2013 a tragic opportunity for improving public health. N Engl J Med. 2018;378:106\u20138.PubMedCrossRefGoogle Scholar",
            "42. Christopher GW, Cieslak TJ, Pavlin JA, Eitzen EM Jr. Biological warfare. A historical perspective. JAMA. 1997;278:412\u20137.PubMedCrossRefGoogle Scholar",
            "43. Kwit N, Nelson C, Kugeler K, et al Human plague - United States, 2015. MMWR Morb Mortal Wkly Rep. 2015;64:918\u20139.PubMedCrossRefGoogle Scholar",
            "44. Crook LD, Tempest B. Plague. A clinical review of 27 cases. Arch Intern Med. 1992;152:1253\u20136.PubMedCrossRefGoogle Scholar",
            "45. Watson AK, Ellington S, Nelson C, Treadwell T, Jamieson DJ, Meaney-Delman DM. Preparing for biological threats: addressing the needs of pregnant women. Birth Defects Res. 2017;109:391\u20138.PubMedCrossRefGoogle Scholar",
            "46. Wong TW. Plague in a pregnant patient. Trop Dr. 1986;16:187\u20139.CrossRefGoogle Scholar",
            "47. Welty TK, Grabman J, Kompare E, et al Nineteen cases of plague in Arizona. A spectrum including ecthyma gangrenosum due to plague and plague in pregnancy. West J Med. 1985;142:641\u20136.PubMedPubMedCentralGoogle Scholar",
            "48. Guinet F, Ave P, Filali S, et al Dissociation of tissue destruction and bacterial expansion during bubonic plague. PLoS Pathog. 2015;11:e1005222.PubMedPubMedCentralCrossRefGoogle Scholar",
            "49. Guinet F, Ave P, Jones L, Huerre M, Carniel E. Defective innate cell response and lymph node infiltration specify Yersinia pestis infection. PLoS One. 2008;3:e1688.PubMedPubMedCentralCrossRefGoogle Scholar",
            "50. Sodeinde OA, Subrahmanyam YV, Stark K, Quan T, Bao Y, Goguen JD. A surface protease and the invasive character of plague. Science. 1992;258:1004\u20137.PubMedCrossRefGoogle Scholar",
            "51. Straley SC. The plasmid-encoded outer-membrane proteins of Yersinia pestis. Rev Infect Dis. 1988;10 Suppl 2:S323\u20136.PubMedCrossRefGoogle Scholar",
            "52. Straley SC, Skrzypek E, Plano GV, Bliska JB. Yops of Yersinia spp. pathogenic for humans. Infect Immun. 1993;61:3105\u201310.PubMedPubMedCentralGoogle Scholar",
            "53. Lemaitre N, Sebbane F, Long D, Hinnebusch BJ. Yersinia pestis YopJ suppresses tumor necrosis factor alpha induction and contributes to apoptosis of immune cells in the lymph node but is not required for virulence in a rat model of bubonic plague. Infect Immun. 2006;74:5126\u201331.PubMedPubMedCentralCrossRefGoogle Scholar",
            "54. Zhou D, Han Y, Yang R. Molecular and physiological insights into plague transmission, virulence and etiology. Microbes Infect. 2006;8:273\u201384.PubMedCrossRefGoogle Scholar",
            "55. Ketai L, Tchoyoson Lim CC. Radiology of biological weapons--old and the new? Semin Roentgenol. 2007;42:49\u201359.PubMedCrossRefGoogle Scholar",
            "56. Siegel JD, Rhinehart E, Jackson M, Chiarello L; the Healthcare Infection Control Practices Advisory Committee. 2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Healthcare Settings. Updated September 2018. Accessed online on 11 March 2019 at https://www.cdc.gov/infectioncontrol/guidelines/isolation/index.html.",
            "57. Pechous RD, Sivaraman V, Stasulli NM, Goldman WE. Pneumonic plague: the darker side of Yersinia pestis. Trends Microbiol. 2016;24:190\u20137.PubMedCrossRefGoogle Scholar",
            "58. Silver S. Laboratory-acquired lethal infections by potential bioweapons pathogens including Ebola in 2014. FEMS Microbiol Lett. 2015;362:1\u20136.PubMedCrossRefGoogle Scholar",
            "59. Kugeler KJ, Staples JE, Hinckley AF, Gage KL, Mead PS. Epidemiology of human plague in the United States, 1900\u20132012. Emerg Infect Dis. 2015;21:16\u201322.PubMedPubMedCentralCrossRefGoogle Scholar",
            "60. Forrester JD, Apangu T, Griffith K, et al Patterns of human plague in Uganda, 2008\u20132016. Emerg Infect Dis. 2017;23:1517\u201321.PubMedPubMedCentralCrossRefGoogle Scholar",
            "61. Hull HF, Montes JM, Mann JM. Septicemic plague in New Mexico. J Infect Dis. 1987;155:113\u20138.PubMedCrossRefGoogle Scholar",
            "62. Tourdjman M, Ibraheem M, Brett M, et al Misidentification of Yersinia pestis by automated systems, resulting in delayed diagnoses of human plague infections--Oregon and New Mexico, 2010\u20132011. Clin Infect Dis. 2012;55:e58\u201360.PubMedCrossRefGoogle Scholar",
            "63. Demeure CE, Dussurget O, Mas Fiol G, Le Guern AS, Savin C, Pizarro-Cerda J. Yersinia pestis and plague: an updated view on evolution, virulence determinants, immune subversion, vaccination, and diagnostics. Genes Immun. 2019;20:357.PubMedPubMedCentralCrossRefGoogle Scholar",
            "64. Koirala J. Plague: disease, management, and recognition of act of terrorism. Infect Dis Clin N Am. 2006;20:273\u201387, viii.CrossRefGoogle Scholar",
            "65. Mwengee W, Butler T, Mgema S, Mhina G, Almasi Y, Bradley C, Formanik JB, Rochester CG. Treatment of plague with gentamicin or doxycycline in a randomized clinical trial in Tanzania. Clin Infect Dis. 2006;42(5):[614\u2013<a class=\"ref-link\" id=\"c21\" href=\"#r21\">21</a>].PubMedCrossRefGoogle Scholar",
            "66. Russell P, Eley SM, Green M, et al Efficacy of doxycycline and ciprofloxacin against experimental Yersinia pestis infection. J Antimicrob Chemother. 1998;41:301\u20135.PubMedCrossRefGoogle Scholar",
            "67. Steward J, Lever MS, Russell P, et al Efficacy of the latest fluoroquinolones against experimental Yersinia pestis. Int J Antimicrob Agents. 2004;24:609\u201312.PubMedCrossRefGoogle Scholar",
            "68. Heine HS, Hershfield J, Marchand C, et al In vitro antibiotic susceptibilities of Yersinia pestis determined by broth microdilution following CLSI methods. Antimicrob Agents Chemother. 2015;59:1919\u201321.PubMedPubMedCentralCrossRefGoogle Scholar",
            "69. Wendte JM, Ponnusamy D, Reiber D, Blair JL, Clinkenbeard KD. In vitro efficacy of antibiotics commonly used to treat human plague against intracellular Yersinia pestis. Antimicrob Agents Chemother. 2011;55:3752\u20137.PubMedPubMedCentralCrossRefGoogle Scholar",
            "70. Levy Y, Vagima Y, Tidhar A, et al Adjunctive corticosteroid treatment against Yersinia pestis improves bacterial clearance, immunopathology, and survival in the mouse model of bubonic plague. J Infect Dis. 2016;214:970\u20137.PubMedCrossRefPubMedCentralGoogle Scholar",
            "71. Heine HS, Louie A, Adamovicz JJ, et al Evaluation of imipenem for prophylaxis and therapy of Yersinia pestis delivered by aerosol in a mouse model of pneumonic plague. Antimicrob Agents Chemother. 2014;58:3276\u201384.PubMedPubMedCentralCrossRefGoogle Scholar",
            "72. Inglesby TV, Henderson DA, O\u2019Toole T, Dennis DT. Safety precautions to limit exposure from plague-infected patients. JAMA. 2000;284:1648\u20139.PubMedCrossRefPubMedCentralGoogle Scholar",
            "73. Siegel JD, Rhinehart E, Jackson M, Chiarello L, the Healthcare infection Control Practices Advisory Committee. 2007 Guideline for isolation precautions: preventing transmission of infectious agents in healthcare settings. Atlanta: Centers for Disease Control and Prevention; 2007.Google Scholar",
            "74. Hepburn MJ, Simpson AJ. Tularemia: current diagnosis and treatment options. Expert Rev Anti-Infect Ther. 2008;6:231\u201340.PubMedCrossRefPubMedCentralGoogle Scholar",
            "75. Balali-Mood M, Moshiri M, Etemad L. Medical aspects of bio-terrorism. Toxicon. 2013;69:131\u201342.PubMedCrossRefPubMedCentralGoogle Scholar",
            "76. Centers for Disease C, Prevention. Tularemia\u00a0\u2013 United States, 2001\u20132010. MMWR Morb Mortal Wkly Rep. 2013;62:963\u20136.Google Scholar",
            "77. Maurin M, Gyuranecz M. Tularaemia: clinical aspects in Europe. Lancet Infect Dis. 2016;16:113\u201324.PubMedCrossRefGoogle Scholar",
            "78. Vayrynen SA, Saarela E, Henry J, Lahti S, Harju T, Kauma H. Pneumonic tularaemia: experience of 58 cases from 2000 to 2012 in Northern Finland. Infect Dis (Lond). 2017;49:758\u201364.CrossRefGoogle Scholar",
            "79. Dennis DT, Inglesby TV, Henderson DA, et al Tularemia as a biological weapon: medical and public health management. JAMA. 2001;285:2763\u201373.PubMedCrossRefGoogle Scholar",
            "80. Rubin SA. Radiographic spectrum of pleuropulmonary tularemia. AJR Am J Roentgenol. 1978;131:277\u201381.PubMedCrossRefGoogle Scholar",
            "81. Yanes H, Hennebique A, Pelloux I, et al Evaluation of in-house and commercial serological tests for diagnosis of human tularemia. J Clin Microbiol. 2018;56.Google Scholar",
            "82. Chaignat V, Djordjevic-Spasic M, Ruettger A, et al Performance of seven serological assays for diagnosing tularemia. BMC Infect Dis. 2014;14:234.PubMedPubMedCentralCrossRefGoogle Scholar",
            "83. Kilic S, Celebi B, Yesilyurt M. Evaluation of a commercial immunochromatographic assay for the serologic diagnosis of tularemia. Diagn Microbiol Infect Dis. 2012;74:1\u20135.PubMedCrossRefGoogle Scholar",
            "84. Gunnell MK, Lovelace CD, Satterfield BA, Moore EA, O\u2019Neill KL, Robison RA. A multiplex real-time PCR assay for the detection and differentiation of Francisella tularensis subspecies. J Med Microbiol. 2012;61:1525\u201331.PubMedCrossRefGoogle Scholar",
            "85. Yapar D, Erenler AK, Terzi O, Akdogan O, Ece Y, Baykam N. Predicting tularemia with clinical, laboratory and demographical findings in the ED. Am J Emerg Med. 2016;34:218\u201321.PubMedCrossRefGoogle Scholar",
            "86. Mulligan MJ, Stapleton JT, Keitel WA, et al Tularemia vaccine: safety, reactogenicity, \u201cTake\u201d skin reactions, and antibody responses following vaccination with a new lot of the Francisella tularensis live vaccine strain\u00a0\u2013 a phase 2 randomized clinical Trial. Vaccine. 2017;35:4730\u20137.PubMedPubMedCentralCrossRefGoogle Scholar",
            "87. Todd SR, Dahlgren FS, Traeger MS, Beltr\u00e1n-Aguilar ED, Marianos DW, Hamilton C, McQuiston JH, Regan JJ. No visible dental staining in children treated with doxycycline for suspected Rocky Mountain spotted fever. J Pediatr. 2015;16e(5):1246\u201351.CrossRefGoogle Scholar",
            "88. Boulanger LL, Ettestad P, Fogarty JD, Dennis DT, Romig D, Mertz G. Gentamicin and tetracyclines for the treatment of human plague: review of 75 cases in New Mexico, 1985\u20131999. Clin Infect Dis. 2004;38(5):663\u20139.PubMedCrossRefGoogle Scholar"
        ]
    },
    "participants": [
        {
            "participant": "cases",
            "number": 42,
            "context": "Abramova FA, Grinberg LM, Yampolskaya OV, Walker DH. <mark class=\"stats\">Pathology of inhalational anthrax in 42 cases from the Sverdlovsk outbreak of 1979</mark>. Proc Natl Acad Sci U S A. 1993;90:2291\u20134.PubMedPubMedCentralCrossRefGoogle Scholar"
        },
        {
            "participant": "surviving patients",
            "number": 2,
            "context": "17. <mark class=\"stats\">Mayer TA, Bersoff-Matcha S, Murphy C, et al Clinical presentation of inhalational anthrax following bioterrorism exposure: report of 2 surviving patients</mark>. JAMA. 2001;286:2549\u201353.PubMedCrossRefGoogle Scholar"
        },
        {
            "participant": "cases",
            "number": 27,
            "context": "Plague. <mark class=\"stats\">A clinical review of 27 cases</mark>. Arch Intern Med. 1992;152:1253\u20136.PubMedCrossRefGoogle Scholar"
        },
        {
            "participant": "cases",
            "number": 19,
            "context": "47. <mark class=\"stats\">Welty TK, Grabman J, Kompare E, et al Nineteen cases of plague in Arizona</mark>. A spectrum including ecthyma gangrenosum due to plague and plague in pregnancy"
        },
        {
            "participant": "cases",
            "number": 58,
            "context": "Vayrynen SA, Saarela E, Henry J, Lahti S, Harju T, Kauma H. <mark class=\"stats\">Pneumonic tularaemia: experience of 58 cases from 2000 to 2012 in Northern Finland</mark>. Infect Dis (Lond). 2017;49:758\u201364.CrossRefGoogle Scholar"
        },
        {
            "participant": "cases",
            "number": 75,
            "context": "Boulanger LL, Ettestad P, Fogarty JD, Dennis DT, Romig D, Mertz G. <mark class=\"stats\">Gentamicin and tetracyclines for the treatment of human plague: review of 75 cases in New Mexico, 1985\u20131999</mark>. Clin Infect Dis. 2004;38(5):663\u20139.PubMedCrossRefGoogle Scholar"
        }
    ],
    "statistics": [],
    "keywords": [
        "empiric therapy",
        "critical care",
        "antibiotics",
        "raxibacumab",
        "clinical trial",
        "bioterrorism",
        "tularemia",
        "Yersinia pestis",
        "united states",
        "emerg infect dis",
        "inhalational anthrax",
        "aminoglycosides",
        "biological weapon",
        "systematic review",
        "anthrax immune globulin intravenous"
    ],
    "keyword_relevance": {
        "Yersinia pestis": 0.2545454545454545,
        "inhalational anthrax": 0.2,
        "tularemia": 0.12727272727272726,
        "bioterrorism": 0.10909090909090909,
        "biological weapon": 0.09090909090909091,
        "antibiotics": 0.05454545454545454,
        "systematic review": 0.03636363636363636,
        "anthrax immune globulin intravenous": 0.03636363636363636,
        "empiric therapy": 0.01818181818181818,
        "critical care": 0.01818181818181818,
        "raxibacumab": 0.01818181818181818,
        "clinical trial": 0.01818181818181818,
        "aminoglycosides": 0.01818181818181818,
        "united states": 0.0,
        "emerg infect dis": 0.0
    },
    "species": [
        "Yersinia pestis"
    ],
    "summary": [
        "Bacterial zoonotic infections are rare in developed countries in the twenty-first century but may cause major morbidity and mortality in developing regions of the world.",
        "Empiric therapy with aminoglycosides may be life-saving for plague and tularemia, while the treatment of anthrax is complex and varies depending on the site of infection.",
        "Index case of fatal inhalational anthrax due to bioterrorism in the United States.",
        "Systematic review: a century of inhalational anthrax cases from 1900 to 2005.",
        "Emerg Infect Dis. 2014;20:e130687.PubMedCentralCrossRefPubMedGoogle Scholar",
        "Clinical Infect Dis. 2016;62:1537\u201345.CrossRefGoogle Scholar",
        "Emerg Infect Dis. 2014;20.Google Scholar",
        "Inglesby TV, O\u2019Toole T, Henderson DA, et al Anthrax as a biological weapon, 2002: updated recommendations for management.",
        "Yamamoto BJ, Shadiack AM, Carpenter S, et al Obiltoxaximab prevents disseminated Bacillus anthracis infection and improves survival during pre- and postexposure prophylaxis in animal models of inhalational anthrax.",
        "Eur J Clin Microbiol Infect Dis. 1999;18:1\u201315.PubMedCrossRefPubMedCentralGoogle Scholar",
        "Inglesby TV, Dennis DT, Henderson DA, et al Plague as a biological weapon: medical and public health managemen.",
        "Rev Infect Dis. 1988;10 Suppl 2:S323\u20136.PubMedCrossRefGoogle Scholar",
        "Yersinia pestis YopJ suppresses tumor necrosis factor alpha induction and contributes to apoptosis of immune cells in the lymph node but is not required for virulence in a rat model of bubonic plague.",
        "Emerg Infect Dis. 2017;23:1517\u201321.PubMedPubMedCentralCrossRefGoogle Scholar",
        "J Infect Dis. 1987;155:113\u20138.PubMedCrossRefGoogle Scholar",
        "Tourdjman M, Ibraheem M, Brett M, et al Misidentification of Yersinia pestis by automated systems, resulting in delayed diagnoses of human plague infections--Oregon and New Mexico, 2010\u20132011.",
        "Yersinia pestis and plague: an updated view on evolution, virulence determinants, immune subversion, vaccination, and diagnostics.",
        "Infect Dis Clin N Am. 2006;20:273\u201387, viii.CrossRefGoogle Scholar",
        "In vitro efficacy of antibiotics commonly used to treat human plague against intracellular Yersinia pestis.",
        "Levy Y, Vagima Y, Tidhar A, et al Adjunctive corticosteroid treatment against Yersinia pestis improves bacterial clearance, immunopathology, and survival in the mouse model of bubonic plague.",
        "Heine HS, Louie A, Adamovicz JJ, et al Evaluation of imipenem for prophylaxis and therapy of Yersinia pestis delivered by aerosol in a mouse model of pneumonic plague.",
        "Lancet Infect Dis. 2016;16:113\u201324.PubMedCrossRefGoogle Scholar",
        "Dennis DT, Inglesby TV, Henderson DA, et al Tularemia as a biological weapon: medical and public health management.",
        "Diagn Microbiol Infect Dis. 2012;74:1\u20135.PubMedCrossRefGoogle Scholar",
        "Gentamicin and tetracyclines for the treatment of human plague: review of 75 cases in New Mexico, 1985\u20131999.",
        "Clin Infect Dis. 2004;38(5):663\u20139.PubMedCrossRefGoogle Scholar"
    ],
    "structured_summary": {
        "Introduction": [
            "Bacterial zoonotic infections are rare in developed countries in the twenty-first century but may cause major morbidity and mortality in developing regions of the world.",
            "Empiric therapy with aminoglycosides may be life-saving for plague and tularemia, while the treatment of anthrax is complex and varies depending on the site of infection.",
            "Index case of fatal inhalational anthrax due to bioterrorism in the United States.",
            "Systematic review: a century of inhalational anthrax cases from 1900 to 2005.",
            "Emerg Infect Dis. 2014;20:e130687.PubMedCentralCrossRefPubMedGoogle Scholar"
        ],
        "Results": [
            "Clinical Infect Dis. 2016;62:1537\u201345.CrossRefGoogle Scholar",
            "Emerg Infect Dis. 2014;20.Google Scholar",
            "Inglesby TV, O\u2019Toole T, Henderson DA, et al Anthrax as a biological weapon, 2002: updated recommendations for management.",
            "Yamamoto BJ, Shadiack AM, Carpenter S, et al Obiltoxaximab prevents disseminated Bacillus anthracis infection and improves survival during pre- and postexposure prophylaxis in animal models of inhalational anthrax.",
            "Eur J Clin Microbiol Infect Dis. 1999;18:1\u201315.PubMedCrossRefPubMedCentralGoogle Scholar",
            "Inglesby TV, Dennis DT, Henderson DA, et al Plague as a biological weapon: medical and public health managemen.",
            "Rev Infect Dis. 1988;10 Suppl 2:S323\u20136.PubMedCrossRefGoogle Scholar",
            "Yersinia pestis YopJ suppresses tumor necrosis factor alpha induction and contributes to apoptosis of immune cells in the lymph node but is not required for virulence in a rat model of bubonic plague.",
            "Emerg Infect Dis. 2017;23:1517\u201321.PubMedPubMedCentralCrossRefGoogle Scholar",
            "J Infect Dis. 1987;155:113\u20138.PubMedCrossRefGoogle Scholar",
            "Tourdjman M, Ibraheem M, Brett M, et al Misidentification of Yersinia pestis by automated systems, resulting in delayed diagnoses of human plague infections--Oregon and New Mexico, 2010\u20132011.",
            "Yersinia pestis and plague: an updated view on evolution, virulence determinants, immune subversion, vaccination, and diagnostics.",
            "Infect Dis Clin N Am. 2006;20:273\u201387, viii.CrossRefGoogle Scholar",
            "In vitro efficacy of antibiotics commonly used to treat human plague against intracellular Yersinia pestis.",
            "Levy Y, Vagima Y, Tidhar A, et al Adjunctive corticosteroid treatment against Yersinia pestis improves bacterial clearance, immunopathology, and survival in the mouse model of bubonic plague.",
            "Heine HS, Louie A, Adamovicz JJ, et al Evaluation of imipenem for prophylaxis and therapy of Yersinia pestis delivered by aerosol in a mouse model of pneumonic plague."
        ],
        "Conclusion": [
            "Lancet Infect Dis. 2016;16:113\u201324.PubMedCrossRefGoogle Scholar",
            "Dennis DT, Inglesby TV, Henderson DA, et al Tularemia as a biological weapon: medical and public health management.",
            "Diagn Microbiol Infect Dis. 2012;74:1\u20135.PubMedCrossRefGoogle Scholar",
            "Gentamicin and tetracyclines for the treatment of human plague: review of 75 cases in New Mexico, 1985\u20131999.",
            "Clin Infect Dis. 2004;38(5):663\u20139.PubMedCrossRefGoogle Scholar"
        ]
    },
    "reference_links": [
        {
            "id": "1",
            "alt_id": "Taylor_et+al_2001_a",
            "entry": "1. Taylor LH, Latham SM, Woolhouse ME. Risk factors for human disease emergence. Philos Trans R Soc Lond Ser B Biol Sci. 2001;356:983\u20139.CrossRefGoogle Scholar",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Taylor%2C%20L.H.%20Latham%2C%20S.M.%20Woolhouse%2C%20M.E.%20Risk%20factors%20for%20human%20disease%20emergence.%20Philos%20Trans%20R%20Soc%20Lond%20Ser%202001",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=Taylor%2C%20L.H.%20Latham%2C%20S.M.%20Woolhouse%2C%20M.E.%20Risk%20factors%20for%20human%20disease%20emergence.%20Philos%20Trans%20R%20Soc%20Lond%20Ser%202001",
            "scite": "https://sandbox-api.scholarcy.com/scite_url?query=Taylor%2C%20L.H.%20Latham%2C%20S.M.%20Woolhouse%2C%20M.E.%20Risk%20factors%20for%20human%20disease%20emergence.%20Philos%20Trans%20R%20Soc%20Lond%20Ser%202001"
        },
        {
            "id": "2",
            "alt_id": "Barras_2014_a",
            "entry": "2. Barras V, Greub G. History of biological warfare and bioterrorism. Clin Microbiol Infect. 2014;20:497\u2013502.PubMedCrossRefPubMedCentralGoogle Scholar",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Barras%2C%20V.%20Greub%2C%20G.%20History%20of%20biological%20warfare%20and%20bioterrorism.%20Clin%20Microbiol%20Infect%202014"
        },
        {
            "id": "3",
            "alt_id": "Meselson_et+al_1994_a",
            "entry": "3. Meselson M, Guillemin J, Hugh-Jones M, et al. The Sverdlovsk anthrax outbreak of 1979. Science. 1994;266:1202\u20138.PubMedCrossRefPubMedCentralGoogle Scholar",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Meselson%20M%20Guillemin%20J%20HughJones%20M%20et%20al%20The%20Sverdlovsk%20anthrax%20outbreak%20of%201979%20Science%20199426612028PubMedCrossRefPubMedCentralGoogle%20Scholar",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=Meselson%20M%20Guillemin%20J%20HughJones%20M%20et%20al%20The%20Sverdlovsk%20anthrax%20outbreak%20of%201979%20Science%20199426612028PubMedCrossRefPubMedCentralGoogle%20Scholar",
            "scite": "https://sandbox-api.scholarcy.com/scite_url?query=Meselson%20M%20Guillemin%20J%20HughJones%20M%20et%20al%20The%20Sverdlovsk%20anthrax%20outbreak%20of%201979%20Science%20199426612028PubMedCrossRefPubMedCentralGoogle%20Scholar"
        },
        {
            "id": "4",
            "alt_id": "Jaton_2014_a",
            "entry": "4. Jaton K, Greub G. Clinical microbiologists facing an anthrax alert. Clin Microbiol Infect. 2014;20:503\u20136.PubMedCrossRefPubMedCentralGoogle Scholar",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Jaton%2C%20K.%20Greub%2C%20G.%20Clinical%20microbiologists%20facing%20an%20anthrax%20alert.%20Clin%20Microbiol%20Infect%202014"
        },
        {
            "id": "5",
            "alt_id": "Vieira_et+al_2017_a",
            "entry": "5. Vieira AR, Salzer JS, Traxler RM, et al. Enhancing surveillance and diagnostics in anthrax-endemic countries. Emerg Infect Dis. 2017;23.Google Scholar",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Vieira%20AR%20Salzer%20JS%20Traxler%20RM%20et%20al%20Enhancing%20surveillance%20and%20diagnostics%20in%20anthraxendemic%20countries%20Emerg%20Infect%20Dis%20201723Google%20Scholar",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=Vieira%20AR%20Salzer%20JS%20Traxler%20RM%20et%20al%20Enhancing%20surveillance%20and%20diagnostics%20in%20anthraxendemic%20countries%20Emerg%20Infect%20Dis%20201723Google%20Scholar",
            "scite": "https://sandbox-api.scholarcy.com/scite_url?query=Vieira%20AR%20Salzer%20JS%20Traxler%20RM%20et%20al%20Enhancing%20surveillance%20and%20diagnostics%20in%20anthraxendemic%20countries%20Emerg%20Infect%20Dis%20201723Google%20Scholar"
        },
        {
            "id": "6",
            "alt_id": "Bush_et+al_2001_a",
            "entry": "6. Bush LM, Abrams BH, Beall A, Johnson CC. Index case of fatal inhalational anthrax due to bioterrorism in the United States. N Engl J Med. 2001;345:1607\u201310.PubMedCrossRefPubMedCentralGoogle Scholar",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Bush%2C%20L.M.%20Abrams%2C%20B.H.%20Beall%2C%20A.%20Johnson%2C%20C.C.%20Index%20case%20of%20fatal%20inhalational%20anthrax%20due%20to%20bioterrorism%20in%20the%20United%20States%202001",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=Bush%2C%20L.M.%20Abrams%2C%20B.H.%20Beall%2C%20A.%20Johnson%2C%20C.C.%20Index%20case%20of%20fatal%20inhalational%20anthrax%20due%20to%20bioterrorism%20in%20the%20United%20States%202001",
            "scite": "https://sandbox-api.scholarcy.com/scite_url?query=Bush%2C%20L.M.%20Abrams%2C%20B.H.%20Beall%2C%20A.%20Johnson%2C%20C.C.%20Index%20case%20of%20fatal%20inhalational%20anthrax%20due%20to%20bioterrorism%20in%20the%20United%20States%202001"
        },
        {
            "id": "7",
            "alt_id": "Hughes_2002_a",
            "entry": "7. Hughes JM, Gerberding JL. Anthrax bioterrorism: lessons learned and future directions. Emerg Infect Dis. 2002;8:1013\u20134.PubMedPubMedCentralCrossRefGoogle Scholar",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Hughes%2C%20J.M.%20Gerberding%2C%20J.L.%20Anthrax%20bioterrorism%3A%20lessons%20learned%20and%20future%20directions%202002",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=Hughes%2C%20J.M.%20Gerberding%2C%20J.L.%20Anthrax%20bioterrorism%3A%20lessons%20learned%20and%20future%20directions%202002",
            "scite": "https://sandbox-api.scholarcy.com/scite_url?query=Hughes%2C%20J.M.%20Gerberding%2C%20J.L.%20Anthrax%20bioterrorism%3A%20lessons%20learned%20and%20future%20directions%202002"
        },
        {
            "id": "8",
            "alt_id": "Friebe_et+al_2016_a",
            "entry": "8. Friebe S, van der Goot FG, Burgi J. The ins and outs of anthrax toxin. Toxins (Basel). 2016;8.Google Scholar",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Friebe%20S%20van%20der%20Goot%20FG%20Burgi%20J%20The%20ins%20and%20outs%20of%20anthrax%20toxin%20Toxins%20Basel%2020168Google%20Scholar",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=Friebe%20S%20van%20der%20Goot%20FG%20Burgi%20J%20The%20ins%20and%20outs%20of%20anthrax%20toxin%20Toxins%20Basel%2020168Google%20Scholar",
            "scite": "https://sandbox-api.scholarcy.com/scite_url?query=Friebe%20S%20van%20der%20Goot%20FG%20Burgi%20J%20The%20ins%20and%20outs%20of%20anthrax%20toxin%20Toxins%20Basel%2020168Google%20Scholar"
        },
        {
            "id": "9",
            "alt_id": "Adalja_2015_a",
            "entry": "9. Adalja AA, Toner E, Inglesby TV. Clinical management of potential bioterrorism-related conditions. N Engl J Med. 2015;372:954\u201362.CrossRefGoogle Scholar",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Adalja%2C%20A.A.%20Toner%2C%20E.%20Inglesby%20TV.%20Clinical%20management%20of%20potential%20bioterrorism-related%20conditions%202015",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=Adalja%2C%20A.A.%20Toner%2C%20E.%20Inglesby%20TV.%20Clinical%20management%20of%20potential%20bioterrorism-related%20conditions%202015",
            "scite": "https://sandbox-api.scholarcy.com/scite_url?query=Adalja%2C%20A.A.%20Toner%2C%20E.%20Inglesby%20TV.%20Clinical%20management%20of%20potential%20bioterrorism-related%20conditions%202015"
        },
        {
            "id": "10",
            "alt_id": "Shafazand_2003_a",
            "entry": "10. Shafazand S. When bioterrorism strikes: diagnosis and management of inhalational anthrax. Semin Respir Infect. 2003;18:134\u201345.PubMedGoogle Scholar",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Shafazand%2C%20S.%20When%20bioterrorism%20strikes%3A%20diagnosis%20and%20management%20of%20inhalational%20anthrax%202003",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=Shafazand%2C%20S.%20When%20bioterrorism%20strikes%3A%20diagnosis%20and%20management%20of%20inhalational%20anthrax%202003",
            "scite": "https://sandbox-api.scholarcy.com/scite_url?query=Shafazand%2C%20S.%20When%20bioterrorism%20strikes%3A%20diagnosis%20and%20management%20of%20inhalational%20anthrax%202003"
        },
        {
            "id": "11",
            "alt_id": "Doganay_et+al_2010_a",
            "entry": "11. Doganay M, Metan G, Alp E. A review of cutaneous anthrax and its outcome. J Infect Public Health. 2010;3:98\u2013105.PubMedCrossRefGoogle Scholar",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Doganay%2C%20M.%20Metan%2C%20G.%20Alp%2C%20E.%20A%20review%20of%20cutaneous%20anthrax%20and%20its%20outcome%202010",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=Doganay%2C%20M.%20Metan%2C%20G.%20Alp%2C%20E.%20A%20review%20of%20cutaneous%20anthrax%20and%20its%20outcome%202010",
            "scite": "https://sandbox-api.scholarcy.com/scite_url?query=Doganay%2C%20M.%20Metan%2C%20G.%20Alp%2C%20E.%20A%20review%20of%20cutaneous%20anthrax%20and%20its%20outcome%202010"
        },
        {
            "id": "12",
            "alt_id": "Sirisanthana_2002_a",
            "entry": "12. Sirisanthana T, Brown AE. Anthrax of the gastrointestinal tract. Emerg Infect Dis. 2002;8:649\u201351.PubMedPubMedCentralCrossRefGoogle Scholar",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Sirisanthana%2C%20T.%20Brown%2C%20A.E.%20Anthrax%20of%20the%20gastrointestinal%20tract.%20Emerg%20Infect%20Dis%202002"
        },
        {
            "id": "13",
            "alt_id": "Purcell_et+al_2007_a",
            "entry": "13. Purcell B, Worsham P, Friedlander A. Anthrax. In: Dembek ZS, editor. Medical aspects of biological warfare. Falls Church, VA: Borden Institute and US Army Office of the Surgeon General; 2007.Google Scholar",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Purcell%2C%20B.%20Worsham%2C%20P.%20Friedlander%2C%20A.%20Anthrax%202007",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=Purcell%2C%20B.%20Worsham%2C%20P.%20Friedlander%2C%20A.%20Anthrax%202007",
            "scite": "https://sandbox-api.scholarcy.com/scite_url?query=Purcell%2C%20B.%20Worsham%2C%20P.%20Friedlander%2C%20A.%20Anthrax%202007"
        },
        {
            "id": "14",
            "alt_id": "Barakat_et+al_2002_a",
            "entry": "14. Barakat LA, Quentzel HL, Jernigan JA, et al. Fatal inhalational anthrax in a 94-year-old Connecticut woman. JAMA. 2002;287:863\u20138.PubMedCrossRefGoogle Scholar",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Barakat%2C%20L.A.%20Quentzel%2C%20H.L.%20Jernigan%2C%20J.A.%20Fatal%20inhalational%20anthrax%20in%20a%2094-year-old%20Connecticut%20woman%202002",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=Barakat%2C%20L.A.%20Quentzel%2C%20H.L.%20Jernigan%2C%20J.A.%20Fatal%20inhalational%20anthrax%20in%20a%2094-year-old%20Connecticut%20woman%202002",
            "scite": "https://sandbox-api.scholarcy.com/scite_url?query=Barakat%2C%20L.A.%20Quentzel%2C%20H.L.%20Jernigan%2C%20J.A.%20Fatal%20inhalational%20anthrax%20in%20a%2094-year-old%20Connecticut%20woman%202002"
        },
        {
            "id": "15",
            "alt_id": "Abramova_et+al_1993_a",
            "entry": "15. Abramova FA, Grinberg LM, Yampolskaya OV, Walker DH. Pathology of inhalational anthrax in 42 cases from the Sverdlovsk outbreak of 1979. Proc Natl Acad Sci U S A. 1993;90:2291\u20134.PubMedPubMedCentralCrossRefGoogle Scholar",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Abramova%2C%20F.A.%20Grinberg%2C%20L.M.%20Yampolskaya%2C%20O.V.%20Walker%2C%20D.H.%20Pathology%20of%20inhalational%20anthrax%20in%2042%20cases%20from%20the%20Sverdlovsk%201993",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=Abramova%2C%20F.A.%20Grinberg%2C%20L.M.%20Yampolskaya%2C%20O.V.%20Walker%2C%20D.H.%20Pathology%20of%20inhalational%20anthrax%20in%2042%20cases%20from%20the%20Sverdlovsk%201993",
            "scite": "https://sandbox-api.scholarcy.com/scite_url?query=Abramova%2C%20F.A.%20Grinberg%2C%20L.M.%20Yampolskaya%2C%20O.V.%20Walker%2C%20D.H.%20Pathology%20of%20inhalational%20anthrax%20in%2042%20cases%20from%20the%20Sverdlovsk%201993"
        },
        {
            "id": "16",
            "alt_id": "Bower_et+al_2015_a",
            "entry": "16. Bower WA, Hendricks K, Pillai S, et al. Clinical framework and medical countermeasure use during an anthrax mass-casualty incident. MMWR Recomm Rep. 2015;64:1\u201322.PubMedCrossRefGoogle Scholar",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Bower%2C%20W.A.%20Hendricks%2C%20K.%20Pillai%2C%20S.%20Clinical%20framework%20and%20medical%20countermeasure%20use%20during%20an%20anthrax%20mass-casualty%20incident%202015",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=Bower%2C%20W.A.%20Hendricks%2C%20K.%20Pillai%2C%20S.%20Clinical%20framework%20and%20medical%20countermeasure%20use%20during%20an%20anthrax%20mass-casualty%20incident%202015",
            "scite": "https://sandbox-api.scholarcy.com/scite_url?query=Bower%2C%20W.A.%20Hendricks%2C%20K.%20Pillai%2C%20S.%20Clinical%20framework%20and%20medical%20countermeasure%20use%20during%20an%20anthrax%20mass-casualty%20incident%202015"
        },
        {
            "id": "17",
            "alt_id": "Mayer_et+al_2001_a",
            "entry": "17. Mayer TA, Bersoff-Matcha S, Murphy C, et al. Clinical presentation of inhalational anthrax following bioterrorism exposure: report of 2 surviving patients. JAMA. 2001;286:2549\u201353.PubMedCrossRefGoogle Scholar",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Mayer%2C%20T.A.%20Bersoff-Matcha%2C%20S.%20Murphy%2C%20C.%20Clinical%20presentation%20of%20inhalational%20anthrax%20following%20bioterrorism%20exposure%3A%20report%20of%202%20surviving%20patients%202001",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=Mayer%2C%20T.A.%20Bersoff-Matcha%2C%20S.%20Murphy%2C%20C.%20Clinical%20presentation%20of%20inhalational%20anthrax%20following%20bioterrorism%20exposure%3A%20report%20of%202%20surviving%20patients%202001",
            "scite": "https://sandbox-api.scholarcy.com/scite_url?query=Mayer%2C%20T.A.%20Bersoff-Matcha%2C%20S.%20Murphy%2C%20C.%20Clinical%20presentation%20of%20inhalational%20anthrax%20following%20bioterrorism%20exposure%3A%20report%20of%202%20surviving%20patients%202001"
        },
        {
            "id": "18",
            "alt_id": "Holty_et+al_2006_a",
            "entry": "18. Holty JE, Bravata DM, Liu H, Olshen RA, McDonald KM, Owens DK. Systematic review: a century of inhalational anthrax cases from 1900 to 2005. Ann Intern Med. 2006;144:270\u201380.PubMedCrossRefGoogle Scholar",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Holty%20JE%20Bravata%20DM%20Liu%20H%20Olshen%20RA%20McDonald%20KM%20Owens%20DK%20Systematic%20review%20a%20century%20of%20inhalational%20anthrax%20cases%20from%201900%20to%202005%20Ann%20Intern%20Med%20200614427080PubMedCrossRefGoogle%20Scholar",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=Holty%20JE%20Bravata%20DM%20Liu%20H%20Olshen%20RA%20McDonald%20KM%20Owens%20DK%20Systematic%20review%20a%20century%20of%20inhalational%20anthrax%20cases%20from%201900%20to%202005%20Ann%20Intern%20Med%20200614427080PubMedCrossRefGoogle%20Scholar",
            "scite": "https://sandbox-api.scholarcy.com/scite_url?query=Holty%20JE%20Bravata%20DM%20Liu%20H%20Olshen%20RA%20McDonald%20KM%20Owens%20DK%20Systematic%20review%20a%20century%20of%20inhalational%20anthrax%20cases%20from%201900%20to%202005%20Ann%20Intern%20Med%20200614427080PubMedCrossRefGoogle%20Scholar"
        },
        {
            "id": "19",
            "alt_id": "Holty_et+al_2006_b",
            "entry": "19. Holty JE, Kim RY, Bravata DM. Anthrax: a systematic review of atypical presentations. Ann Emerg Med. 2006;48:200\u201311.PubMedCrossRefGoogle Scholar",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Holty%2C%20J.E.%20Kim%2C%20R.Y.%20Bravata%2C%20D.M.%20Anthrax%3A%20a%20systematic%20review%20of%20atypical%20presentations%202006",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=Holty%2C%20J.E.%20Kim%2C%20R.Y.%20Bravata%2C%20D.M.%20Anthrax%3A%20a%20systematic%20review%20of%20atypical%20presentations%202006",
            "scite": "https://sandbox-api.scholarcy.com/scite_url?query=Holty%2C%20J.E.%20Kim%2C%20R.Y.%20Bravata%2C%20D.M.%20Anthrax%3A%20a%20systematic%20review%20of%20atypical%20presentations%202006"
        },
        {
            "id": "20",
            "alt_id": "Hendricks_et+al_2014_a",
            "entry": "20. Hendricks KA, Wright ME, Shadomy SV, et al. Centers for disease control and prevention expert panel meetings on prevention and treatment of anthrax in adults. Emerg Infect Dis. 2014;20:e130687.PubMedCentralCrossRefPubMedGoogle Scholar",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Hendricks%2C%20K.A.%20Wright%2C%20M.E.%20Shadomy%2C%20S.V.%20Centers%20for%20disease%20control%20and%20prevention%20expert%20panel%20meetings%20on%20prevention%20and%20treatment%20of%20anthrax%20in%20adults.%20Emerg%20Infect%20Dis%202014"
        },
        {
            "id": "21",
            "alt_id": "Katharios-Lanwermeyer_et+al_2016_a",
            "entry": "21. Katharios-Lanwermeyer S, Holty JE, Person M, et al. Identifying meningitis during an anthrax mass casualty incident: systematic review of systemic anthrax since 1880. Clinical Infect Dis. 2016;62:1537\u201345.CrossRefGoogle Scholar",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=KathariosLanwermeyer%20S%20Holty%20JE%20Person%20M%20et%20al%20Identifying%20meningitis%20during%20an%20anthrax%20mass%20casualty%20incident%20systematic%20review%20of%20systemic%20anthrax%20since%201880%20Clinical%20Infect%20Dis%20201662153745CrossRefGoogle%20Scholar",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=KathariosLanwermeyer%20S%20Holty%20JE%20Person%20M%20et%20al%20Identifying%20meningitis%20during%20an%20anthrax%20mass%20casualty%20incident%20systematic%20review%20of%20systemic%20anthrax%20since%201880%20Clinical%20Infect%20Dis%20201662153745CrossRefGoogle%20Scholar",
            "scite": "https://sandbox-api.scholarcy.com/scite_url?query=KathariosLanwermeyer%20S%20Holty%20JE%20Person%20M%20et%20al%20Identifying%20meningitis%20during%20an%20anthrax%20mass%20casualty%20incident%20systematic%20review%20of%20systemic%20anthrax%20since%201880%20Clinical%20Infect%20Dis%20201662153745CrossRefGoogle%20Scholar"
        },
        {
            "id": "22",
            "alt_id": "Meaney-Delman_et+al_2014_a",
            "entry": "22. Meaney-Delman D, Zotti ME, Creanga AA, et al. Special considerations for prophylaxis for and treatment of anthrax in pregnant and postpartum women. Emerg Infect Dis. 2014;20.Google Scholar",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Meaney-Delman%2C%20D.%20Zotti%2C%20M.E.%20Creanga%2C%20A.A.%20Special%20considerations%20for%20prophylaxis%20for%20and%20treatment%20of%20anthrax%20in%20pregnant%20and%20postpartum%20women.%20Emerg%20Infect%20Dis%202014",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=Meaney-Delman%2C%20D.%20Zotti%2C%20M.E.%20Creanga%2C%20A.A.%20Special%20considerations%20for%20prophylaxis%20for%20and%20treatment%20of%20anthrax%20in%20pregnant%20and%20postpartum%20women.%20Emerg%20Infect%20Dis%202014",
            "scite": "https://sandbox-api.scholarcy.com/scite_url?query=Meaney-Delman%2C%20D.%20Zotti%2C%20M.E.%20Creanga%2C%20A.A.%20Special%20considerations%20for%20prophylaxis%20for%20and%20treatment%20of%20anthrax%20in%20pregnant%20and%20postpartum%20women.%20Emerg%20Infect%20Dis%202014"
        },
        {
            "id": "23",
            "alt_id": "Bartlett_et+al_2002_a",
            "entry": "23. Bartlett JG, Inglesby TV Jr, Borio L. Management of anthrax. Clin Infect Dis. 2002;35:851\u20138.PubMedCrossRefGoogle Scholar",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Bartlett%2C%20J.G.%20TV%2C%20Jr%2C%20Inglesby%20Borio%2C%20L.%20Management%20of%20anthrax.%20Clin%20Infect%20Dis%202002"
        },
        {
            "id": "24",
            "alt_id": "Inglesby_et+al_2002_a",
            "entry": "24. Inglesby TV, O\u2019Toole T, Henderson DA, et al. Anthrax as a biological weapon, 2002: updated recommendations for management. JAMA. 2002;287:2236\u201352.PubMedCrossRefGoogle Scholar",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Inglesby%20TV%20OToole%20T%20Henderson%20DA%20et%20al%20Anthrax%20as%20a%20biological%20weapon%202002%20updated%20recommendations%20for%20management%20JAMA%202002287223652PubMedCrossRefGoogle%20Scholar",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=Inglesby%20TV%20OToole%20T%20Henderson%20DA%20et%20al%20Anthrax%20as%20a%20biological%20weapon%202002%20updated%20recommendations%20for%20management%20JAMA%202002287223652PubMedCrossRefGoogle%20Scholar",
            "scite": "https://sandbox-api.scholarcy.com/scite_url?query=Inglesby%20TV%20OToole%20T%20Henderson%20DA%20et%20al%20Anthrax%20as%20a%20biological%20weapon%202002%20updated%20recommendations%20for%20management%20JAMA%202002287223652PubMedCrossRefGoogle%20Scholar"
        },
        {
            "id": "25",
            "alt_id": "Walsh_et+al_2007_a",
            "entry": "25. Walsh JJ, Pesik N, Quinn CP, et al. A case of naturally acquired inhalation anthrax: clinical care and analyses of anti-protective antigen immunoglobulin G and lethal factor. Clin Infect Dis. 2007;44:968\u201371.PubMedCrossRefGoogle Scholar",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Walsh%2C%20J.J.%20Pesik%2C%20N.%20Quinn%2C%20C.P.%20A%20case%20of%20naturally%20acquired%20inhalation%20anthrax%3A%20clinical%20care%20and%20analyses%20of%20anti-protective%20antigen%20immunoglobulin%20G%20and%20lethal%20factor%202007",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=Walsh%2C%20J.J.%20Pesik%2C%20N.%20Quinn%2C%20C.P.%20A%20case%20of%20naturally%20acquired%20inhalation%20anthrax%3A%20clinical%20care%20and%20analyses%20of%20anti-protective%20antigen%20immunoglobulin%20G%20and%20lethal%20factor%202007",
            "scite": "https://sandbox-api.scholarcy.com/scite_url?query=Walsh%2C%20J.J.%20Pesik%2C%20N.%20Quinn%2C%20C.P.%20A%20case%20of%20naturally%20acquired%20inhalation%20anthrax%3A%20clinical%20care%20and%20analyses%20of%20anti-protective%20antigen%20immunoglobulin%20G%20and%20lethal%20factor%202007"
        },
        {
            "id": "26",
            "alt_id": "Klempner_et+al_2010_a",
            "entry": "26. Klempner MS, Talbot EA, Lee SI, Zaki S, Ferraro MJ. Case records of the Massachusetts General Hospital. Case 25-2010. A 24-year-old woman with abdominal pain and shock. N Engl J Med. 2010;363:766\u201377.PubMedCrossRefGoogle Scholar",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Klempner%2C%20M.S.%20Talbot%2C%20E.A.%20Lee%2C%20S.I.%20Zaki%2C%20S.%20Case%20records%20of%20the%20Massachusetts%20General%20Hospital.%20Case%2025-2010.%20A%2024-year-old%20woman%20with%20abdominal%20pain%20and%20shock%202010",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=Klempner%2C%20M.S.%20Talbot%2C%20E.A.%20Lee%2C%20S.I.%20Zaki%2C%20S.%20Case%20records%20of%20the%20Massachusetts%20General%20Hospital.%20Case%2025-2010.%20A%2024-year-old%20woman%20with%20abdominal%20pain%20and%20shock%202010",
            "scite": "https://sandbox-api.scholarcy.com/scite_url?query=Klempner%2C%20M.S.%20Talbot%2C%20E.A.%20Lee%2C%20S.I.%20Zaki%2C%20S.%20Case%20records%20of%20the%20Massachusetts%20General%20Hospital.%20Case%2025-2010.%20A%2024-year-old%20woman%20with%20abdominal%20pain%20and%20shock%202010"
        },
        {
            "id": "27",
            "alt_id": "Webster_et+al_2004_a",
            "entry": "27. Webster JI, Moayeri M, Sternberg EM. Novel repression of the glucocorticoid receptor by anthrax lethal toxin. Ann N Y Acad Sci. 2004;1024:9\u201323.PubMedCrossRefGoogle Scholar",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Webster%2C%20J.I.%20Moayeri%2C%20M.%20Sternberg%2C%20E.M.%20Novel%20repression%20of%20the%20glucocorticoid%20receptor%20by%20anthrax%20lethal%20toxin%202004",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=Webster%2C%20J.I.%20Moayeri%2C%20M.%20Sternberg%2C%20E.M.%20Novel%20repression%20of%20the%20glucocorticoid%20receptor%20by%20anthrax%20lethal%20toxin%202004",
            "scite": "https://sandbox-api.scholarcy.com/scite_url?query=Webster%2C%20J.I.%20Moayeri%2C%20M.%20Sternberg%2C%20E.M.%20Novel%20repression%20of%20the%20glucocorticoid%20receptor%20by%20anthrax%20lethal%20toxin%202004"
        },
        {
            "id": "28",
            "alt_id": "Yamamoto_et+al_2016_a",
            "entry": "28. Yamamoto BJ, Shadiack AM, Carpenter S, et al. Efficacy projection of obiltoxaximab for treatment of inhalational anthrax across a range of disease severity. Antimicrob Agents Chemother. 2016;60:5787\u201395.PubMedPubMedCentralCrossRefGoogle Scholar",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Yamamoto%2C%20B.J.%20Shadiack%2C%20A.M.%20Carpenter%2C%20S.%20Efficacy%20projection%20of%20obiltoxaximab%20for%20treatment%20of%20inhalational%20anthrax%20across%20a%20range%20of%20disease%20severity%202016",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=Yamamoto%2C%20B.J.%20Shadiack%2C%20A.M.%20Carpenter%2C%20S.%20Efficacy%20projection%20of%20obiltoxaximab%20for%20treatment%20of%20inhalational%20anthrax%20across%20a%20range%20of%20disease%20severity%202016",
            "scite": "https://sandbox-api.scholarcy.com/scite_url?query=Yamamoto%2C%20B.J.%20Shadiack%2C%20A.M.%20Carpenter%2C%20S.%20Efficacy%20projection%20of%20obiltoxaximab%20for%20treatment%20of%20inhalational%20anthrax%20across%20a%20range%20of%20disease%20severity%202016"
        },
        {
            "id": "29",
            "alt_id": "Yamamoto_et+al_2016_b",
            "entry": "29. Yamamoto BJ, Shadiack AM, Carpenter S, et al. Obiltoxaximab prevents disseminated Bacillus anthracis infection and improves survival during pre- and postexposure prophylaxis in animal models of inhalational anthrax. Antimicrob Agents Chemother. 2016;60:5796\u2013805.PubMedPubMedCentralCrossRefGoogle Scholar",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Yamamoto%2C%20B.J.%20Shadiack%2C%20A.M.%20Carpenter%2C%20S.%20Obiltoxaximab%20prevents%20disseminated%20Bacillus%20anthracis%20infection%20and%20improves%20survival%20during%20pre-%20and%20postexposure%20prophylaxis%20in%20animal%20models%20of%20inhalational%20anthrax%202016",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=Yamamoto%2C%20B.J.%20Shadiack%2C%20A.M.%20Carpenter%2C%20S.%20Obiltoxaximab%20prevents%20disseminated%20Bacillus%20anthracis%20infection%20and%20improves%20survival%20during%20pre-%20and%20postexposure%20prophylaxis%20in%20animal%20models%20of%20inhalational%20anthrax%202016",
            "scite": "https://sandbox-api.scholarcy.com/scite_url?query=Yamamoto%2C%20B.J.%20Shadiack%2C%20A.M.%20Carpenter%2C%20S.%20Obiltoxaximab%20prevents%20disseminated%20Bacillus%20anthracis%20infection%20and%20improves%20survival%20during%20pre-%20and%20postexposure%20prophylaxis%20in%20animal%20models%20of%20inhalational%20anthrax%202016"
        },
        {
            "id": "30",
            "alt_id": "Migone_et+al_2015_a",
            "entry": "30. Migone TS, Bolmer S, Zhong J, et al. Added benefit of raxibacumab to antibiotic treatment of inhalational anthrax. Antimicrob Agents Chemother. 2015;59:1145\u201351.PubMedPubMedCentralCrossRefGoogle Scholar",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Migone%2C%20T.S.%20Bolmer%2C%20S.%20Zhong%2C%20J.%20Added%20benefit%20of%20raxibacumab%20to%20antibiotic%20treatment%20of%20inhalational%20anthrax%202015",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=Migone%2C%20T.S.%20Bolmer%2C%20S.%20Zhong%2C%20J.%20Added%20benefit%20of%20raxibacumab%20to%20antibiotic%20treatment%20of%20inhalational%20anthrax%202015",
            "scite": "https://sandbox-api.scholarcy.com/scite_url?query=Migone%2C%20T.S.%20Bolmer%2C%20S.%20Zhong%2C%20J.%20Added%20benefit%20of%20raxibacumab%20to%20antibiotic%20treatment%20of%20inhalational%20anthrax%202015"
        },
        {
            "id": "31",
            "alt_id": "Kummerfeldt_2014_a",
            "entry": "31. Kummerfeldt CE. Raxibacumab: potential role in the treatment of inhalational anthrax. Infect Drug Resist. 2014;7:101\u20139.PubMedPubMedCentralCrossRefGoogle Scholar",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Kummerfeldt%2C%20C.E.%20Raxibacumab%3A%20potential%20role%20in%20the%20treatment%20of%20inhalational%20anthrax%202014",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=Kummerfeldt%2C%20C.E.%20Raxibacumab%3A%20potential%20role%20in%20the%20treatment%20of%20inhalational%20anthrax%202014",
            "scite": "https://sandbox-api.scholarcy.com/scite_url?query=Kummerfeldt%2C%20C.E.%20Raxibacumab%3A%20potential%20role%20in%20the%20treatment%20of%20inhalational%20anthrax%202014"
        },
        {
            "id": "32",
            "alt_id": "Kammanadiminti_et+al_2014_a",
            "entry": "32. Kammanadiminti S, Patnaikuni RK, Comer J, Meister G, Sinclair C, Kodihalli S. Combination therapy with antibiotics and anthrax immune globulin intravenous (AIGIV) is potentially more effective than antibiotics alone in rabbit model of inhalational anthrax. PLoS One. 2014;9:e106393.PubMedPubMedCentralCrossRefGoogle Scholar",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Kammanadiminti%2C%20S.%20Patnaikuni%2C%20R.K.%20Comer%2C%20J.%20Meister%2C%20G.%20Combination%20therapy%20with%20antibiotics%20and%20anthrax%20immune%20globulin%20intravenous%20%28AIGIV%29%20is%20potentially%20more%20effective%20than%20antibiotics%20alone%20in%20rabbit%20model%20of%20inhalational%20anthrax%202014",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=Kammanadiminti%2C%20S.%20Patnaikuni%2C%20R.K.%20Comer%2C%20J.%20Meister%2C%20G.%20Combination%20therapy%20with%20antibiotics%20and%20anthrax%20immune%20globulin%20intravenous%20%28AIGIV%29%20is%20potentially%20more%20effective%20than%20antibiotics%20alone%20in%20rabbit%20model%20of%20inhalational%20anthrax%202014",
            "scite": "https://sandbox-api.scholarcy.com/scite_url?query=Kammanadiminti%2C%20S.%20Patnaikuni%2C%20R.K.%20Comer%2C%20J.%20Meister%2C%20G.%20Combination%20therapy%20with%20antibiotics%20and%20anthrax%20immune%20globulin%20intravenous%20%28AIGIV%29%20is%20potentially%20more%20effective%20than%20antibiotics%20alone%20in%20rabbit%20model%20of%20inhalational%20anthrax%202014"
        },
        {
            "id": "33",
            "alt_id": "Andrianaivoarimanana_et+al_2013_a",
            "entry": "33. Andrianaivoarimanana V, Kreppel K, Elissa N, et al. Understanding the persistence of plague foci in Madagascar. PLoS Negl Trop Dis. 2013;7:e2382.PubMedPubMedCentralCrossRefGoogle Scholar",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Andrianaivoarimanana%2C%20V.%20Kreppel%2C%20K.%20Elissa%2C%20N.%20Understanding%20the%20persistence%20of%20plague%20foci%20in%20Madagascar%202013",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=Andrianaivoarimanana%2C%20V.%20Kreppel%2C%20K.%20Elissa%2C%20N.%20Understanding%20the%20persistence%20of%20plague%20foci%20in%20Madagascar%202013",
            "scite": "https://sandbox-api.scholarcy.com/scite_url?query=Andrianaivoarimanana%2C%20V.%20Kreppel%2C%20K.%20Elissa%2C%20N.%20Understanding%20the%20persistence%20of%20plague%20foci%20in%20Madagascar%202013"
        },
        {
            "id": "34",
            "alt_id": "Hinnebusch_et+al_2017_a",
            "entry": "34. Hinnebusch BJ, Bland DM, Bosio CF, Jarrett CO. Comparative ability of Oropsylla montana and Xenopsylla cheopis fleas to transmit Yersinia pestis by two different mechanisms. PLoS Negl Trop Dis. 2017;11:e0005276.PubMedPubMedCentralCrossRefGoogle Scholar",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Hinnebusch%2C%20B.J.%20Bland%2C%20D.M.%20Bosio%2C%20C.F.%20Jarrett%2C%20C.O.%20Comparative%20ability%20of%20Oropsylla%20montana%20and%20Xenopsylla%20cheopis%20fleas%20to%20transmit%20Yersinia%20pestis%20by%20two%20different%20mechanisms%202017",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=Hinnebusch%2C%20B.J.%20Bland%2C%20D.M.%20Bosio%2C%20C.F.%20Jarrett%2C%20C.O.%20Comparative%20ability%20of%20Oropsylla%20montana%20and%20Xenopsylla%20cheopis%20fleas%20to%20transmit%20Yersinia%20pestis%20by%20two%20different%20mechanisms%202017",
            "scite": "https://sandbox-api.scholarcy.com/scite_url?query=Hinnebusch%2C%20B.J.%20Bland%2C%20D.M.%20Bosio%2C%20C.F.%20Jarrett%2C%20C.O.%20Comparative%20ability%20of%20Oropsylla%20montana%20and%20Xenopsylla%20cheopis%20fleas%20to%20transmit%20Yersinia%20pestis%20by%20two%20different%20mechanisms%202017"
        },
        {
            "id": "35",
            "alt_id": "Smego_et+al_1999_a",
            "entry": "35. Smego RA, Frean J, Koornhof HJ. Yersiniosis I: microbiological and clinicoepidemiological aspects of plague and non-plague Yersinia infections. Eur J Clin Microbiol Infect Dis. 1999;18:1\u201315.PubMedCrossRefPubMedCentralGoogle Scholar",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Smego%2C%20R.A.%20Frean%2C%20J.%20Koornhof%2C%20H.J.%20Yersiniosis%20I%3A%20microbiological%20and%20clinicoepidemiological%20aspects%20of%20plague%20and%20non-plague%20Yersinia%20infections%201999",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=Smego%2C%20R.A.%20Frean%2C%20J.%20Koornhof%2C%20H.J.%20Yersiniosis%20I%3A%20microbiological%20and%20clinicoepidemiological%20aspects%20of%20plague%20and%20non-plague%20Yersinia%20infections%201999",
            "scite": "https://sandbox-api.scholarcy.com/scite_url?query=Smego%2C%20R.A.%20Frean%2C%20J.%20Koornhof%2C%20H.J.%20Yersiniosis%20I%3A%20microbiological%20and%20clinicoepidemiological%20aspects%20of%20plague%20and%20non-plague%20Yersinia%20infections%201999"
        },
        {
            "id": "36",
            "alt_id": "Inglesby_et+al_2000_a",
            "entry": "36. Inglesby TV, Dennis DT, Henderson DA, et al. Plague as a biological weapon: medical and public health managemen. Working Group on Civilian Biodefense t. JAMA. 2000;283:2281\u201390.PubMedCrossRefGoogle Scholar",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Inglesby%2C%20T.V.%20Dennis%2C%20D.T.%20Henderson%2C%20D.A.%20Plague%20as%20a%20biological%20weapon%3A%20medical%20and%20public%20health%20managemen.%20Working%20Group%20on%20Civilian%20Biodefense%20t%202000",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=Inglesby%2C%20T.V.%20Dennis%2C%20D.T.%20Henderson%2C%20D.A.%20Plague%20as%20a%20biological%20weapon%3A%20medical%20and%20public%20health%20managemen.%20Working%20Group%20on%20Civilian%20Biodefense%20t%202000",
            "scite": "https://sandbox-api.scholarcy.com/scite_url?query=Inglesby%2C%20T.V.%20Dennis%2C%20D.T.%20Henderson%2C%20D.A.%20Plague%20as%20a%20biological%20weapon%3A%20medical%20and%20public%20health%20managemen.%20Working%20Group%20on%20Civilian%20Biodefense%20t%202000"
        },
        {
            "id": "37",
            "alt_id": "Atkinson_2016_a",
            "entry": "37. Atkinson S, Williams P. Yersinia virulence factors\u00a0\u2013 a sophisticated arsenal for combating host defences. F1000Res. 2016;5.CrossRefGoogle Scholar",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Atkinson%2C%20S.%20Williams%2C%20P.%20Yersinia%20virulence%20factors%20%E2%80%93%20a%20sophisticated%20arsenal%20for%20combating%20host%20defences.%20F1000Res%202016",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=Atkinson%2C%20S.%20Williams%2C%20P.%20Yersinia%20virulence%20factors%20%E2%80%93%20a%20sophisticated%20arsenal%20for%20combating%20host%20defences.%20F1000Res%202016",
            "scite": "https://sandbox-api.scholarcy.com/scite_url?query=Atkinson%2C%20S.%20Williams%2C%20P.%20Yersinia%20virulence%20factors%20%E2%80%93%20a%20sophisticated%20arsenal%20for%20combating%20host%20defences.%20F1000Res%202016"
        },
        {
            "id": "38",
            "alt_id": "Knirel_2012_a",
            "entry": "38. Knirel YA, Anisimov AP. Lipopolysaccharide of Yersinia pestis, the cause of plague: structure, genetics, biological properties. Acta Nat. 2012;4:46\u201358.CrossRefGoogle Scholar",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Knirel%2C%20Y.A.%20Anisimov%2C%20A.P.%20Lipopolysaccharide%20of%20Yersinia%20pestis%2C%20the%20cause%20of%20plague%3A%20structure%2C%20genetics%2C%20biological%20properties%202012",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=Knirel%2C%20Y.A.%20Anisimov%2C%20A.P.%20Lipopolysaccharide%20of%20Yersinia%20pestis%2C%20the%20cause%20of%20plague%3A%20structure%2C%20genetics%2C%20biological%20properties%202012",
            "scite": "https://sandbox-api.scholarcy.com/scite_url?query=Knirel%2C%20Y.A.%20Anisimov%2C%20A.P.%20Lipopolysaccharide%20of%20Yersinia%20pestis%2C%20the%20cause%20of%20plague%3A%20structure%2C%20genetics%2C%20biological%20properties%202012"
        },
        {
            "id": "39",
            "alt_id": "Khan_2004_a",
            "entry": "39. Khan IA. Plague: the dreadful visitation occupying the human mind for centuries. Trans R Soc Trop Med Hyg. 2004;98:270\u20137.PubMedCrossRefPubMedCentralGoogle Scholar",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Khan%2C%20I.A.%20Plague%3A%20the%20dreadful%20visitation%20occupying%20the%20human%20mind%20for%20centuries.%20Trans%20R%20Soc%20Trop%20Med%20Hyg%202004"
        },
        {
            "id": "40",
            "alt_id": "Andrianaivoarimanana_et+al_2019_a",
            "entry": "40. Andrianaivoarimanana V, Piola P, Wagner DM, et al. Trends of human plague, Madagascar, 1998\u20132016. Emerg Infect Dis. 2019;25:220\u20138.PubMedPubMedCentralCrossRefGoogle Scholar",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Andrianaivoarimanana%20V%20Piola%20P%20Wagner%20DM%20et%20al%20Trends%20of%20human%20plague%20Madagascar%2019982016%20Emerg%20Infect%20Dis%202019252208PubMedPubMedCentralCrossRefGoogle%20Scholar"
        },
        {
            "id": "41",
            "alt_id": "Mead_2018_a",
            "entry": "41. Mead PS. Plague in Madagascar\u00a0\u2013 a tragic opportunity for improving public health. N Engl J Med. 2018;378:106\u20138.PubMedCrossRefGoogle Scholar",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Mead%2C%20P.S.%20Plague%20in%20Madagascar%20%E2%80%93%20a%20tragic%20opportunity%20for%20improving%20public%20health%202018",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=Mead%2C%20P.S.%20Plague%20in%20Madagascar%20%E2%80%93%20a%20tragic%20opportunity%20for%20improving%20public%20health%202018",
            "scite": "https://sandbox-api.scholarcy.com/scite_url?query=Mead%2C%20P.S.%20Plague%20in%20Madagascar%20%E2%80%93%20a%20tragic%20opportunity%20for%20improving%20public%20health%202018"
        },
        {
            "id": "42",
            "alt_id": "Christopher_et+al_1997_a",
            "entry": "42. Christopher GW, Cieslak TJ, Pavlin JA, Eitzen EM Jr. Biological warfare. A historical perspective. JAMA. 1997;278:412\u20137.PubMedCrossRefGoogle Scholar",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Christopher%2C%20G.W.%20Cieslak%2C%20T.J.%20Pavlin%2C%20J.A.%20EM%2C%20Jr%2C%20Eitzen%20Biological%20warfare.%20A%20historical%20perspective%201997",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=Christopher%2C%20G.W.%20Cieslak%2C%20T.J.%20Pavlin%2C%20J.A.%20EM%2C%20Jr%2C%20Eitzen%20Biological%20warfare.%20A%20historical%20perspective%201997",
            "scite": "https://sandbox-api.scholarcy.com/scite_url?query=Christopher%2C%20G.W.%20Cieslak%2C%20T.J.%20Pavlin%2C%20J.A.%20EM%2C%20Jr%2C%20Eitzen%20Biological%20warfare.%20A%20historical%20perspective%201997"
        },
        {
            "id": "43",
            "alt_id": "Kwit_et+al_2015_a",
            "entry": "43. Kwit N, Nelson C, Kugeler K, et al. Human plague - United States, 2015. MMWR Morb Mortal Wkly Rep. 2015;64:918\u20139.PubMedCrossRefGoogle Scholar",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Kwit%20N%20Nelson%20C%20Kugeler%20K%20et%20al%20Human%20plague%20%20United%20States%202015%20MMWR%20Morb%20Mortal%20Wkly%20Rep%202015649189PubMedCrossRefGoogle%20Scholar",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=Kwit%20N%20Nelson%20C%20Kugeler%20K%20et%20al%20Human%20plague%20%20United%20States%202015%20MMWR%20Morb%20Mortal%20Wkly%20Rep%202015649189PubMedCrossRefGoogle%20Scholar",
            "scite": "https://sandbox-api.scholarcy.com/scite_url?query=Kwit%20N%20Nelson%20C%20Kugeler%20K%20et%20al%20Human%20plague%20%20United%20States%202015%20MMWR%20Morb%20Mortal%20Wkly%20Rep%202015649189PubMedCrossRefGoogle%20Scholar"
        },
        {
            "id": "44",
            "alt_id": "Crook_1992_a",
            "entry": "44. Crook LD, Tempest B. Plague. A clinical review of 27 cases. Arch Intern Med. 1992;152:1253\u20136.PubMedCrossRefGoogle Scholar",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Crook%2C%20L.D.%20Tempest%2C%20B.%20Plague.%20A%20clinical%20review%20of%2027%20cases%201992",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=Crook%2C%20L.D.%20Tempest%2C%20B.%20Plague.%20A%20clinical%20review%20of%2027%20cases%201992",
            "scite": "https://sandbox-api.scholarcy.com/scite_url?query=Crook%2C%20L.D.%20Tempest%2C%20B.%20Plague.%20A%20clinical%20review%20of%2027%20cases%201992"
        },
        {
            "id": "45",
            "alt_id": "Watson_et+al_2017_a",
            "entry": "45. Watson AK, Ellington S, Nelson C, Treadwell T, Jamieson DJ, Meaney-Delman DM. Preparing for biological threats: addressing the needs of pregnant women. Birth Defects Res. 2017;109:391\u20138.PubMedCrossRefGoogle Scholar",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Watson%2C%20A.K.%20Ellington%2C%20S.%20Nelson%2C%20C.%20Treadwell%2C%20T.%20Preparing%20for%20biological%20threats%3A%20addressing%20the%20needs%20of%20pregnant%20women%202017",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=Watson%2C%20A.K.%20Ellington%2C%20S.%20Nelson%2C%20C.%20Treadwell%2C%20T.%20Preparing%20for%20biological%20threats%3A%20addressing%20the%20needs%20of%20pregnant%20women%202017",
            "scite": "https://sandbox-api.scholarcy.com/scite_url?query=Watson%2C%20A.K.%20Ellington%2C%20S.%20Nelson%2C%20C.%20Treadwell%2C%20T.%20Preparing%20for%20biological%20threats%3A%20addressing%20the%20needs%20of%20pregnant%20women%202017"
        },
        {
            "id": "46",
            "alt_id": "Wong_1986_a",
            "entry": "46. Wong TW. Plague in a pregnant patient. Trop Dr. 1986;16:187\u20139.CrossRefGoogle Scholar",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Wong%2C%20T.W.%20Plague%20in%20a%20pregnant%20patient.%20Trop%20Dr%201986",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=Wong%2C%20T.W.%20Plague%20in%20a%20pregnant%20patient.%20Trop%20Dr%201986",
            "scite": "https://sandbox-api.scholarcy.com/scite_url?query=Wong%2C%20T.W.%20Plague%20in%20a%20pregnant%20patient.%20Trop%20Dr%201986"
        },
        {
            "id": "47",
            "alt_id": "Welty_et+al_1985_a",
            "entry": "47. Welty TK, Grabman J, Kompare E, et al. Nineteen cases of plague in Arizona. A spectrum including ecthyma gangrenosum due to plague and plague in pregnancy. West J Med. 1985;142:641\u20136.PubMedPubMedCentralGoogle Scholar",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Welty%2C%20T.K.%20Grabman%2C%20J.%20Kompare%2C%20E.%20Nineteen%20cases%20of%20plague%20in%20Arizona.%20A%20spectrum%20including%20ecthyma%20gangrenosum%20due%20to%20plague%20and%20plague%20in%20pregnancy%201985",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=Welty%2C%20T.K.%20Grabman%2C%20J.%20Kompare%2C%20E.%20Nineteen%20cases%20of%20plague%20in%20Arizona.%20A%20spectrum%20including%20ecthyma%20gangrenosum%20due%20to%20plague%20and%20plague%20in%20pregnancy%201985",
            "scite": "https://sandbox-api.scholarcy.com/scite_url?query=Welty%2C%20T.K.%20Grabman%2C%20J.%20Kompare%2C%20E.%20Nineteen%20cases%20of%20plague%20in%20Arizona.%20A%20spectrum%20including%20ecthyma%20gangrenosum%20due%20to%20plague%20and%20plague%20in%20pregnancy%201985"
        },
        {
            "id": "48",
            "alt_id": "Guinet_et+al_2015_a",
            "entry": "48. Guinet F, Ave P, Filali S, et al. Dissociation of tissue destruction and bacterial expansion during bubonic plague. PLoS Pathog. 2015;11:e1005222.PubMedPubMedCentralCrossRefGoogle Scholar",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Guinet%2C%20F.%20Ave%2C%20P.%20Filali%2C%20S.%20Dissociation%20of%20tissue%20destruction%20and%20bacterial%20expansion%20during%20bubonic%20plague%202015",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=Guinet%2C%20F.%20Ave%2C%20P.%20Filali%2C%20S.%20Dissociation%20of%20tissue%20destruction%20and%20bacterial%20expansion%20during%20bubonic%20plague%202015",
            "scite": "https://sandbox-api.scholarcy.com/scite_url?query=Guinet%2C%20F.%20Ave%2C%20P.%20Filali%2C%20S.%20Dissociation%20of%20tissue%20destruction%20and%20bacterial%20expansion%20during%20bubonic%20plague%202015"
        },
        {
            "id": "49",
            "alt_id": "Guinet_et+al_2008_a",
            "entry": "49. Guinet F, Ave P, Jones L, Huerre M, Carniel E. Defective innate cell response and lymph node infiltration specify Yersinia pestis infection. PLoS One. 2008;3:e1688.PubMedPubMedCentralCrossRefGoogle Scholar",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Guinet%2C%20F.%20Ave%2C%20P.%20Jones%2C%20L.%20Huerre%2C%20M.%20Defective%20innate%20cell%20response%20and%20lymph%20node%20infiltration%20specify%20Yersinia%20pestis%20infection%202008",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=Guinet%2C%20F.%20Ave%2C%20P.%20Jones%2C%20L.%20Huerre%2C%20M.%20Defective%20innate%20cell%20response%20and%20lymph%20node%20infiltration%20specify%20Yersinia%20pestis%20infection%202008",
            "scite": "https://sandbox-api.scholarcy.com/scite_url?query=Guinet%2C%20F.%20Ave%2C%20P.%20Jones%2C%20L.%20Huerre%2C%20M.%20Defective%20innate%20cell%20response%20and%20lymph%20node%20infiltration%20specify%20Yersinia%20pestis%20infection%202008"
        },
        {
            "id": "50",
            "alt_id": "Sodeinde_et+al_1992_a",
            "entry": "50. Sodeinde OA, Subrahmanyam YV, Stark K, Quan T, Bao Y, Goguen JD. A surface protease and the invasive character of plague. Science. 1992;258:1004\u20137.PubMedCrossRefGoogle Scholar",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Sodeinde%2C%20O.A.%20Subrahmanyam%2C%20Y.V.%20Stark%2C%20K.%20Quan%2C%20T.%20A%20surface%20protease%20and%20the%20invasive%20character%20of%20plague%201992",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=Sodeinde%2C%20O.A.%20Subrahmanyam%2C%20Y.V.%20Stark%2C%20K.%20Quan%2C%20T.%20A%20surface%20protease%20and%20the%20invasive%20character%20of%20plague%201992",
            "scite": "https://sandbox-api.scholarcy.com/scite_url?query=Sodeinde%2C%20O.A.%20Subrahmanyam%2C%20Y.V.%20Stark%2C%20K.%20Quan%2C%20T.%20A%20surface%20protease%20and%20the%20invasive%20character%20of%20plague%201992"
        },
        {
            "id": "51",
            "alt_id": "Straley_1988_a",
            "entry": "51. Straley SC. The plasmid-encoded outer-membrane proteins of Yersinia pestis. Rev Infect Dis. 1988;10 Suppl 2:S323\u20136.PubMedCrossRefGoogle Scholar",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Straley%2C%20S.C.%20The%20plasmid-encoded%20outer-membrane%20proteins%20of%20Yersinia%20pestis%201988",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=Straley%2C%20S.C.%20The%20plasmid-encoded%20outer-membrane%20proteins%20of%20Yersinia%20pestis%201988",
            "scite": "https://sandbox-api.scholarcy.com/scite_url?query=Straley%2C%20S.C.%20The%20plasmid-encoded%20outer-membrane%20proteins%20of%20Yersinia%20pestis%201988"
        },
        {
            "id": "52",
            "alt_id": "Straley_et+al_1993_a",
            "entry": "52. Straley SC, Skrzypek E, Plano GV, Bliska JB. Yops of Yersinia spp. pathogenic for humans. Infect Immun. 1993;61:3105\u201310.PubMedPubMedCentralGoogle Scholar",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Straley%2C%20S.C.%20Skrzypek%2C%20E.%20Plano%2C%20G.V.%20Bliska%2C%20J.B.%20Yops%20of%20Yersinia%20spp.%20pathogenic%20for%20humans%201993",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=Straley%2C%20S.C.%20Skrzypek%2C%20E.%20Plano%2C%20G.V.%20Bliska%2C%20J.B.%20Yops%20of%20Yersinia%20spp.%20pathogenic%20for%20humans%201993",
            "scite": "https://sandbox-api.scholarcy.com/scite_url?query=Straley%2C%20S.C.%20Skrzypek%2C%20E.%20Plano%2C%20G.V.%20Bliska%2C%20J.B.%20Yops%20of%20Yersinia%20spp.%20pathogenic%20for%20humans%201993"
        },
        {
            "id": "53",
            "alt_id": "Lemaitre_et+al_2006_a",
            "entry": "53. Lemaitre N, Sebbane F, Long D, Hinnebusch BJ. Yersinia pestis YopJ suppresses tumor necrosis factor alpha induction and contributes to apoptosis of immune cells in the lymph node but is not required for virulence in a rat model of bubonic plague. Infect Immun. 2006;74:5126\u201331.PubMedPubMedCentralCrossRefGoogle Scholar",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Lemaitre%2C%20N.%20Sebbane%2C%20F.%20Long%2C%20D.%20Hinnebusch%2C%20B.J.%20Yersinia%20pestis%20YopJ%20suppresses%20tumor%20necrosis%20factor%20alpha%20induction%20and%20contributes%20to%20apoptosis%20of%20immune%20cells%20in%20the%20lymph%20node%20but%20is%20not%20required%20for%20virulence%20in%20a%20rat%20model%20of%20bubonic%20plague%202006",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=Lemaitre%2C%20N.%20Sebbane%2C%20F.%20Long%2C%20D.%20Hinnebusch%2C%20B.J.%20Yersinia%20pestis%20YopJ%20suppresses%20tumor%20necrosis%20factor%20alpha%20induction%20and%20contributes%20to%20apoptosis%20of%20immune%20cells%20in%20the%20lymph%20node%20but%20is%20not%20required%20for%20virulence%20in%20a%20rat%20model%20of%20bubonic%20plague%202006",
            "scite": "https://sandbox-api.scholarcy.com/scite_url?query=Lemaitre%2C%20N.%20Sebbane%2C%20F.%20Long%2C%20D.%20Hinnebusch%2C%20B.J.%20Yersinia%20pestis%20YopJ%20suppresses%20tumor%20necrosis%20factor%20alpha%20induction%20and%20contributes%20to%20apoptosis%20of%20immune%20cells%20in%20the%20lymph%20node%20but%20is%20not%20required%20for%20virulence%20in%20a%20rat%20model%20of%20bubonic%20plague%202006"
        },
        {
            "id": "54",
            "alt_id": "Zhou_et+al_2006_a",
            "entry": "54. Zhou D, Han Y, Yang R. Molecular and physiological insights into plague transmission, virulence and etiology. Microbes Infect. 2006;8:273\u201384.PubMedCrossRefGoogle Scholar",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Zhou%2C%20D.%20Han%2C%20Y.%20Yang%2C%20R.%20Molecular%20and%20physiological%20insights%20into%20plague%20transmission%2C%20virulence%20and%20etiology%202006",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=Zhou%2C%20D.%20Han%2C%20Y.%20Yang%2C%20R.%20Molecular%20and%20physiological%20insights%20into%20plague%20transmission%2C%20virulence%20and%20etiology%202006",
            "scite": "https://sandbox-api.scholarcy.com/scite_url?query=Zhou%2C%20D.%20Han%2C%20Y.%20Yang%2C%20R.%20Molecular%20and%20physiological%20insights%20into%20plague%20transmission%2C%20virulence%20and%20etiology%202006"
        },
        {
            "id": "55",
            "alt_id": "Ketai_2007_a",
            "entry": "55. Ketai L, Tchoyoson Lim CC. Radiology of biological weapons--old and the new? Semin Roentgenol. 2007;42:49\u201359.PubMedCrossRefGoogle Scholar",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Ketai%2C%20L.%20Tchoyoson%20Lim%20CC.%20Radiology%20of%20biological%20weapons--old%20and%20the%20new%3F%202007",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=Ketai%2C%20L.%20Tchoyoson%20Lim%20CC.%20Radiology%20of%20biological%20weapons--old%20and%20the%20new%3F%202007",
            "scite": "https://sandbox-api.scholarcy.com/scite_url?query=Ketai%2C%20L.%20Tchoyoson%20Lim%20CC.%20Radiology%20of%20biological%20weapons--old%20and%20the%20new%3F%202007"
        },
        {
            "id": "56",
            "alt_id": "Siegel_et+al_2007_a",
            "entry": "56. Siegel JD, Rhinehart E, Jackson M, Chiarello L; the Healthcare Infection Control Practices Advisory Committee. 2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Healthcare Settings. Updated September 2018. Accessed online on 11 March 2019 at https://www.cdc.gov/infectioncontrol/guidelines/isolation/index.html.",
            "url": "https://www.cdc.gov/infectioncontrol/guidelines/isolation/index.html"
        },
        {
            "id": "57",
            "alt_id": "Pechous_et+al_2016_a",
            "entry": "57. Pechous RD, Sivaraman V, Stasulli NM, Goldman WE. Pneumonic plague: the darker side of Yersinia pestis. Trends Microbiol. 2016;24:190\u20137.PubMedCrossRefGoogle Scholar",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Pechous%2C%20R.D.%20Sivaraman%2C%20V.%20Stasulli%2C%20N.M.%20Goldman%2C%20W.E.%20Pneumonic%20plague%3A%20the%20darker%20side%20of%20Yersinia%20pestis%202016",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=Pechous%2C%20R.D.%20Sivaraman%2C%20V.%20Stasulli%2C%20N.M.%20Goldman%2C%20W.E.%20Pneumonic%20plague%3A%20the%20darker%20side%20of%20Yersinia%20pestis%202016",
            "scite": "https://sandbox-api.scholarcy.com/scite_url?query=Pechous%2C%20R.D.%20Sivaraman%2C%20V.%20Stasulli%2C%20N.M.%20Goldman%2C%20W.E.%20Pneumonic%20plague%3A%20the%20darker%20side%20of%20Yersinia%20pestis%202016"
        },
        {
            "id": "58",
            "alt_id": "Silver_2015_a",
            "entry": "58. Silver S. Laboratory-acquired lethal infections by potential bioweapons pathogens including Ebola in 2014. FEMS Microbiol Lett. 2015;362:1\u20136.PubMedCrossRefGoogle Scholar",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Silver%20S%20Laboratoryacquired%20lethal%20infections%20by%20potential%20bioweapons%20pathogens%20including%20Ebola%20in%202014%20FEMS%20Microbiol%20Lett%20201536216PubMedCrossRefGoogle%20Scholar"
        },
        {
            "id": "59",
            "alt_id": "Kugeler_et+al_2015_a",
            "entry": "59. Kugeler KJ, Staples JE, Hinckley AF, Gage KL, Mead PS. Epidemiology of human plague in the United States, 1900\u20132012. Emerg Infect Dis. 2015;21:16\u201322.PubMedPubMedCentralCrossRefGoogle Scholar",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Kugeler%20KJ%20Staples%20JE%20Hinckley%20AF%20Gage%20KL%20Mead%20PS%20Epidemiology%20of%20human%20plague%20in%20the%20United%20States%2019002012%20Emerg%20Infect%20Dis%202015211622PubMedPubMedCentralCrossRefGoogle%20Scholar",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=Kugeler%20KJ%20Staples%20JE%20Hinckley%20AF%20Gage%20KL%20Mead%20PS%20Epidemiology%20of%20human%20plague%20in%20the%20United%20States%2019002012%20Emerg%20Infect%20Dis%202015211622PubMedPubMedCentralCrossRefGoogle%20Scholar",
            "scite": "https://sandbox-api.scholarcy.com/scite_url?query=Kugeler%20KJ%20Staples%20JE%20Hinckley%20AF%20Gage%20KL%20Mead%20PS%20Epidemiology%20of%20human%20plague%20in%20the%20United%20States%2019002012%20Emerg%20Infect%20Dis%202015211622PubMedPubMedCentralCrossRefGoogle%20Scholar"
        },
        {
            "id": "60",
            "alt_id": "Forrester_et+al_2017_a",
            "entry": "60. Forrester JD, Apangu T, Griffith K, et al. Patterns of human plague in Uganda, 2008\u20132016. Emerg Infect Dis. 2017;23:1517\u201321.PubMedPubMedCentralCrossRefGoogle Scholar",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Forrester%20JD%20Apangu%20T%20Griffith%20K%20et%20al%20Patterns%20of%20human%20plague%20in%20Uganda%2020082016%20Emerg%20Infect%20Dis%20201723151721PubMedPubMedCentralCrossRefGoogle%20Scholar"
        },
        {
            "id": "61",
            "alt_id": "Hull_et+al_1987_a",
            "entry": "61. Hull HF, Montes JM, Mann JM. Septicemic plague in New Mexico. J Infect Dis. 1987;155:113\u20138.PubMedCrossRefGoogle Scholar",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Hull%2C%20H.F.%20Montes%2C%20J.M.%20Mann%2C%20J.M.%20Septicemic%20plague%20in%20New%20Mexico%201987",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=Hull%2C%20H.F.%20Montes%2C%20J.M.%20Mann%2C%20J.M.%20Septicemic%20plague%20in%20New%20Mexico%201987",
            "scite": "https://sandbox-api.scholarcy.com/scite_url?query=Hull%2C%20H.F.%20Montes%2C%20J.M.%20Mann%2C%20J.M.%20Septicemic%20plague%20in%20New%20Mexico%201987"
        },
        {
            "id": "62",
            "alt_id": "Tourdjman_et+al_2012_a",
            "entry": "62. Tourdjman M, Ibraheem M, Brett M, et al. Misidentification of Yersinia pestis by automated systems, resulting in delayed diagnoses of human plague infections--Oregon and New Mexico, 2010\u20132011. Clin Infect Dis. 2012;55:e58\u201360.PubMedCrossRefGoogle Scholar",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Tourdjman%20M%20Ibraheem%20M%20Brett%20M%20et%20al%20Misidentification%20of%20Yersinia%20pestis%20by%20automated%20systems%20resulting%20in%20delayed%20diagnoses%20of%20human%20plague%20infectionsOregon%20and%20New%20Mexico%2020102011%20Clin%20Infect%20Dis%20201255e5860PubMedCrossRefGoogle%20Scholar",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=Tourdjman%20M%20Ibraheem%20M%20Brett%20M%20et%20al%20Misidentification%20of%20Yersinia%20pestis%20by%20automated%20systems%20resulting%20in%20delayed%20diagnoses%20of%20human%20plague%20infectionsOregon%20and%20New%20Mexico%2020102011%20Clin%20Infect%20Dis%20201255e5860PubMedCrossRefGoogle%20Scholar",
            "scite": "https://sandbox-api.scholarcy.com/scite_url?query=Tourdjman%20M%20Ibraheem%20M%20Brett%20M%20et%20al%20Misidentification%20of%20Yersinia%20pestis%20by%20automated%20systems%20resulting%20in%20delayed%20diagnoses%20of%20human%20plague%20infectionsOregon%20and%20New%20Mexico%2020102011%20Clin%20Infect%20Dis%20201255e5860PubMedCrossRefGoogle%20Scholar"
        },
        {
            "id": "63",
            "alt_id": "Demeure_et+al_2019_a",
            "entry": "63. Demeure CE, Dussurget O, Mas Fiol G, Le Guern AS, Savin C, Pizarro-Cerda J. Yersinia pestis and plague: an updated view on evolution, virulence determinants, immune subversion, vaccination, and diagnostics. Genes Immun. 2019;20:357.PubMedPubMedCentralCrossRefGoogle Scholar",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Demeure%2C%20C.E.%20Dussurget%2C%20O.%20Mas%20Fiol%2C%20G.%20Le%20Guern%2C%20A.S.%20Yersinia%20pestis%20and%20plague%3A%20an%20updated%20view%20on%20evolution%2C%20virulence%20determinants%2C%20immune%20subversion%2C%20vaccination%2C%20and%20diagnostics%202019",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=Demeure%2C%20C.E.%20Dussurget%2C%20O.%20Mas%20Fiol%2C%20G.%20Le%20Guern%2C%20A.S.%20Yersinia%20pestis%20and%20plague%3A%20an%20updated%20view%20on%20evolution%2C%20virulence%20determinants%2C%20immune%20subversion%2C%20vaccination%2C%20and%20diagnostics%202019",
            "scite": "https://sandbox-api.scholarcy.com/scite_url?query=Demeure%2C%20C.E.%20Dussurget%2C%20O.%20Mas%20Fiol%2C%20G.%20Le%20Guern%2C%20A.S.%20Yersinia%20pestis%20and%20plague%3A%20an%20updated%20view%20on%20evolution%2C%20virulence%20determinants%2C%20immune%20subversion%2C%20vaccination%2C%20and%20diagnostics%202019"
        },
        {
            "id": "64",
            "alt_id": "Koirala_2006_a",
            "entry": "64. Koirala J. Plague: disease, management, and recognition of act of terrorism. Infect Dis Clin N Am. 2006;20:273\u201387, viii.CrossRefGoogle Scholar",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Koirala%2C%20J.%20Plague%3A%20disease%2C%20management%2C%20and%20recognition%20of%20act%20of%20terrorism%202006",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=Koirala%2C%20J.%20Plague%3A%20disease%2C%20management%2C%20and%20recognition%20of%20act%20of%20terrorism%202006",
            "scite": "https://sandbox-api.scholarcy.com/scite_url?query=Koirala%2C%20J.%20Plague%3A%20disease%2C%20management%2C%20and%20recognition%20of%20act%20of%20terrorism%202006"
        },
        {
            "id": "65",
            "alt_id": "Mwengee_et+al_2006_a",
            "entry": "65. Mwengee W, Butler T, Mgema S, Mhina G, Almasi Y, Bradley C, Formanik JB, Rochester CG. Treatment of plague with gentamicin or doxycycline in a randomized clinical trial in Tanzania. Clin Infect Dis. 2006;42(5):614\u201321.PubMedCrossRefGoogle Scholar",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Mwengee%2C%20W.%20Butler%2C%20T.%20Mgema%2C%20S.%20Mhina%2C%20G.%20Treatment%20of%20plague%20with%20gentamicin%20or%20doxycycline%20in%20a%20randomized%20clinical%20trial%20in%20Tanzania%202006",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=Mwengee%2C%20W.%20Butler%2C%20T.%20Mgema%2C%20S.%20Mhina%2C%20G.%20Treatment%20of%20plague%20with%20gentamicin%20or%20doxycycline%20in%20a%20randomized%20clinical%20trial%20in%20Tanzania%202006",
            "scite": "https://sandbox-api.scholarcy.com/scite_url?query=Mwengee%2C%20W.%20Butler%2C%20T.%20Mgema%2C%20S.%20Mhina%2C%20G.%20Treatment%20of%20plague%20with%20gentamicin%20or%20doxycycline%20in%20a%20randomized%20clinical%20trial%20in%20Tanzania%202006"
        },
        {
            "id": "66",
            "alt_id": "Russell_et+al_1998_a",
            "entry": "66. Russell P, Eley SM, Green M, et al. Efficacy of doxycycline and ciprofloxacin against experimental Yersinia pestis infection. J Antimicrob Chemother. 1998;41:301\u20135.PubMedCrossRefGoogle Scholar",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Russell%2C%20P.%20Eley%2C%20S.M.%20Green%2C%20M.%20Efficacy%20of%20doxycycline%20and%20ciprofloxacin%20against%20experimental%20Yersinia%20pestis%20infection%201998",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=Russell%2C%20P.%20Eley%2C%20S.M.%20Green%2C%20M.%20Efficacy%20of%20doxycycline%20and%20ciprofloxacin%20against%20experimental%20Yersinia%20pestis%20infection%201998",
            "scite": "https://sandbox-api.scholarcy.com/scite_url?query=Russell%2C%20P.%20Eley%2C%20S.M.%20Green%2C%20M.%20Efficacy%20of%20doxycycline%20and%20ciprofloxacin%20against%20experimental%20Yersinia%20pestis%20infection%201998"
        },
        {
            "id": "67",
            "alt_id": "Steward_et+al_2004_a",
            "entry": "67. Steward J, Lever MS, Russell P, et al. Efficacy of the latest fluoroquinolones against experimental Yersinia pestis. Int J Antimicrob Agents. 2004;24:609\u201312.PubMedCrossRefGoogle Scholar",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Steward%2C%20J.%20Lever%2C%20M.S.%20Russell%2C%20P.%20Efficacy%20of%20the%20latest%20fluoroquinolones%20against%20experimental%20Yersinia%20pestis%202004",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=Steward%2C%20J.%20Lever%2C%20M.S.%20Russell%2C%20P.%20Efficacy%20of%20the%20latest%20fluoroquinolones%20against%20experimental%20Yersinia%20pestis%202004",
            "scite": "https://sandbox-api.scholarcy.com/scite_url?query=Steward%2C%20J.%20Lever%2C%20M.S.%20Russell%2C%20P.%20Efficacy%20of%20the%20latest%20fluoroquinolones%20against%20experimental%20Yersinia%20pestis%202004"
        },
        {
            "id": "68",
            "alt_id": "Heine_et+al_2015_a",
            "entry": "68. Heine HS, Hershfield J, Marchand C, et al. In vitro antibiotic susceptibilities of Yersinia pestis determined by broth microdilution following CLSI methods. Antimicrob Agents Chemother. 2015;59:1919\u201321.PubMedPubMedCentralCrossRefGoogle Scholar",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Heine%2C%20H.S.%20Hershfield%2C%20J.%20Marchand%2C%20C.%20In%20vitro%20antibiotic%20susceptibilities%20of%20Yersinia%20pestis%20determined%20by%20broth%20microdilution%20following%20CLSI%20methods%202015",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=Heine%2C%20H.S.%20Hershfield%2C%20J.%20Marchand%2C%20C.%20In%20vitro%20antibiotic%20susceptibilities%20of%20Yersinia%20pestis%20determined%20by%20broth%20microdilution%20following%20CLSI%20methods%202015",
            "scite": "https://sandbox-api.scholarcy.com/scite_url?query=Heine%2C%20H.S.%20Hershfield%2C%20J.%20Marchand%2C%20C.%20In%20vitro%20antibiotic%20susceptibilities%20of%20Yersinia%20pestis%20determined%20by%20broth%20microdilution%20following%20CLSI%20methods%202015"
        },
        {
            "id": "69",
            "alt_id": "Wendte_et+al_2011_a",
            "entry": "69. Wendte JM, Ponnusamy D, Reiber D, Blair JL, Clinkenbeard KD. In vitro efficacy of antibiotics commonly used to treat human plague against intracellular Yersinia pestis. Antimicrob Agents Chemother. 2011;55:3752\u20137.PubMedPubMedCentralCrossRefGoogle Scholar",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Wendte%2C%20J.M.%20Ponnusamy%2C%20D.%20Reiber%2C%20D.%20Blair%2C%20J.L.%20In%20vitro%20efficacy%20of%20antibiotics%20commonly%20used%20to%20treat%20human%20plague%20against%20intracellular%20Yersinia%20pestis%202011",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=Wendte%2C%20J.M.%20Ponnusamy%2C%20D.%20Reiber%2C%20D.%20Blair%2C%20J.L.%20In%20vitro%20efficacy%20of%20antibiotics%20commonly%20used%20to%20treat%20human%20plague%20against%20intracellular%20Yersinia%20pestis%202011",
            "scite": "https://sandbox-api.scholarcy.com/scite_url?query=Wendte%2C%20J.M.%20Ponnusamy%2C%20D.%20Reiber%2C%20D.%20Blair%2C%20J.L.%20In%20vitro%20efficacy%20of%20antibiotics%20commonly%20used%20to%20treat%20human%20plague%20against%20intracellular%20Yersinia%20pestis%202011"
        },
        {
            "id": "70",
            "alt_id": "Levy_et+al_2016_a",
            "entry": "70. Levy Y, Vagima Y, Tidhar A, et al. Adjunctive corticosteroid treatment against Yersinia pestis improves bacterial clearance, immunopathology, and survival in the mouse model of bubonic plague. J Infect Dis. 2016;214:970\u20137.PubMedCrossRefPubMedCentralGoogle Scholar",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Levy%2C%20Y.%20Vagima%2C%20Y.%20Tidhar%2C%20A.%20Adjunctive%20corticosteroid%20treatment%20against%20Yersinia%20pestis%20improves%20bacterial%20clearance%2C%20immunopathology%2C%20and%20survival%20in%20the%20mouse%20model%20of%20bubonic%20plague%202016",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=Levy%2C%20Y.%20Vagima%2C%20Y.%20Tidhar%2C%20A.%20Adjunctive%20corticosteroid%20treatment%20against%20Yersinia%20pestis%20improves%20bacterial%20clearance%2C%20immunopathology%2C%20and%20survival%20in%20the%20mouse%20model%20of%20bubonic%20plague%202016",
            "scite": "https://sandbox-api.scholarcy.com/scite_url?query=Levy%2C%20Y.%20Vagima%2C%20Y.%20Tidhar%2C%20A.%20Adjunctive%20corticosteroid%20treatment%20against%20Yersinia%20pestis%20improves%20bacterial%20clearance%2C%20immunopathology%2C%20and%20survival%20in%20the%20mouse%20model%20of%20bubonic%20plague%202016"
        },
        {
            "id": "71",
            "alt_id": "Heine_et+al_2014_a",
            "entry": "71. Heine HS, Louie A, Adamovicz JJ, et al. Evaluation of imipenem for prophylaxis and therapy of Yersinia pestis delivered by aerosol in a mouse model of pneumonic plague. Antimicrob Agents Chemother. 2014;58:3276\u201384.PubMedPubMedCentralCrossRefGoogle Scholar",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Heine%2C%20H.S.%20Louie%2C%20A.%20Adamovicz%2C%20J.J.%20Evaluation%20of%20imipenem%20for%20prophylaxis%20and%20therapy%20of%20Yersinia%20pestis%20delivered%20by%20aerosol%20in%20a%20mouse%20model%20of%20pneumonic%20plague%202014",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=Heine%2C%20H.S.%20Louie%2C%20A.%20Adamovicz%2C%20J.J.%20Evaluation%20of%20imipenem%20for%20prophylaxis%20and%20therapy%20of%20Yersinia%20pestis%20delivered%20by%20aerosol%20in%20a%20mouse%20model%20of%20pneumonic%20plague%202014",
            "scite": "https://sandbox-api.scholarcy.com/scite_url?query=Heine%2C%20H.S.%20Louie%2C%20A.%20Adamovicz%2C%20J.J.%20Evaluation%20of%20imipenem%20for%20prophylaxis%20and%20therapy%20of%20Yersinia%20pestis%20delivered%20by%20aerosol%20in%20a%20mouse%20model%20of%20pneumonic%20plague%202014"
        },
        {
            "id": "72",
            "alt_id": "Inglesby_et+al_2000_b",
            "entry": "72. Inglesby TV, Henderson DA, O\u2019Toole T, Dennis DT. Safety precautions to limit exposure from plague-infected patients. JAMA. 2000;284:1648\u20139.PubMedCrossRefPubMedCentralGoogle Scholar",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Inglesby%2C%20T.V.%20Henderson%2C%20D.A.%20O%E2%80%99Toole%2C%20T.%20Dennis%2C%20D.T.%20Safety%20precautions%20to%20limit%20exposure%20from%20plague-infected%20patients%202000",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=Inglesby%2C%20T.V.%20Henderson%2C%20D.A.%20O%E2%80%99Toole%2C%20T.%20Dennis%2C%20D.T.%20Safety%20precautions%20to%20limit%20exposure%20from%20plague-infected%20patients%202000",
            "scite": "https://sandbox-api.scholarcy.com/scite_url?query=Inglesby%2C%20T.V.%20Henderson%2C%20D.A.%20O%E2%80%99Toole%2C%20T.%20Dennis%2C%20D.T.%20Safety%20precautions%20to%20limit%20exposure%20from%20plague-infected%20patients%202000"
        },
        {
            "id": "73",
            "alt_id": "Siegel_et+al_2007_a",
            "entry": "73. Siegel JD, Rhinehart E, Jackson M, Chiarello L, the Healthcare infection Control Practices Advisory Committee. 2007 Guideline for isolation precautions: preventing transmission of infectious agents in healthcare settings. Atlanta: Centers for Disease Control and Prevention; 2007.Google Scholar",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Siegel%20JD%20Rhinehart%20E%20Jackson%20M%20Chiarello%20L%20the%20Healthcare%20infection%20Control%20Practices%20Advisory%20Committee%202007%20Guideline%20for%20isolation%20precautions%20preventing%20transmission%20of%20infectious%20agents%20in%20healthcare%20settings%20Atlanta%20Centers%20for%20Disease%20Control%20and%20Prevention%202007Google%20Scholar",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=Siegel%20JD%20Rhinehart%20E%20Jackson%20M%20Chiarello%20L%20the%20Healthcare%20infection%20Control%20Practices%20Advisory%20Committee%202007%20Guideline%20for%20isolation%20precautions%20preventing%20transmission%20of%20infectious%20agents%20in%20healthcare%20settings%20Atlanta%20Centers%20for%20Disease%20Control%20and%20Prevention%202007Google%20Scholar",
            "scite": "https://sandbox-api.scholarcy.com/scite_url?query=Siegel%20JD%20Rhinehart%20E%20Jackson%20M%20Chiarello%20L%20the%20Healthcare%20infection%20Control%20Practices%20Advisory%20Committee%202007%20Guideline%20for%20isolation%20precautions%20preventing%20transmission%20of%20infectious%20agents%20in%20healthcare%20settings%20Atlanta%20Centers%20for%20Disease%20Control%20and%20Prevention%202007Google%20Scholar"
        },
        {
            "id": "74",
            "alt_id": "Hepburn_2008_a",
            "entry": "74. Hepburn MJ, Simpson AJ. Tularemia: current diagnosis and treatment options. Expert Rev Anti-Infect Ther. 2008;6:231\u201340.PubMedCrossRefPubMedCentralGoogle Scholar",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Hepburn%2C%20M.J.%20Simpson%2C%20A.J.%20Tularemia%3A%20current%20diagnosis%20and%20treatment%20options%202008",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=Hepburn%2C%20M.J.%20Simpson%2C%20A.J.%20Tularemia%3A%20current%20diagnosis%20and%20treatment%20options%202008",
            "scite": "https://sandbox-api.scholarcy.com/scite_url?query=Hepburn%2C%20M.J.%20Simpson%2C%20A.J.%20Tularemia%3A%20current%20diagnosis%20and%20treatment%20options%202008"
        },
        {
            "id": "75",
            "alt_id": "Balali-Mood_et+al_2013_a",
            "entry": "75. Balali-Mood M, Moshiri M, Etemad L. Medical aspects of bio-terrorism. Toxicon. 2013;69:131\u201342.PubMedCrossRefPubMedCentralGoogle Scholar",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Balali-Mood%2C%20M.%20Moshiri%2C%20M.%20Etemad%2C%20L.%20Medical%20aspects%20of%20bio-terrorism.%20Toxicon%202013"
        },
        {
            "id": "76",
            "alt_id": "76._2013_a",
            "entry": "76. Centers for Disease C, Prevention. Tularemia\u00a0\u2013 United States, 2001\u20132010. MMWR Morb Mortal Wkly Rep. 2013;62:963\u20136.Google Scholar",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Centers%20for%20Disease%20C%20Prevention%20Tularemia%C2%A0%20United%20States%2020012010%20MMWR%20Morb%20Mortal%20Wkly%20Rep%202013629636Google%20Scholar",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=Centers%20for%20Disease%20C%20Prevention%20Tularemia%C2%A0%20United%20States%2020012010%20MMWR%20Morb%20Mortal%20Wkly%20Rep%202013629636Google%20Scholar",
            "scite": "https://sandbox-api.scholarcy.com/scite_url?query=Centers%20for%20Disease%20C%20Prevention%20Tularemia%C2%A0%20United%20States%2020012010%20MMWR%20Morb%20Mortal%20Wkly%20Rep%202013629636Google%20Scholar"
        },
        {
            "id": "77",
            "alt_id": "Maurin_2016_a",
            "entry": "77. Maurin M, Gyuranecz M. Tularaemia: clinical aspects in Europe. Lancet Infect Dis. 2016;16:113\u201324.PubMedCrossRefGoogle Scholar",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Maurin%2C%20M.%20Gyuranecz%2C%20M.%20Tularaemia%3A%20clinical%20aspects%20in%20Europe.%20Lancet%20Infect%20Dis%202016"
        },
        {
            "id": "78",
            "alt_id": "Vayrynen_et+al_2017_a",
            "entry": "78. Vayrynen SA, Saarela E, Henry J, Lahti S, Harju T, Kauma H. Pneumonic tularaemia: experience of 58 cases from 2000 to 2012 in Northern Finland. Infect Dis (Lond). 2017;49:758\u201364.CrossRefGoogle Scholar",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Vayrynen%20SA%20Saarela%20E%20Henry%20J%20Lahti%20S%20Harju%20T%20Kauma%20H%20Pneumonic%20tularaemia%20experience%20of%2058%20cases%20from%202000%20to%202012%20in%20Northern%20Finland%20Infect%20Dis%20Lond%2020174975864CrossRefGoogle%20Scholar",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=Vayrynen%20SA%20Saarela%20E%20Henry%20J%20Lahti%20S%20Harju%20T%20Kauma%20H%20Pneumonic%20tularaemia%20experience%20of%2058%20cases%20from%202000%20to%202012%20in%20Northern%20Finland%20Infect%20Dis%20Lond%2020174975864CrossRefGoogle%20Scholar",
            "scite": "https://sandbox-api.scholarcy.com/scite_url?query=Vayrynen%20SA%20Saarela%20E%20Henry%20J%20Lahti%20S%20Harju%20T%20Kauma%20H%20Pneumonic%20tularaemia%20experience%20of%2058%20cases%20from%202000%20to%202012%20in%20Northern%20Finland%20Infect%20Dis%20Lond%2020174975864CrossRefGoogle%20Scholar"
        },
        {
            "id": "79",
            "alt_id": "Dennis_et+al_2001_a",
            "entry": "79. Dennis DT, Inglesby TV, Henderson DA, et al. Tularemia as a biological weapon: medical and public health management. JAMA. 2001;285:2763\u201373.PubMedCrossRefGoogle Scholar",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Dennis%2C%20D.T.%20Inglesby%2C%20T.V.%20Henderson%2C%20D.A.%20Tularemia%20as%20a%20biological%20weapon%3A%20medical%20and%20public%20health%20management%202001",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=Dennis%2C%20D.T.%20Inglesby%2C%20T.V.%20Henderson%2C%20D.A.%20Tularemia%20as%20a%20biological%20weapon%3A%20medical%20and%20public%20health%20management%202001",
            "scite": "https://sandbox-api.scholarcy.com/scite_url?query=Dennis%2C%20D.T.%20Inglesby%2C%20T.V.%20Henderson%2C%20D.A.%20Tularemia%20as%20a%20biological%20weapon%3A%20medical%20and%20public%20health%20management%202001"
        },
        {
            "id": "80",
            "alt_id": "Rubin_1978_a",
            "entry": "80. Rubin SA. Radiographic spectrum of pleuropulmonary tularemia. AJR Am J Roentgenol. 1978;131:277\u201381.PubMedCrossRefGoogle Scholar",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Rubin%2C%20S.A.%20Radiographic%20spectrum%20of%20pleuropulmonary%20tularemia%201978",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=Rubin%2C%20S.A.%20Radiographic%20spectrum%20of%20pleuropulmonary%20tularemia%201978",
            "scite": "https://sandbox-api.scholarcy.com/scite_url?query=Rubin%2C%20S.A.%20Radiographic%20spectrum%20of%20pleuropulmonary%20tularemia%201978"
        },
        {
            "id": "81",
            "alt_id": "Yanes_et+al_2018_a",
            "entry": "81. Yanes H, Hennebique A, Pelloux I, et al. Evaluation of in-house and commercial serological tests for diagnosis of human tularemia. J Clin Microbiol. 2018;56.Google Scholar",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Yanes%2C%20H.%20Hennebique%2C%20A.%20Pelloux%2C%20I.%20Evaluation%20of%20in-house%20and%20commercial%20serological%20tests%20for%20diagnosis%20of%20human%20tularemia%202018",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=Yanes%2C%20H.%20Hennebique%2C%20A.%20Pelloux%2C%20I.%20Evaluation%20of%20in-house%20and%20commercial%20serological%20tests%20for%20diagnosis%20of%20human%20tularemia%202018",
            "scite": "https://sandbox-api.scholarcy.com/scite_url?query=Yanes%2C%20H.%20Hennebique%2C%20A.%20Pelloux%2C%20I.%20Evaluation%20of%20in-house%20and%20commercial%20serological%20tests%20for%20diagnosis%20of%20human%20tularemia%202018"
        },
        {
            "id": "82",
            "alt_id": "Chaignat_et+al_2014_a",
            "entry": "82. Chaignat V, Djordjevic-Spasic M, Ruettger A, et al. Performance of seven serological assays for diagnosing tularemia. BMC Infect Dis. 2014;14:234.PubMedPubMedCentralCrossRefGoogle Scholar",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Chaignat%2C%20V.%20Djordjevic-Spasic%2C%20M.%20Ruettger%2C%20A.%20Performance%20of%20seven%20serological%20assays%20for%20diagnosing%20tularemia%202014",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=Chaignat%2C%20V.%20Djordjevic-Spasic%2C%20M.%20Ruettger%2C%20A.%20Performance%20of%20seven%20serological%20assays%20for%20diagnosing%20tularemia%202014",
            "scite": "https://sandbox-api.scholarcy.com/scite_url?query=Chaignat%2C%20V.%20Djordjevic-Spasic%2C%20M.%20Ruettger%2C%20A.%20Performance%20of%20seven%20serological%20assays%20for%20diagnosing%20tularemia%202014"
        },
        {
            "id": "83",
            "alt_id": "Kilic_et+al_2012_a",
            "entry": "83. Kilic S, Celebi B, Yesilyurt M. Evaluation of a commercial immunochromatographic assay for the serologic diagnosis of tularemia. Diagn Microbiol Infect Dis. 2012;74:1\u20135.PubMedCrossRefGoogle Scholar",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Kilic%2C%20S.%20Celebi%2C%20B.%20Yesilyurt%2C%20M.%20Evaluation%20of%20a%20commercial%20immunochromatographic%20assay%20for%20the%20serologic%20diagnosis%20of%20tularemia%202012",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=Kilic%2C%20S.%20Celebi%2C%20B.%20Yesilyurt%2C%20M.%20Evaluation%20of%20a%20commercial%20immunochromatographic%20assay%20for%20the%20serologic%20diagnosis%20of%20tularemia%202012",
            "scite": "https://sandbox-api.scholarcy.com/scite_url?query=Kilic%2C%20S.%20Celebi%2C%20B.%20Yesilyurt%2C%20M.%20Evaluation%20of%20a%20commercial%20immunochromatographic%20assay%20for%20the%20serologic%20diagnosis%20of%20tularemia%202012"
        },
        {
            "id": "84",
            "alt_id": "Gunnell_et+al_2012_a",
            "entry": "84. Gunnell MK, Lovelace CD, Satterfield BA, Moore EA, O\u2019Neill KL, Robison RA. A multiplex real-time PCR assay for the detection and differentiation of Francisella tularensis subspecies. J Med Microbiol. 2012;61:1525\u201331.PubMedCrossRefGoogle Scholar",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Gunnell%2C%20M.K.%20Lovelace%2C%20C.D.%20Satterfield%2C%20B.A.%20Moore%2C%20E.A.%20A%20multiplex%20real-time%20PCR%20assay%20for%20the%20detection%20and%20differentiation%20of%20Francisella%20tularensis%20subspecies%202012",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=Gunnell%2C%20M.K.%20Lovelace%2C%20C.D.%20Satterfield%2C%20B.A.%20Moore%2C%20E.A.%20A%20multiplex%20real-time%20PCR%20assay%20for%20the%20detection%20and%20differentiation%20of%20Francisella%20tularensis%20subspecies%202012",
            "scite": "https://sandbox-api.scholarcy.com/scite_url?query=Gunnell%2C%20M.K.%20Lovelace%2C%20C.D.%20Satterfield%2C%20B.A.%20Moore%2C%20E.A.%20A%20multiplex%20real-time%20PCR%20assay%20for%20the%20detection%20and%20differentiation%20of%20Francisella%20tularensis%20subspecies%202012"
        },
        {
            "id": "85",
            "alt_id": "Yapar_et+al_2016_a",
            "entry": "85. Yapar D, Erenler AK, Terzi O, Akdogan O, Ece Y, Baykam N. Predicting tularemia with clinical, laboratory and demographical findings in the ED. Am J Emerg Med. 2016;34:218\u201321.PubMedCrossRefGoogle Scholar",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Yapar%2C%20D.%20Erenler%2C%20A.K.%20Terzi%2C%20O.%20Akdogan%2C%20O.%20Predicting%20tularemia%20with%20clinical%2C%20laboratory%20and%20demographical%20findings%20in%20the%202016",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=Yapar%2C%20D.%20Erenler%2C%20A.K.%20Terzi%2C%20O.%20Akdogan%2C%20O.%20Predicting%20tularemia%20with%20clinical%2C%20laboratory%20and%20demographical%20findings%20in%20the%202016",
            "scite": "https://sandbox-api.scholarcy.com/scite_url?query=Yapar%2C%20D.%20Erenler%2C%20A.K.%20Terzi%2C%20O.%20Akdogan%2C%20O.%20Predicting%20tularemia%20with%20clinical%2C%20laboratory%20and%20demographical%20findings%20in%20the%202016"
        },
        {
            "id": "86",
            "alt_id": "Mulligan_et+al_2017_a",
            "entry": "86. Mulligan MJ, Stapleton JT, Keitel WA, et al. Tularemia vaccine: safety, reactogenicity, \u201cTake\u201d skin reactions, and antibody responses following vaccination with a new lot of the Francisella tularensis live vaccine strain\u00a0\u2013 a phase 2 randomized clinical Trial. Vaccine. 2017;35:4730\u20137.PubMedPubMedCentralCrossRefGoogle Scholar",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Mulligan%2C%20M.J.%20Stapleton%2C%20J.T.%20Keitel%2C%20W.A.%20Tularemia%20vaccine%3A%20safety%2C%20reactogenicity%2C%20%E2%80%9CTake%E2%80%9D%20skin%20reactions%2C%20and%20antibody%20responses%20following%20vaccination%20with%20a%20new%20lot%20of%20the%20Francisella%20tularensis%20live%20vaccine%20strain%20%E2%80%93%20a%20phase%202%20randomized%20clinical%20Trial.%20Vaccine%202017"
        },
        {
            "id": "87",
            "alt_id": "Todd_et+al_2015_a",
            "entry": "87. Todd SR, Dahlgren FS, Traeger MS, Beltr\u00e1n-Aguilar ED, Marianos DW, Hamilton C, McQuiston JH, Regan JJ. No visible dental staining in children treated with doxycycline for suspected Rocky Mountain spotted fever. J Pediatr. 2015;16e(5):1246\u201351.CrossRefGoogle Scholar",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Todd%2C%20SR%2C%20Dahlgren%20FS%2C%20Traeger%20MS%2C%20Beltr%C3%A1n-Aguilar%20ED%2C%20Marianos%20No%20visible%20dental%20staining%20in%20children%20treated%20with%20doxycycline%20for%20suspected%20Rocky%20Mountain%20spotted%20fever%202015",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=Todd%2C%20SR%2C%20Dahlgren%20FS%2C%20Traeger%20MS%2C%20Beltr%C3%A1n-Aguilar%20ED%2C%20Marianos%20No%20visible%20dental%20staining%20in%20children%20treated%20with%20doxycycline%20for%20suspected%20Rocky%20Mountain%20spotted%20fever%202015",
            "scite": "https://sandbox-api.scholarcy.com/scite_url?query=Todd%2C%20SR%2C%20Dahlgren%20FS%2C%20Traeger%20MS%2C%20Beltr%C3%A1n-Aguilar%20ED%2C%20Marianos%20No%20visible%20dental%20staining%20in%20children%20treated%20with%20doxycycline%20for%20suspected%20Rocky%20Mountain%20spotted%20fever%202015"
        },
        {
            "id": "88",
            "alt_id": "Boulanger_et+al_2004_a",
            "entry": "88. Boulanger LL, Ettestad P, Fogarty JD, Dennis DT, Romig D, Mertz G. Gentamicin and tetracyclines for the treatment of human plague: review of 75 cases in New Mexico, 1985\u20131999. Clin Infect Dis. 2004;38(5):663\u20139.PubMedCrossRefGoogle Scholar ",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Boulanger%20LL%20Ettestad%20P%20Fogarty%20JD%20Dennis%20DT%20Romig%20D%20Mertz%20G%20Gentamicin%20and%20tetracyclines%20for%20the%20treatment%20of%20human%20plague%20review%20of%2075%20cases%20in%20New%20Mexico%2019851999%20Clin%20Infect%20Dis%2020043856639PubMedCrossRefGoogle%20Scholar",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=Boulanger%20LL%20Ettestad%20P%20Fogarty%20JD%20Dennis%20DT%20Romig%20D%20Mertz%20G%20Gentamicin%20and%20tetracyclines%20for%20the%20treatment%20of%20human%20plague%20review%20of%2075%20cases%20in%20New%20Mexico%2019851999%20Clin%20Infect%20Dis%2020043856639PubMedCrossRefGoogle%20Scholar",
            "scite": "https://sandbox-api.scholarcy.com/scite_url?query=Boulanger%20LL%20Ettestad%20P%20Fogarty%20JD%20Dennis%20DT%20Romig%20D%20Mertz%20G%20Gentamicin%20and%20tetracyclines%20for%20the%20treatment%20of%20human%20plague%20review%20of%2075%20cases%20in%20New%20Mexico%2019851999%20Clin%20Infect%20Dis%2020043856639PubMedCrossRefGoogle%20Scholar"
        }
    ],
    "facts": [
        "Bacterial zoonotic infections are rare in developed countries in the twenty-first century",
        "only plague has a risk of direct human-to-human transmission",
        "Empiric therapy with aminoglycosides may be life-saving for plague and tularemia",
        "a fluoroquinolone is recommended for all three diseases",
        "et al Evaluation of imipenem for prophylaxis and therapy of Yersinia pestis delivered by aerosol in a mouse model"
    ],
    "claims": [],
    "findings": [],
    "processes": [],
    "key_statements": [
        "Bacterial zoonotic infections are rare in developed countries in the twenty-first century but may cause major morbidity and mortality in developing regions of the world",
        "All three may be transmitted as infectious aerosols, only plague has a risk of direct human-to-human transmission",
        "Empiric therapy with aminoglycosides may be life-saving for plague and tularemia, while the treatment of anthrax is complex and varies depending on the site of infection",
        "In outbreaks or for post-exposure prophylaxis, treatment with doxycycline or a fluoroquinolone is recommended for all three diseases",
        "Heine HS, Louie A, Adamovicz JJ, et al Evaluation of imipenem for prophylaxis and therapy of Yersinia pestis delivered by aerosol in a mouse model of pneumonic plague"
    ],
    "top_statements": [
        "Bacterial zoonotic infections are rare in developed countries in the twenty-first century but may cause major morbidity and mortality in developing regions of the world",
        "All three may be transmitted as infectious aerosols, only plague has a risk of direct human-to-human transmission",
        "Empiric therapy with aminoglycosides may be life-saving for plague and tularemia, while the treatment of anthrax is complex and varies depending on the site of infection",
        "In outbreaks or for post-exposure prophylaxis, treatment with doxycycline or a fluoroquinolone is recommended for all three diseases",
        "Heine HS, Louie A, Adamovicz JJ, et al Evaluation of imipenem for prophylaxis and therapy of Yersinia pestis delivered by aerosol in a mouse model of pneumonic plague"
    ],
    "headline": "Bacterial zoonotic infections are rare in developed countries in the twenty-first century but may cause major morbidity and mortality in developing regions of the world",
    "contexts": [],
    "abbreviations": {
        "AIGIV": "anthrax immune globulin intravenous"
    }
}
